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ABSTRACT
The neurons in hippocampal subfield CA3 contain corticosteroid mineralocorticoid
(MR) and glucocorticoid (GR) receptors. The neurons in subfield CA3 have a critical
role in hippocampal neural signal processing, yet very little is known about the effects
of corticosteroids on neural activity in this subfield. Therefore, the actions of chronic
corticosteroid treatment on neuron membrane electrical properties and the 5-HT 1A
receptor system (receptor-G protein-potassium channel) were examined in rat
hippocampal subfield CA3 pyramidal cells. The treatment groups used in these
investigations were: adrenalectomy, MR activation with aldosterone or low levels of
corticosterone, MR and GR activation with high levels of corticosterone, and sham.
Based on intracellular recording experiments, corticosteroid treatment altered the
percentage of nonburst and burst firing neurons. There was a higher percentage of
nonbursting cells from adrenalectomized animals compared to aldosterone and sham
treated animals. The action potential duration was also longer in cells from
adrenalectomized compared to cells from high corticosterone and aldosterone treated
animals.
Corticosteroids altered the 5-HT concentration-response curve characteristics for
the 5-HT lA receptor. The ECso value was smaller in cells from adrenalectomized
animals compared to the other treatment groups. The Emax value was smaller in cells
IV

from animals treated with high corticosterone levels compared to sham and
adrenalectomized animals. G protein function was also altered by corticosterone
treatment. G protein activation elicited a smaller current in cells from high
corticosterone treated animals compared to the other treatment groups and in cells
from sham compared to adrenalectomized animals.
Western blot and immunohistochemistry techniques were used to determine the
effects of corticosterone on G protein levels and distribution in the hippocampus.
Treatment with high concentrations of corticosterone increased the levels of Gs, Gil and 2
and Go a-subunits when compared to sham. Adrenalectomy had no effect on Gs,

Gil and 2 or Go a-subunits levels. No change in the intracellular location of G protein
a-subunits was detected using immunohistochemistry.
This dissertation work has demonstrated that corticosteroids alter neuron electrical
membrane properties and the 5-HT IA receptor signal transduction system in
hippocampal subfield CA3 neurons.
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CHAPTER I
INTRODUCTION
Corticosteroids are steroid hormones that maintain energy, ion, and endocrine
homeostasis (de Kloet, 1991; Henkin, 1970; Munck et al., 1984). There are two classes
of corticosteroids: glucocorticoids and mineralocorticoids. Glucocorticoids regulate
glucose metabolism while mineralocorticoids maintain ion homeostasis (reviewed by
Dallman et al., 1987, 1994; de Kloet, 1991; Tempel and Leibowitz, 1994).
Corticosterone is the principal glucocorticoid in rats while in man the principal
glucocorticoid is cortisol. Aldosterone is the principal mineralocorticoid in both man and
rats.
Corticosteroids regulate gene expression through the interaction with two receptor
subtypes: mineralocorticoid receptor (MR) and glucocorticoid receptor (GR). MR has
a high affinity for corticosterone, Kn = 0. 5 - 0. 7 nM, and aldosterone (Krozowski and
Funder, 1983; Reul and de Kloet, 1985). GR has a lower affinity for corticosterone,
Kn= 2.5 - 5 nM and aldosterone (Krozowski and Funder; 1983; Reul and de Kloet,
1985).
The synthesis and release of corticosteroids are regulated by the hypothalamicpituitary-adrenal axis (HP A) (reviewed by Feldman and Weidenfeld, 1995). In response
to various stimuli, paraventricular (PVN) neurons in the hypothalamus release
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corticotropin releasing factor (CRF) into the portal circulation. CRF then stimulates the
synthesis and release of adrenocorticotropic hormone (ACTH) from the corticotropes in
the anterior pituitary. ACTH enters the circulatory system and drives the synthesis and
release of corticosteroids from the adrenal cortex.
There are two physiological processes that drive HP A axis activity: circadian
rhythm and stress (reviewed by Dallman et al., 1987, 1994). Corticosteroid plasma
levels are lower ( < 10 µg/dl) during hours when the animals is resting (i.e., during day
light for rats) and higher ( > 15 µg/dl) during hours when the animal is active (i.e., at
night for rats) or stressed. The relative occupation of l\1R and GR changes with
physiological fluctuations in the plasma corticosteroid levels. l\1R is 70-80% occupied at
basal physiological corticosterone plasma levels (Reul and de Kloet, 1985; Reul et al.,
1987). GR occupancy changes from 15% at basal to 90% at peak and stress circulating
corticosterone levels (Reul and de Kloet, 1985; Reul et al., 1987a,b). HPA axis activity
is regulated by higher cortical and brainstem inputs that converge at the hypothalamus
and influence CRF secretion (reviewed by Feldman and Weidenfeld, 1995). However,
corticosteroids also modulate HP A axis activity through feedback inhibition via the
activation ofl\1R and GR in the PVN, pituitary, and hippocampus (reviewed by Dallman

eta/., 1987, 1994).
The relationship between the serotonin (5-HT) system and HPA axis has been
examined in different biological states including depression (reviewed by Lesch and
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Lerer, 1991), development (reviewed by Meaney et al., 1994), and in animal strains
characterized by altered HPA activity (Burnet et al., 1994). For example, it was
demonstrated that postnatal handling of rat pups reduces the HP A response to stress
(reviewed by Meaney et al., 1994). Meaney et al., (1994) hypothesize that the
decreased HP A response to stress is due to a more sensitive corticosteroid feedback
inhibition. Furthermore, the increased feedback inhibition may be related to an increase
in 5-HT turnover (Smythe et al., 1994) and GR receptor expression in the hippocampus
(Meaney and Aitken, 1985; O'Donnell et al., 1994).
The hippocampus contains the highest concentration of corticosteroid receptors in
the central nervous system (McEwen et al., 1968; Coirini et al., 1983, 1985; Reul and de
Kloet 1985, 1986; Magarinos et al., 1989). Corticosteroid receptors have at least two
physiological roles in the hippocampus: influencing HP A axis activity via a negative
feedback mechanism and modulating hippocampus related behaviors (reviewed by
Jacobson and Sapolsky, 1991; de Kloet et al., 1993). It is still not clear how corticosteroids influence neural signal processing in the hippocampus. Several important
questions remained answered. For example, exactly where in the hippocampus are
corticosteroids exerting their modulatory effect?
The hippocampus is divided into three regions; hippocampus proper, dentate gyms,
and the subiculum (reviewed by Knowles, 1992; Bernard and Wheal, 1994). The
hippocampus proper is further divided into four subfields, CAl-4. The cells in the
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different hippocampal regions and subfields have unique roles in hippocampal signal
processing based on their different positions within the trisynaptic circuit. The cells in
subfield CA3 receive their inputs from the dentate gyms, perforant pathway axons,
neighboring CA3 cells. The cells in subfield CAI receive their inputs almost entirely
from subfield CA3 (reviewed by Knowles, I 992; Bernard and Wheal, I 994).
Corticosteroid modulate pyramidal cell membrane properties and the response
elicited by the activation of 5-HT IA receptors on subfield CAI cells (Joels and de Kloet,
I994; Beck et al., I994, I996). Activation of the 5-HTIA receptor in the hippocampus
hyperpolarizes the cell membrane potential (Andrade and Nicoll, I 987; Colino and
Haliwell, I987; Beck and Choi, I99I; Beck et al., I992). The 5-HTIA receptor signal
transduction system mediating the hyperpolarization is composed of a receptor,
heterotrimeric guanine nucleotide binding protein (G protein), and potassium channel
(Andrade et al., I 986; Okuhara and Beck, I 994).
The actions of corticosteroids on pyramidal cell membrane electrical properties and
the 5-HT IA receptor signal transduction system in subfield CA3 are not known, yet this
information is crucial towards elucidating the mechanism by which corticosteroids
modulate signal processing in the hippocampus. In addition to their differences in
neuronal organization and synaptic inputs, the pyramidal neurons in subfields CAI and
CA3 have different cell membrane electrical properties (Nunez et al., I990; Beck et al.,
I 992; Spruston and Johnston, I 992), 5-HT IA receptor concentration-response curve
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characteristics (Beck et al., 1992, Okuhara and Beck, 1994), and when these regions are
stimulated their effects on HPA axis activity are not the same (Kawakami et al., 1968;
Dunn and Orr, 1984; Daniels et al., 1994). Therefore information on the actions of
corticosteroids on pyramidal cell membrane electrical properties and the 5-HT IA receptor
signal transduction system in subfield CA3 will contribute to a basic understanding of
how corticosteroids alter cell excitability, responses elicited by the activation of
G protein-linked neurotransmitter receptors, and help to elucidate the role of
corticosteroid receptors in information processing in the hippocampus.
The goal of this dissertation is 1) to determine the effects of chronic corticosteroid
treatment on neuron membrane electrical properties and/or 2) the 5-HT 1A receptormediated response on pyramidal cells in hippocampal subfield CA3 and 3) determine
which component(s) of the 5-HT IA receptor signal transduction system is modulated by
corticosteroids. The underlying hypothesis of this dissertation is that chronic
corticosteroid treatment modulates pyramidal cell excitability and/or the 5-HT 1A receptor
signal transduction system in hippocampal subfield CA3. This hypothesis was tested
with experiments designed to address four specific aims.
Four treatment groups were used in this dissertation. Adult rats were surgically
treated to achieve 1) no corticosteroid receptor occupancy, 2) MR occupancy only,
3) occupancy of both MR and GR, and 4) sham. All treatments were for 13 -15 days.

6

Specific Aim 1: Determine if corticosteroids alter pyramidal cell electrophysiological
properties in hippocampal subfield CA3.
Intracellular recording techniques were used in hippocampal slices maintained in

vivo to measure passive and active membrane electrical characteristics.

Specific Aim 2: Determine if corticosteroids alter the 5-HT concentration-response
curve characteristics for the 5-HT IA receptor in hippocampal CA3 pyramidal cells.
Intracellular recording techniques were used in hippocampal slices maintained in

vivo to examine the 5-HT concentration-response curve characteristic for the 5-HT IA
receptor.

Specific Aim 3: Determine the effects of corticosteroids on the 5-HT IA signal
transduction components: (1) The current evoked by direct activation of G proteins and
(2) the current-voltage relationship for the potassium current linked to the 5-HT IA
receptor.
Corticosteroids may modulate one or more of the 5-HT 1A signal transduction
components (i.e., receptor, G protein, or ion channel). Therefore, intracellular
recording techniques were used in hippocampal slices maintained in vivo to examine
the action of corticosteroids on I) the outward current evoked by the activation of
G proteins with GTPyS, and 2) the current-voltage (1-V) relationship of the potassium
channels linked to the 5-HT IA receptor.

7

Specific Aim 4: Determine the effects of corticosteroids on the 5-HT lA signal

transduction components: G protein expression in the hippocampus.
Western blot and immunohistochemistry techniques were used to determine the
effects of corticosteroids on G protein levels and distribution in the hippocampus.

CHAPTER II
REVIEW OF RELATED LITERATURE

Introduction
Adrenal corticosteroids are divided into two classes, glucocorticoids and
mineralocorticoids (Figure 1). Corticosteroids maintain homeostasis, influence mood,
sensory detection, and perception (reviewed by Henkin 1970; Munck et al., 1984; de
Kloet, 1991 ). T. Addison first published his results on the death of patients with adrenal
destruction in 1855. Later, H. Cushing (1932) and Harris (1948) established that the
hypothalamus-pituitary-adrenal (HP A) axis regulates corticosteroid synthesis and
secretion. The actions of corticosteroids are mediated mainly through two receptor
subtypes: glucocorticoid and mineralocorticoid receptors.
The first section of this literature review covers the description, pharmacology,
function, and regulation of corticosteroid receptors in mammals. Section two describes
the components, function, and regulation of the HP A axis. The regulation of HP A axis
activity is complex, involving several feedback loops and extrahypothalamic pathways.
One system which has an important modulatory influence on HP A axis activity is the
limbic system, in particular, hippocampal inputs into the HP A axis. Section three
reviews the role of the hippocampus in regulating HPA activity. In addition to their
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physiological effects in the periphery, corticosteroids also influence neural activity.
Section four reviews the available information on corticosteroid-induced changes in
neuron electrophysiological properties and the responses elicited by the activation of the
5-HT IA receptor in the hippocampus. The final section summarizes the known and
proposed roles of corticosteroids in pathological conditions. The scientific contribution
of this dissertation is also addressed in this section.

Corticosteroids Receptors
Glucocorticoids have a wide variety of effects on many cell functions (reviewed by
Kraus-Friedmann, 1984; Pilkis and Granner, 1992). Glucocorticoids stimulate
gluconeogenesis, increase amino acid uptake by the liver and kidney, increase amino acid
release through muscle catabolism, and stimulate lipolysis. The primary role of
glucocorticoids is to provide glucose for energy demanding tissues such as the brain and
heart, especially under conditions of stress. Glucocorticoids also have immunosuppressive, anti-inflammatory, and anti-asthmatic properties (Falaschi et al., 1994;
Derijk and Sternberg, 1994; Barnes, 1996; Laitinen and Laitinen, 1996; Schwiebert et

al., 1996) while supraphysiological levels decrease muscle mass, leading to muscle
weakness (Caldwell et., 1978; Goldberg et al., 1980; Fiorini, 1987; Smith et al., 1990).
Glucocorticoids exert their effects directly by regulating the synthesis of key
enzymes and proteins, or permissively, by influencing the sensitivity of cells to other
hormones or extracellular signals. For example, glucocorticoids elevate blood glucose

10

Corticosterone

OH

Cortisol

Glucocorticoids

Aldosterone

Mineralocorticoid

Figure 1. Major corticosteroids in rat and humans. The two classes of
corticosteroids are glucocorticoids and mineralocorticoids. Corticosterone is the major
glucocorticoid in rat, while cortisol is the major glucocorticoid in humans.
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levels directly by increasing the synthesis of hepatic phosphoenolpyruvate carboxykinase
(Beale et al., 1982; Lamers et al., 1982) and branched-chain a-ketoacid dehydrogenase
(Block et al., 1970; Block and Buse, 1990), rate limiting enzymes for gluconeogenesis
and skeletal muscle catabolism respectively. Glucocorticoids act permissively by
increasing the sensitivity of adipose cells to catecholamines (reviewed by Munck and
Guyre, 1986; Malbon et al., 1988).
Mineralocorticoids maintain fluid and electrolyte homeostasis. Aldosterone
primarily acts at the kidney to increase Na+ reabsorption and excretion ofK+ and Ir
(O'Neil, 1990; Funder, 1993; Horisberger and Rossier, 1995; Eaton et al., 1995).
Aldosterone affects electrolyte transport at the distal tubules and collecting ducts by
increasing the synthesis ofNa+ (Chu and Edelman, 1972; Rousseau and Crabbe, 1972;
Lahav et al., 1973; Rossier et al., 1978; Garty, 1986) and K+ channels (Kopppen et al.,
1983; Stokes, 1985; Sansom and O'Neil, 1986; Sansom et al., 1989; Illek et al., 1990;
Schafer et al., 1990) and the Na+,K+-ATPase pump (Geering et al., 1982; Ewart and
Klip, 1990; Verry, 1990; Shahedi et al., 1993).
Glucocorticoids regulate gene expression through the interaction with at least two
receptor subtypes; type I or MR and the type II or GR. Both types of corticosteroid
receptors are intracellular receptors which bind to DNA and influence gene transcription
(reviewed by Dahlman-Wright et al., 1992). The two receptors are distinguished
pharmacologically by their relative affinity for corticosterone and other selective ligands.
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Structure and Mechanism of Action
Corticosteroid receptors are intracellular receptors that regulate the expression of
specific genes. Both l\1R and GR have been cloned and their sequences are highly
homologous (Arriza et al., 1987; Patel et al., 1989). GR has been the focus for the
majority of the biochemical and functional studies, therefore, the following section
reviews the information available for GR. However, since both l\1R and GR belong to
the same steroid receptor family, they have many functional similarities (Pearce, 1994).
The unoccupied receptor usually resides in the cytoplasm, translocating into the
nucleus after binding to the steroid (Govindan, 1980; Papmichail et al., 1980; Antakly et

al., 1984; Fuxe et al., 1985; Wikstrom, et al., 1987; Picard, 1987; Lafond et al., 1988;
Gase et al., 1989). The unoccupied receptor is maintained in an inactive state by a multiprotein complex. This complex contains GR (Okret, 1985) associated with heat shock
proteins hsp56 (Sanchez, 1990), hsp70 (Sanchez, 1990; Sanchez et al., 1990), and hsp90
(Catelli et al., 1985; Sanchez et al., 1985; Sanchez et al., 1990). Steroid binding
dissociates hsp90 from GR (Mendel et al., 1986; Sanchez et al., 1987a), forming an
'activated' receptor with increased affinity for DNA (Sanchez et al., 1987b; Howard and
Distelhorst, 1988a,b). Activated GRs dimerize and bind to specific DNA sequences
(Tsai et al., 1988; Wrange et al., 1989; Chalepakis et al., 1990), known as glucocorticoid response elements (GRE) and influence gene transcription (Yamamoto, 1985).
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A great deal of information is known about the structure of MR and GR. Purified
GR is 90-100 kDa when resolved by SDS-gel electrophoresis (Govindan and Manz,
1980; Bernard and Joh, 1984; Govindan and Gronemeyer, 1984; Grandics et al., 1984;
Idziorek et al., 1985; Lustenberger et al., 1985; Webb et al., 1985). Based on
nucleotide sequences of MR and GR, the two receptors are comprised of approximately
780 amino acids and are highly conserved across different species (Hollenberg et al.,
1985; Danielsen et al., 1986; Miesfeld et al., 1986; Arriza et al., 1987; Patel et al.,
1989). Corticosteroid hormone receptors are single chain polypeptides containing three
distinct functional domains: ligand binding, DNA binding, and N-terminal domains

(Figure 2) (reviewed by Gustafsson et al., 1987; Dahlman-Wright et al., 1992; Wright et

al., 1993). The different domains were first identified through limited proteolysis of the
purified protein (Carlstedt-Duke et al., 1977, 1982, 1987; Wrange and Gustaffsson,
1978; Westphal et al., 1984; Wrange et al., 1984). Point mutation analysis of the cDNA
clones allowed researchers to identify the amino acid residues critical for the proper
function of each domain (reviewed by Dahlman-Wright et al., 1992; Gehring, 1993).
The ligand binding domain is in the carboxy-terminal end of the peptide, covering
approximately 250 amino acids (Carlstedt-Duke et al., 1987; Hollenberg et al., 1987;
Rusconi and Yamamoto, 1987). The hormone binding domain in MR and GR share a
57 % homology in humans (Arriza et al., 1987) and 59 % in rats (Patel et al., 1989).
Removal of this domain produces a constitutively active receptor (Danielson et al., 1987;
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Figure 2. Schematic representation of the MR and GR protein and its major
domains. The domains are labeled at the top of the diagram while the approximate
amino acid size of the domain is located at the bottom.

Godowski et al., 1987; Hollenberg et al., 1987; Meisfeld et al., 1987). Biochemical
analysis of this domain reveals that it folds into a complex secondary and tertiary
structure, important for proper steroid binding (reviewed by Dahlman-Wright, et al.,
1992; Gehring 1993) and translocation into the nucleus (Picard and Yamamoto, 1987).
The DNA binding domain is in the middle of the polypeptide. The MR and GR
DNA binding domains are 94 % homologous in humans (Arriza et al., 1987) and 76 %
in rats (Patel et al., 1989). This domain contains 70 amino acids which are highly
conserved with other steroid receptors (Giguere et al., 1986; Carlstedt-Duke et al.,
1987; Danielson et al., 1987; Hollenberg et al., 1987; Meisfeld et al., 1987; Rusconi and
Yamamoto, 1987; Evans, 1988; Hard et al., 1990). The prominent feature of this
domain is the coordination of cysteine residues and zinc ions to form the DNA binding
structure (Freedman et al., 1988; Seveme et al., 1988; Hard et al., 1990).

15

The N-terminal domain sequence is highly variable with other intracellular steroid
receptors (reviewed by Evans, 1988; Beato, 1989). The N-terminal domain in :MR and
GR share only a 15 % homolgy in humans (Arriza et al., 1987) and 40 % in rats (Patel et

al., 1989). Very little is known about the function of this domain and how the different
amino acids contribute to the activity of the receptors. This domain may be important
for the transactivation of GR with other transcription factors (Hollenberg et al., 1987;
Danielson et al., 1987; Gehring and Segnitz, 1988; Hollenberg and Evans, 1988).

Pharmacology and Distribution
Several experimental techniques, including in situ hybridization, autoradiography,
and immunohistochemistry were used to map the distribution of :MR and GR in the
central nervous system (CNS). Convincing pharmacological evidence for the existence
of two corticosteroid receptor subtypes came with the development of drugs that were
selective for :MR and GR and allowed researchers to distinguish the two receptors and
their differential distribution in the CNS.
[

3

H]corticosterone binding macromolecules in the brain were initially identified in

the early 1970's (McEwen and Plapinger, 1970; Grosser et al., 1971; Gerlach and
McEwen, 1972; McEwen et al., 1972; Grosser et al., 1973). These early investigations
demonstrated that corticosterone binding was not uniformly distributed. Corticosterone
binding was much higher in limbic areas, especially the hippocampus, compared to other
regions of the brain (McEwen et al., 1969, 1970, 1972; McEwen and Plapinger, 1970;
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Grosser et al., 1971; Stevens et al., 1971; Gerlach and McEwen, 1972; Warembourg,
1975; Stumpf and Sar, 1979; Sapolsky et al., 1983b). However, binding experiments
with the native mineralocorticoid aldosterone (Anderson and Fanestil, 1976;
Moguilevski and Raynaud, 1980; De Nicola et al., 1981; Veldhuis et al., 1982;
Beaumont and Fanestil, 1983; Krozowski and Funder, 1983; Wrange and Yu, 1983) and
synthetic glucocorticoid dexamethasone (de Kloet ER et al., 1975; Rees et al., 1975;
Rhees et al., 197 5; Warembourg, 197 5) produced two different corticosteroid receptor
distributions. The accumulated data lead investigators to suggest that two corticosteroid
receptor populations existed in the brain.
The development of selective MR antagonist RU 26752 and RU 26813 (Coirini et

al., 1985), GR agonist RU 26988 and RU 28362 (Moguilewsky and Raynaud, 1980;
Coirini et al., 1985), and GR antagonist RU 38486 (Gagne et al., 1985) allowed
researchers to pharmacologically characterize and map the distribution of MR and GR in
the CNS. The two receptor subtypes are distinguished by their relative affinities for the
endogenous corticosteroids corticosterone and aldosterone. MR has a high affinity for
corticosterone (Kn= 0.5 nM) and aldosterone. In contrast, GR has a low affinity for
corticosterone (Kn = 2 - 5 nM) and aldosterone (Veldhuis et al., 1982; Beaumont and
Fanestil, 1983; Krozowski and Funder, 1983; Coirini et al., 1985; Reul and de Kloet,
1985; Sheppard and Funder, 1987). Dexamethasone is a synthetic glucocorticoid with a
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higher affinity for GR (Veldhuis et al., 1982; Krozowski and Funder, 1983; Coirini et al.,
1985).
The hippocampus contains the highest concentration of?\1R and GR in the CNS.
MR binding is almost exclusively located in the hippocampus while GR binding is also
found in other CNS areas including the cortex, ventromedial thalamic nuclei, arcuate,
and lateral septum (Coirini et al., 1983, 1985; Reul and de Kloet 1985, 1986; Magarinos

et al., 1989).

Regulation
Corticosteroid receptor levels in the brain are dynamically regulated by
neuropeptides, neurotransmitters, and corticosteroids (via an autoregulatory mechanism)
(reviewed by de Kloet et al., 1986a; Herman, 1993; Budziszewska and Larson, 1994).
The regulation of?\1R and GR depends upon the brain area (i.e., hippocampus versus
hypothalamus) and which physiological factor is evoking the change in J\1R and GR
binding (i.e., neurotransmitters versus autoregulation). Furthermore, the regulation of
corticosteroid receptors by neuropeptides, neurotransmitters, or corticosteroids may
represent three independent physiological mechanisms underlying control of HP A axis
activity (see Hypothalamic-Pituitary-Adrenal Axis). A large number of investigations
have focused on the regulation of corticosteroid receptors in the hippocampus, where
corticosteroid receptors have an important role in HP A axis feedback and behavior
(Jacobson and Sapolsky, 1991).
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Regulation by Neuropeptides
HPA axis activity is regulated by two principal neuropeptides, CRF and ACTH (see
Hypothalamic-Pituitary-Adrenal Axis). CRF and the ACTH analog ORG 2766 both
modulate corticosteroid receptor levels. CRF decreases GR binding and mRNA levels in
the anterior pituitary and in AT20 anterior pituitary corticotrope cell culture (Sheppard

et al., 1990, 1991), but increases the GR mRNA levels in the hippocampus (Sheppard et
al., 1990). ORG 2766 is an ACTH analog that has no effect on corticosteroid secretion
from the adrenal gland (Greven and de Weid, 1973; de Weid and Jolles, 1982).
However, ORG 2766 administration increases corticosteroid receptor binding in the
hippocampus (Rigter et al., 1984; Reul et al., 1988). Selective MR and GR ligands were
used to demonstrate that ORG 2766 selectively increases MR binding in the
hippocampus (Reul et al., 1988). The effects ofORG 2766 in the pituitary and
hypothalamus are not known.
Another neuropeptide which is also released from the hypothalamus is vasopressin
(Kiss et al., 1984; Plotsky et al., 1985; Davis et al., 1986; Holmes et al., 1986; Fink et

al., 1988; Canny et al., 1989). Vasopressin is released by hypothalamic PVN neurons in
response to stress (Plotsky et al., 1985; Canny et al., 1989) and influences water-intake,
learning and memory (de Wied, 1971; Bohus et al., 1975; de Weid et al., 1975; de Kloet
and de Wied, 1980). Vasopressin increases corticosteroid receptor binding capacity in
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the hippocampus and GR receptors in the anterior pituitary (Veldhuis and de Kloet,
1982).
The mechanisms underlying the neuropeptide-induced changes in corticosteroid
receptor binding are largely unknown. However, the neuropeptide actions are
independent of corticosteroid hormones (Veldhuis and de Kloet, 1982; Reul et al., 1988;
Shepherd et al., 1990). While the normal physiological roles ofCRF-, ACTH-, and
vasopressin-induced changes in corticosteroid receptor levels are not known, these
peptides generally display trophic effects in certain diseased and aged brains, restoring
deficient corticosteroid receptors and HP A responsiveness (de Kloet et al., l 986a; Reul

eta/., 1988).

Regulation by Neurotransmitters
One brain area in which neurotransmitters appear to have an important role in
regulating corticosteroid receptor expression is the hippocampus (Siegel et al., 1983;
Weidenfeld et al., 1983). Modulation of corticosteroid receptors in the hippocampus by
neurotransmitters may be important in affecting mood, behavior, and neuroendocrine
responses (Azmitia et al., 1984; Budziszewska and Larson, 1994).
The 5-HT neurotransmitter system regulates corticosteroid receptor binding.
Lesioning 5-HT neurons in the raphe nucleus or depleting neurons of 5-HT decreases
corticosteriod receptor binding in the mediobasal hypothalamus and hippocampus (Siegel

et al., 1983; Weidenfeld et al., 1983; Weidenfeld and Feldman, 199la; Novotney and
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Lowy, 1995). Lesioning 5-HT neurons in the raphe nucleus also decreases GR and MR
mRNA levels in the hippocampus (Seckl et al., 1990; Seckl and Fink, 1991). In cultured
hippocampal neurons, 5-HT increases GR binding capacity without altering the binding
capacity of MR (Mitchell et al., 1990). The 5-HT receptor mediating the upregulation
of GR binding capacity in cultured hippocampal neurons is the 5-HT2 receptor (Mitchell

et al., 1992). In contrast to cultured neurons, 5-HT 1A agonists increase MR binding
capacity in the hippocampus in vivo (Budziszewska et al., 1995).
Other neurotransmitter systems which also modulate corticosteroid receptor binding
capacity or mRNA levels in the brain are the noradrenergic (Maccari et al., 1990;
1992a,b; Yau and Seckl, 1992; Kabbaj et al., 1995), cholinergic (Nyakas et al., 1979;
Yau et al., 1992), and dopaminergic systems (Casolini et al., 1993). Interestingly, the
different neurotransmitter systems have different effects on corticosteroid receptor
binding capacity and mRNA levels. Noradrenaline (NA) alters corticosteroid receptor
binding capacity and mRNA levels (Maccari et al., 1992a,b; Yau and Seckl, 1992;
Kabbaj et al., 1995). Cholinergic neurotransmitters do not modulate MR and GR
binding capacity but alter their mRNA levels (Nyakas et al., 1979; Yau et al., 1992).
Dopamine does not alter MR and GR binding capacity but alters the affinity of GR for
corticosterone (Casolini et al., 1993).
The mechanisms underlying the neurotransmitter-induced changes in corticosteroid
receptor binding capacity are not known. Changes in corticosteroid receptor mRNA
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levels do not always parallel the changes in receptor binding capacity. Furthermore, in
certain cases (i.e., 5-HT2 modulation of GR) (Mitchell et al., 1992), changes in
corticosteroid receptor binding capacity are dependent on the production of secondmessengers by the activated neurotransmitter receptor. Indeed, protein kinase A
dependent mechanisms (Kendal and Robinson, 1990) have been shown to phosphorylate
corticosteroid receptors (Dalman et al., 1988; Smith et al., 1989) and convert them to
their inactive form (reviewed by Sanchez et al., 1987; Dahlman-Wright et al., 1992),
increasing their binding capacity in the cytosol.
Modulation of corticosteroid receptors by neurotransmitters may be the initial phase
leading to an eventual shift in HPA axis activity (Kabbaj et al., 1995). For example,
activation of 5-HT or NA neurons increases HP A axis activity (Feldman and Weidenfeld,
1995). However, prolonged activation of these receptors have opposite effects on
hippocampal corticosteroid receptor binding capacity. NA decreases (Maccari et al.,
1992a; Kabbaj et al., 1995) while 5-HT increases (Seckl and Fink, 1991; Budziszewska

et al., 1995) corticosteroid receptor levels. Clearly, the selective physiological activation
of different neurotransmitter pathways will have different effects on corticosteroid
receptor function and may underlie modulatory and pathophysiological processes.

Autoregulation
Receptor autoregulation is a mechanism which occurs for a large number of
receptor systems, including corticosteroid receptors (reviewed by Schmidt and Meyer,

22

1994). A common feature of receptor autoregulation in all systems is a correlation
between ligand availability and receptor binding capacity. What is different between
receptor systems is how ligand availability and receptor binding correlate (directly or
inversely) and their mechanism of autoregulation. An adrenalectomy-induced increase in
hippocampal corticosteroid binding capacity was first demonstrated by McEwen et al.,
(1970). Later, it was reported that corticosteroid receptor binding capacity in the
hippocampus was reduced by high levels of corticosterone or stress (Tomello et al.,
1982; Sapolsky et al., 1984a). Investigators then sought to determine the individual
roles of hippocampal MR and GR in receptor autoregulation and their function in HP A
axis feedback.
The binding capacities of MR and GR are differentially regulated by changes in
steroid levels. Hippocampal MR binding capacity may either increase (Chao et al.,
1989) or show no change (Reul et al., 1987b; Reul et al., 1989; Lowy, 1991; Spencer et

al., 1991) with adrenalectomy. MR mRNA levels increase with adrenalectomy (Herman
et al., 1989a, 1993). Activation of either MR or GR has different effects on MR binding
capacity. The activation of MR does not alter MR binding capacity (Reul et al., 1987b;
Spencer et al., 1991) while GR activation alone increases MR binding capacity and
mRNA levels (Reul et al., 1987b; Reul et al., 1989). Coactivation of MR and GR
decreases MR binding capacity and mRNA levels (Lowy, 1991; Spencer et al., 1991).
MR binding capacity and mRNA levels also display circadian variation. However, there
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are different reports supporting either a peak- (Reul et al., 1987b) or a nadir-associated
(Chao et al., 1989) increase in MR binding capacity during the circadian cycle. MR
mRNA levels are higher during the nadir (Herman et al., 1993; Holmes et al., 1995a).
Unlike MR, hippocampal GR binding capacity shows a reproducible increase with
adrenalectomy that returns to control levels with corticosterone or dexamethasone
treatment (Reul et al., 1987; Chao et al., 1989; Lowy, 1991; Spencer et al., 1991). The
adrenalectomy-induced increase in GR binding capacity is also paralleled by an increase
in GR mRNA levels (Kalinyak et al., 1987; Herman et al., 1989a, 1993; Reul et al.,
1989; Sheppard et al., 1990; Peiffer et al., 1991 ). GR binding capacity in the
hippocampus does not change with diurnal variation (Reul et al., 1987b) but GR mRNA
levels are higher during the nadir of the circadian cycle (Herman et al., 1993; Holmes et

al., 1995a). In contrast to MR, activating both or each corticosteroid receptor
selectively, decreases GR binding capacity in hippocampal sections and tissue culture
(Sapolsky et al., 1984a; Sapolsky and McEwen, 1985; Luttge et al., 1989; Vedder et al.,
1993; O'Donnell and Meaney, 1994).
Corticosteroid receptor autoregulation does not occur in all brain areas. Adrenalectomy increases MR and GR mRNA levels in the hippocampus and amygdala but not in
the hypothalamus, neocortex, dorsomedial thalamus, hypothalamic PVN, and arcuate
nucleus (Pfeifer et al., 1991; Herman et al., 1993). Corticosterone decreases
corticosteroid receptor binding capacity in the rat hippocampus but not in the
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hypothalamus, amygdala, or pituitary (Tornello et al., 1982; Sapolsky and McEwen,
1985). Interestingly, dexamethasone decreases GR binding capacity in the pituitary and
amygdala but not in the hippocampus (Sapolsky and McEwen, 1985).
The autoregulation of corticosteroid receptors is an important feedback mechanism
(Schmidt and Meyer, 1994). The mechanism underlying corticosteroid receptor
autoregulation is complex. Influencing the transcription of their own gene (Burstein et

al., 1991), mRNA stability, alternative splicing, and receptor protein turnover rate may
all be involved in the autoregulation mechanism (Schmidt and Meyer, 1994; Herman and
Watson, 1995). Finally, the pronounced autoregulation of corticosteroid receptors in the
hippocampus as compared to other brain areas, supports the important role that the
hippocampus has in influencing HP A axis activity and corticosteroid-induced behaviors
(Jacobson and Sapolsky, 1991).

Function
It has been proposed by de Kloet ( 1991) that homeostasis is maintained by MR and
GR via a 'corticosteroids receptor balance hypothesis'. This hypothesis simply states
that the physiological functions of MR and GR depend on the differential occupation of
the two receptors and is based on two important corticosteroid receptor properties.
First, MR and GR have different affinities for corticosterone. Second, the fractional
occupancy of MR and GR changes with physiological fluctuations in corticosterone
plasma concentrations. MR has a high affinity for corticosterone (Kn= 0.5 - 0. 7 nM)
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and is 70-80% occupied at basal physiological corticosterone plasma levels (Krozowski
and Funder, 1983; Reul and de Kloet, 1985; Reul et al., 1987). GR has a lower affinity
for corticosterone, Kn= 2.5 - 5 nM, and its occupancy changes from 15% at basal to
90% at peak and stress circulating corticosterone levels (Reul and de Kloet, 1985; Reul

et al., 1987a,b). One important point should be emphasized about the physiological
function of MR and GR. GR occupation without concomitant MR occupation has not
been demonstrated to occur physiologically.
Brain MR and GR have distinct physiological functions that are often
complementary and not antagonistic. For example, MR and GR are important in
maintaining homeostasis. However MR maintains ion homeostasis while GR maintains
glucose availability (Dallman et al., 1987, 1994; Tempel and Leibowitz, 1994). MR and
GR influence different aspects of behavior. MR permits the proper acquisition of
behavior reactivity in rats while GR facilitates memory storage (Micco et al., 1980;
Jefferys et al., 1983; Veldhuis et al, 1985; McEwen and Brinton 1987; Oitzl and de
Kloet, 1992, 1994; de Kloet et al., 1993). One example of the different roles MR and
GR have on behavior is the performance of rats in the Morris water maze. MR
activation is important in developing the strategy used by the animal to find the platform
in the water while GR activation is important for acquiring and storing spatial
information (Oitzl and de Kloet, 1992; Oitzl et al., 1994).
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Concluding Remarks
MR and GR are intracellular receptors that bind to DNA and regulate the expression
of specific genes. MR and GR have different physiological functions. MR and GR also
have different affinities for corticosterone. Therefore, homeostasis is maintained by MR
and GR via changes in their fractional occupancy with fluctuating corticosteroid plasma
levels. MR and GR are differentially expressed in the brain. The hippocampus contains
the highest density of MR and GR binding sites and mRNA levels.
Corticosteroid receptor levels are autoregulated and influenced by neuropeptides
and neurotransmitters which may represent three different physiological mechanisms
underlying the modulation of HP A axis activity. Neuropeptides provide trophic effects
which may be important in maintaining normal corticosteroid receptor levels (reviewed
by de Kloet et al., 1986a). Neurotransmitters provide a rapid mechanism for modulating
corticosteroid receptor levels via the activation of selective neurotransmitter pathways.
Finally, corticosteroids autoregulate their own receptor levels, providing a HP A axis
feedback mechanism (reviewed by Schmidt and Meyer, 1994). Corticosteroid receptor
regulation occurs in several brain

areas~

however, the hippocampus shows the greatest

sensitivity.

Hypothalamic-Pituitary-Adrenal Axis
The synthesis and release of corticosteroids are regulated by the hypothalamicpituitary-adrenal axis (HPA) (Figure 3) (reviewed by Feldman and Weidenfeld, 1995).
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Figure 3. Schematic model of the HPA axis. The major components, peptides, and
hormones are pictured in this diagram. The solid arrows depict released constituents,
while the broken arrow depicts feedback.

28

In response to various stimuli, PVN neurons in the hypothalamus release CRF into the
portal circulation. CRF then stimulates the synthesis and release of ACTH from the
corticotropes in the anterior pituitary. ACTH enters the circulatory system and drives
the synthesis and release of corticosteroids from the adrenal cortex.

Regulation of The HP A axis
HP A axis activity is driven by two physiological mechanisms, circadian rhythm and
stress. Circulating glucocorticoid levels in nocturnal rats are lowest during 'lights-on',
peak during 'lights-off (Guillemin et al., 1959; Scheving and Pauly, 1966; Zimmermann
and Critchlow, 1967; Ader et al., 1968; Retiene, 1970; Dunn et al., 1972), and increase
in response to stress (Ganong, 1963; Mangili et al., 1966; Yates, 1967; Ader et al.,
1968; Gibbs, 1970; Dunn et al., 1972). It is well established that extrahypothalamic
structures regulate circadian rhythm and stress-induced HP A axis activity (Slusher, 1964;
Davidson and Feldman, 1967; Halasz et al., 1967; Palka et al., 1969; Wilson and
Critchlow, 1975; Phelps et al., 1978). Extrahypothalamic structures affect HPA axis
activity through the release ofvasopressin, oxytocin, epinephrine or 5-HT at the
hypothalamus (Weiner and Ganong, 1978; Fuller, 1981; Swanson et al., 1983; Plotsky
1985, 1987; Antoni, 1986; Plotsky et al., 1987, 1989; Feldman et al., 1990, Feldman and
Weidenfeld, 1991 ).
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Neurotransmitter Systems Influencing HPA Axis Activity
5-HT neurons arising from raphe nuclei innervate the parvocellular region of the
PVN in the hypothalamus (Palkovits et al., 1977; Sawchenko et al., 1983). 5-HT
neurons innervate CRF synthesizing neurons in the PVN (Lipositis et al., 1987) and
stimulate the synthesis and release of CRF in vivo (Saphier and Feldman, 1989;
Swanson and Simmons, 1989; Feldman et al., 1991) and from isolated rat hypothalamic
cells (Calogero et al., 1989).
5-HT neurons facilitate circadian- and stress-induced release of CRF or corticosterone (Szafarczyk et al., 1980; Fuller, 1981; Feldman et al., 1995). The 5-HT
receptors mediating the release ofCRF, ACTH or corticosterone are the 5-HT1A and
5-HT2 receptors (Koenig et al., 1987, 1988: Lorens and Van de Kar, 1987; Gilbert et

al., 1988; King et al., 1989; Fuller and Snoddy, 1990).
NA fibers located in the ventral noradrenergic ascending bundle (VNAB) have an
important role in regulating HP A axis activity (Feldman et al., 1984; Plotsky et al., 1989;
Feldman and Weidenfeld, 1995, Feldman et al., 1995). VNAB fibers originate in the
brainstem, mainly from the locus coeruleus. A subset of these fibers innervate the
hypothalamic PVN, via the medial forebrain bundle (Cunningham and Sawchenko, 1988;
Cunningham et al., 1990; Saphier and Feldman, 1991), and stimulate CRF release
(Guillaume et al., 1987; Plotsky, 1987; Weidenfeld and Feldman, 199lb).

30

Lesioning the VNAB or medial forebrain bundle with the catecholamine neurotoxin
6-hydroxy-dopamine (6-0HDA) prevents the circadian release of ACTH and
corticosterone (Szafarczyk et al., 1985) and the stress-induced release of CRF (Feldman

et al., 1984; Szafarczyk et al., 1985, 1987; Plotsky, 1987; Sawchenko, 1988). The NA
receptors mediating the release of CRF are the a.1- and a.2-receptors (Saphier and
Feldman, 1991; Daniels et al., 1993).
The cholinergic system also influences HP A axis activity. Cholinergic agonists
stimulate CRF, ACTH, and corticosterone release (Makara and Stark, 1976; Plotsky et

al., 1987; Weidenfeld et al., 1989a). Cholinergic antagonists attenuated both basal- and
stress-induced release of ACTH (Hedge and Smelik, 1968; Kaplanski and Smelik, 1973;
Makara and Stark, 1976; Guillaume et al., 1987). The cholingeric receptors mediating
the release of corticosterone are nicotinic receptors (Brenner et al., 1986; Weidenfeld et

al., 1989a).

Feedback Regulation by Corticosteroids
While extrahypothalamic pathways are important for the initial stimulation (or
inhibition) of HP A axis activity, more direct control of the HP A axis is mediated through
feedback loops within the axis (Figure 3) (reviewed by Feldman and Weidenfeld, 1995).
Corticosteroids act at both the hypothalamus and pituitary to directly inhibit their own
synthesis and secretion. Some controversy still exists surrounding the mechanism by
which corticosteroids directly act at the hypothalamus to decrease ACTH secretion
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(reviewed by Bradbury et al., 1991; Dallman et al., 1994; Feldman et al., 1995).
Corticosteroid receptors and CRF are both present within the same cells in the PVN
(Ceccatelli et al., 1989). Adrenalectomy or stress (initiated via photic, acoustic, or
sciatic nerve stimulation) increases hypothalamic CRF peptide and mRNA levels (Paull
and Gibbs; 1983; Westlund et al., 1985; Plotsky and Sawchenko, 1987; Sawchenko,
1987; Beyer et al., 1988; Fink et al., 1988; Weidenfeld et al., 1989b; Feldman et al.,
1992; Kwak et al., 1993), resulting in an increase in ACTH secretion from the pituitary.
However, corticosteroid implants in the hypothalamus attenuated only the neural
(photic) stimulated CRF mRNA levels and peptide secretion (Feldman et al., 1992) and
did not reliably decrease the adrenalectomy stimulated ACTH secretion in animals
(Dallman et al., 1985; Kovacs et al., 1986; Sawchenko, 1987; Kovacs and Makara,
1988; Levin et al., 1988). Therefore, HP A axis feedback inhibition may occur at other
brain sites in addition to the hypothalamus (Feldman et al., 1992).
Corticosteroids also act in the pituitary to inhibit ACTH secretion (reviewed by
Dallman et al., 1987). GR and ACTH are both localized within the same cells in the
pituitary (Cintra and Bortolotti, 1992). Corticosteroids decrease CRF- (Koch et al.,
1979; Dallman et al., 1985), adrenergic- (Giguere et al., 1982), and stress- (Walker et

al., 1986) stimulated ACTH release from the pituitary. The inhibitory effect of
corticosteroids on ACTH secretion occurs within 10-30 min (Brattin and Portanova,
1977; Buckingham and Hodges, 1977; Mulder and Smelik, 1977; Gilles and Lowry,
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1978; Widmaier and Dallman, 1984; Abou-Samra et al., 1986; Dayanithi and Antoni,
1989) and requires protein synthesis (Dayanithi and Antoni, 1989). The requirement for
protein synthesis suggests that corticosteroids decrease CRF and/or ACTH synthesis by
increasing the synthesis of inhibitory transcription factors (Dayanithi and Antoni, 1989).
MR and GR have different roles in HPA axis feedback (Dallman et al., 1987, 1994;
de Kloet and Reul, 1987; Dayanithi and Antoni, 1989; Ratka et al., 1989; Sapolsky et

al., 1990; Bradbury et al., 1991, 1994). MRs mediate HPA axis feedback inhibition
during the circadian trough, when MR is 70-80% occupied at basal physiological
corticosterone plasma levels (Krozowski and Funder; 1983; Reul and de Kloet, 1985;
Reul et al., 1987a,b). GRs mediate HP A axis negative feedback regulation during the
diurnal peak or stress, when its occupancy changes from 15% at basal to 90% at peak
and stress circulating corticosterone levels (Reul and de Kloet, 1985; Reul et al.,
1987a,b).
Interestingly, the hypothalamus-pituitary brain areas are important in feedback
during the circadian trough while other brain areas are important during the peak (Akana

et al., 1986; Suemaru et al., 1995). Stress-induced increase in HPA axis activity is
mediated through several different neural pathways (Feldman, 1985; Canny et al., 1989)
and feedback is provided by both the HP A axis and other cortical areas (Kaneko and
Hiroshige, 1978a,b; Keller-Wood and Dallman 1984; Dallman et al., 1987; Canny et al.,
1989).
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The Hippocampus and HP A Axis Feedback Regulation
The hippocampus has a significant role in regulating HPA axis activity. While it is
well established that the hippocampus is a site of negative feedback for the HPA axis, it
is not known how the hippocampus exerts its influence on the axis (reviewed by
Jacobson and Sapolsky, 1991). The neural circuit in the hippocampus is complex. The
hippocampal structure is divided into different regions: hippocampus proper, dentate
gyros, and subiculum. These regions are interconnected to form the hippocampal
circuitry. The neurons within these regions have different cell properties,
neurotransmitter receptor-mediated responses, and when these regions are stimulated
their effects on HP A axis activity are not the same.

Hippocampal Anatomy
The hippocampus is divided into three regions; hippocampus proper, dentate gyros,
and the subiculum (reviewed by Knowles, 1992; Bernard and Wheal, 1994). The
hippocampus proper is further divided into several subfields, CAl-4. Pyramidal cells are
the primary projection neurons in the hippocampal subfields (Knowles, 1992; Bernard
and Wheal, 1994) and share the same general shape as the pyramidal cells in the cortex
(Peters and Jones, 1984). They have triangular or ovoid shaped cell bodies with one to
three long apical dendrites. There are also a wide variety of interneurons in the
hippocampus. The interneurons mainly release y-aminobutyric acid (GABA) as their
neurotransmitter and are classified by their shape, neurophysiology, and location
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(Knowles, I992; Bernard and Wheal, I994).
The hippocampal circuitry is established through a hierarchy of connections that
produce unidirectional signal processing within the structure (Andersen et al., I97Ib;
Andersen, I975; Bernard and Wheal, I994). Figure 4 illustrates a diagrammatic model
of the trisynaptic circuit. The major hippocampal inputs are received at the dentate gyros
granule cells from the entorhinal cortex through the perforant pathway. Mossy fibers
from the dentate gyros project to subfield CA3 pyramidal cells, which in turn, send
Schaffer collaterals to subfield CAI pyramidal cells. Subfield CAI cells then provide the
major output for the hippocampus through the fornix and subiculum.
There are several important differences in the cellular organization and physiology
between the various subfields. The pyramidal cells in subfield CA3 are larger and more
densely packed compared to the cells in subfield CAI (Knowles, I992). The pyramidal
cells in subfields CAI and CA3 are interconnected differently. The pyramidal cells in
subfield CA3 are highly interconnected with nearby pyramidal cells and interneurons
through an extensive local network of axon collaterals (Miles and Wong, I 986; Ishizuka

et al., I 990). In contrast, the pyramidal neurons in subfield CAI have few excitatory
collaterals between neighboring pyramidal cells (Knowles and Schwartzkroin, I98Ia,b).
The extensive interconnection of cells in subfield CA3 are hypothesized to be important
in the synchronized burst firing of these cells (Miles and Wong, I 986; Ishizuka et al.,
I990).
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Figure 4. Schematic representation of the hippocampal trisynaptic circuit. Only
the major cell types, projections, and synapses are depicted in this diagram.
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Hippocampal pyramidal cell excitability is determined by at least two factors:
membrane electrical properties and neurotransmitter responses and both of these factors
are different among the various subfields. For example, in subfields CAI and CA3, the
pyramidal cell's passive and active membrane properties are different (Nunez et al.,
I990; Beck et al., I992; Spruston and Johnston, I992). Therefore, the cells in these two
subfields may integrate synaptic potentials and encode their outputs differently. The
responses elicited by the activation of at least two neurotransmitter receptors are
different between subfield CAI and CA3. The 5-HT or baclofen concentration-response
curve characteristics for the 5-HT IA and y-aminobutyric acids (GABA8 ) receptors,
respectively, are different between subfields CAI and CA3 (Beck et al., I992, I995).

Corticosteroid Receptor Distribution and Regulation
in the Hippocampus
There is some uncertainty concerning the relative distribution of corticosteroid
receptors in the individual hippocampal subfields. Based on radioligand binding assays,
MR binding density is greatest in subfield CAI and least in subfield CA3. This is also
supported by in situ hybridization and immunohistochemistry investigations with probes
for the MR mRNA and protein (Arriza et al., I988; Van Eekelen et al., I988; Herman et

al., I989a; Ahima et al., I99I). GR binding density is higher in subfield CA3 compared
to CAI. However, the results from in situ hybridization and immunohistochemistry
experiments indicate that subfield CA3 has very little GR mRNA and immunoreactivity
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(Fuxe et al., I985; Van Eekelen et al., I988; Herman et al., I989a). In a recent
immunohistochemistry investigation, Ahima and Harlan (I990) reported that GR labeling
is equally intense throughout subfields CAI-CA3. There has been no attempts to
resolve the differences in GR binding, immunoreactivity, and mRNA distribution in the
hippocampus. Some of the possible explanations for the disparate results are differences
in GR mRNA translation, stability, or post-translation modifications between subfields
CAI and CA3 ( Herman et al., I 989a).
As reviewed above, the hippocampus is highly sensitive to corticosteroid receptor
autoregulation compared to other brain areas. Interestingly, corticosteroid receptor
autoregulation in the hippocampus is different between subfields CAI and CA3.
Corticosterone decreases corticosteroid receptor binding sites in hippocampal subfields
CAI and CA2, not in CA3 (Sapolsky and McEwen, I 985). Adrenalectomy increases
GR and MR mRNA levels in subfield CAI but not in subfield CA3 (Herman et al.,
I989a).

Hippocampus Influence on HP A Axis Activity
Based on several lines of evidence, the hippocampus is an important site for HPA
axis negative feedback regulation. First, corticosterone is capable of decreasing its own
release by acting through the hippocampus. Corticosterone or dexamethasone implants
into the dorsal hippocampus decreases adrenalectomy-induced ACTH secretion
(Davidson and Feldman, I967; Kovacs and Makara, I988). Second, the hippocampus
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exerts a negative influence on HPA axis activity. Dorsal hippocampectomy decreases
the diurnal variation in circulating corticosterone levels by increasing basal (nadir) ACTH
and corticosterone plasma levels (Fendler et al., 1961; Moberg et al., 1971; Fischette et

al., 1980; Wilson et al., 1980; Margarinos et al., 1987; Sapolsky et al., 1989;).
Hippocampectomy also increases CRF and vasopressin mRNA levels in the PVN
(Herman et al., 1989b, 1992).
Hippocampal lesions alter stress-induced HPA axis activity (Sapolsky et al., 1984b).
Corticosterone levels increase during stress and return to pre-stress levels approximately
one hour after the stressor is terminated (Sapolsky et al., l 984b ). Rats with hippocampal
lesions have higher circulating plasma corticosterone levels in response to stress and the
high level is maintained for at least four hours after the stressor is terminated (Kant et

al., 1984; Sapolsky et al., 1984b). A common test for corticosterone feedback inhibition
is the use of dexamethasone to suppress the stress-induced corticosterone secretion in
rats. When the hippocampus or fornix are lesioned, the efficacy of dexamethasone to
suppress stress-induced corticosterone secretion is significantly diminished (Feldman and
Conforti, 1976; Margarinos et al., 1987).
Finally, hippocampal regulation of the HP A axis is also supported by investigations
using electrical stimulation of the hippocampus. Electrical stimulation of subfield CA2CA3 or the dentate gyrus decreases while stimulating subfield CAI increases plasma
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corticosterone levels in rats (Kawakami et al., I968; Dunn and Orr, I984; Daniels et al.,
I994).

Concluding Remarks
Several lines of evidence suggest that corticosteroids have an important role in
modulating hippocampal neural activity. The hippocampus has the highest density of
corticosteroid receptors in the brain. The distribution of MR and GR may be different
between subfields CAI and CA3; therefore, the two receptors may selectively modulate
the hippocampal circuitry at specific sites. The hippocampus is a site of HPA axis
negative feedback, influencing both circadian and stress driven corticosteroid secretion.
However, it is not known how the feedback signal is processed in the hippocampus.
Neuronal signal processing in the hippocampus is complex and corticosteroid
modification of hippocampal neural activity is not completely understood.

Corticosteroid Modulation ofHippocampal Neuron Properties
Neuron Membrane Electrical Properties
One way that corticosteroids may influence signal processing in the hippocampus is
by modulating the electrical properties ofhippocampal neurons. Indeed, it has been
demonstrated that corticosteroids alter neuron membrane electrical properties in
hippocampal CAI pyramidal cells. Chronic (two weeks) MR activation with basal levels
of corticosterone increases the membrane input resistance and time constant of pyramidal
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cells in subfield CAI (Beck et al., I994). The membrane input resistance and time
constant determine the decay of synaptic potentials in the dendrites and soma, which in
tum, influences the integration of postsynaptic potentials in the cell (Rall, I 977).
Therefore, corticosteroids may alter the integration of postsynaptic potentials in subfield
CAI cells.
Chronic MR activation with basal levels of corticosterone also increases the action
potential peak amplitude and duration (Beck et al., I994). Altering the shape of the
action potential may be physiologically important. Wheeler et al., (I 996) recently
reported that increasing the action potential duration leads to an increase in Ca2+ influx at
the presynaptic terminal and enhances synaptic strength. Consequently, MR activation in
subfield CAI neurons may increase the release of neurotransmitters at the nerve terminal.
2

Corticosteroids alter two characteristics that rely on a Ca +-dependent K+ current:
spike accommodation and slow afterhyperpolarization (sAHP) (Madison and Nicoll,
I984~

Lancaster and Nicoll, I987). When a prolonged (300 - 500 ms) depolarizing

current pulse is injected into hippocampal pyramidal cells, the cell fires a short train of
action potentials at the beginning of the pulse. The frequency of action potentials then
decreases over the duration of the pulse. Accommodation is a term used to describe the
neuron's ability to adapt and prevent the firing of action potentials during the
depolarizing pulse. Once the depolarizing pulse is terminated, a sAHP is apparent.
Accommodation is determined by the magnitude and duration of the sAHP.
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In subfield CAI, the sAHP is smaller in cells from adrenalectomized animals
compared to cells from adrenally-intact animals (Joels and de Kloet, 1989; Kerr et al.,
1989). Short term (20 min to 4 hrs) and chronic MR activation decreases spike
accommodation and the sAHP (Joels and de Kloet, 1989, 1990; Kerr et al., 1989; Beck et

al., 1994). MR and GR activation or GR activation alone increases accommodation and
the sAHP (Joels and de Kloet, 1989, 1990; Kerr et al., 1989).
The actions of corticosteroids on several ionic conductances in the hippocampus
have also been examined. The L- and T - type Ca2+ currents are larger in cells from
adrenalectomized as compared to intact animals (Karst and Joels, 1994). Short-term
MR activation returns the magnitude of the L- and T- type Ca2+ currents to control
values (Karst and Joels, 1994). Due to conflicting reports, the effects of GR activation
on Ca2+ currents in the hippocampus is still unclear. There are reports that GR activation
induces either larger (Kerr et al., 1992) or smaller (Karst and Joels, 1994) Ca2+ currents
in subfield CAI pyramidal cells compared to cells from adrenalectomized animals. IQ is
also modulated by MR and GR activation. The IQ current is small when either MR or
GR are occupied alone but increases when both MR and GR are occupied (Karst et al.,
1993).
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Hippocampus 5-HT 1A Signal Transduction System
in Subfields CAI and CA3
In addition to altering cell membrane electrical properties, corticosteroids may also
influence neural activity by modulating the responses elicited by the activation of
neurotransmitter receptors. Corticosteroids have been shown to modulate
neurotransmitter receptor systems in the brain including NA, muscarinic, glutamate, and
5-HT systems (reviewed by Joels and de Kloet, 1994; McEwen. 1996). The action of
corticosteroids on the 5-HT 1A receptor system has been reported by several different
groups (Joels and de Kloet, 1994; Chaouloff, 1995; Beck et al., 1996). However, the
mechanism by which corticosteroids alter the responses elicited by the activation of the
5-HT 1A receptor is still not known. One reason the mechanism remains elusive is the
effects of corticosteroids on the different components of the 5-HT 1A receptor signal
transduction pathway are not known.
The hippocampus receives an extensive 5-HT innervation from the dorsal and
median raphe (Azmitia and Segal 1978; Molliver, 1987). Stimulation of ascending 5-HT
containing axons from the rap he decreases the cell firing rate of hippocampal subfield
CA3 pyramidal cells (Segal, 1975). Locally applied 5-HT also decreases pyramidal cell
firing rate (De Montigny and Aghajanian, 1978; Otmakhov and Bragin, 1982).
Activation of the 5-HT 1A receptor in the hippocampus hyperpolarizes the cell membrane
potential (Andrade and Nicoll, 1987; Colino and Haliwell, 1987; Beck and Choi, 1991;
Beck et al., 1992). The 5-HT 1A receptor signal transduction system mediating the
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hyperpolarization is composed of a receptor, heterotrimeric guanine nucleotide binding
protein (G protein), and potassium channel (Andrade et al., 1986; Okuhara and Beck,
1994).

5-HT lA Receptor Structure and Distribution
The 5-HT iA receptor belongs to the family of G protein-coupled receptors
(reviewed by Iismaa and Shrine, 1992). G protein-coupled receptors are single chain
polypeptides that contain seven putative membrane-spanning domains. The human
5-HT1A receptor was first cloned in the late 1980's (Kobilka et al., 1987; Fargin et al.,
1988). The rat 5-HT lA receptor was later cloned by two separate groups (Albert et al.,
1990; Fujiwara et al., 1990) and encoded a protein approximately 420 amino acids in
length.
There are three important features of G protein-coupled receptors which is also
shared by the 5-HT1A receptor. First, the three dimensional arrangement of the seven
transmembrane domains are proposed to form a ligand binding pocket (Hartig, 1989;
Sylte et al., 1993) (Figure 5). The three dimensional arrangement places specific amino
acid residues, located within the transmembrane domains, in areas critical for the
interaction with receptor agonists and antagonists (Guan et al., 1992; Ho et al., 1992;
Chanda et al., 1993). Second, the third cytoplasmic loop is the proposed site where
G protein coupling occurs. The amino acids in the third cytoplasmic loop are highly
divergent as compared with other G protein-coupled receptors (El Mestikawy et al.,
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Figure 5. Diagrammatic representation of the 5-HT1A receptor. The seven
transmembrane regions (cylinders labeled in roman numerals) are shown in a hypothetical
arrangement. The amino terminal (N) is located outside the cell while the carboxy
terminal (C) is in the cytoplasm. The third cytoplasmic loop is also displayed.

45

I99I). The amino acids bordering each end of the third cytoplasmic loop are thought to
confer G protein selectivity (Strader et al., I987; Kobilka et al., I988; O'Dowd et al.,
I 988). Finally, 5-HT iA receptor binding is modulated by phosphorylation. In a cell line
where the 5-HT lA receptor was stably transfected, protein kinase C activation
phosphorylated and desensitized the receptor (Raymond, I99I).
The 5-HT 1Areceptor is expressed through out the periphery and brain. The
distribution of 5-HT lA receptors has been examined in several mammalian species (i.e.,
rat, pig, cat, mouse, and human) with similar results. The highest density of 5-HT lA
binding sites and mRNA are located in limbic system structures: hippocampus, amygdala,
septum, and cortical limbic areas (reviewed by Zifa and Fillion, I992; Boess and Martin,
I 994). Within the hippocampus, the number of 5-HT IA receptor binding sites is different
between subfields CAI and CA3. Subfield CAI has approximately a two times higher
density of receptor binding sites compared to CA3 (Verge et al., I986; Radja et al.,
I99I).

G protein Structure and Function
G proteins are heterotrimeric proteins that bind guanine nucleotides (reviewed by
Bimbaumer and Bimbaumer, I 995). G proteins that are involved in receptor signal
transduction systems function as transducers. These G proteins couple, or link, the
activation of specific plasma membrane receptors to other cellular proteins (commonly
referred to as effector proteins) located within the membrane.
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The G protein complex is composed of three subunits: a, p, and y . The a-subunit
binds to guanosine triphosphate (GTP) and hydrolyzes it to guanosine diphosphate
(GDP). The a-GTP complex is capable of dissociating from the py subunits (Fung,
1983; Northup et al., 1983a,b). The PY subunits anchor the G protein complex to the
plasma membrane and facilitates the interaction between G proteins and receptors
(Kanaho et al., 1984; Florio and Stemweis, 1985, 1989; Watkins et al., 1985; Navon
and Fung, 1987). All three subunits have been reported to interact with effector
molecules (reviewed by Bimbaumer, 1992; Bimbaumer and Bimbaumer, 1995). There
are at least three major G protein families; Gs, Gi, and Gq. The G protein families, and
their respective subtypes, were originally classified by their ability to either stimulate (Gs)
or inhibit (Gi) adenylyl cyclase, or other effector molecules. Presently, they are classified
by their a-subunit sequences (reviewed by Bimbaumer et al., 1990).
Activation of receptors coupled to G proteins initiates a cycle which is the hallmark
ofG protein-coupled receptor signal transduction systems (reviewed by Bimbaumer and
Bimbaumer, 1995). The signal transduction cycle is described in Figure 6. The
activated receptor couples with a G protein. The G protein a-subunit binds a molecule
of GTP and begins to hydrolyze it to GDP. The a-GTP complex dissociates from the py
subunits. The a-GTP and/or py subunits interact with effector molecules. The
hydrolysis of GTP to GDP terminates the interaction of the a-subunit with the effector
molecule and the apy complex is reformed.
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Figure 6. Cartoon illustration of the G protein cycle. 1. The activated receptor
couples with the inactive G protein (GDP bound to the a-subunit). 2. The G protein
a-subunit binds a molecule of GTP and begins to hydrolyze it to GDP. 3. The a-GTP
complex dissociates from the py subunits. The a-GTP and/or py subunits interact with
their effector proteins (El and E2). 4. The hydrolysis of GTP to GDP terminates the
interaction of the a-su.bunit with the effector molecule. The mechanism (?) underlying
the dissociation of the py subunits from their effector molecule is not known. 5. The
G protein subunits dissociate from their effector proteins and reform the apy complex.
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A tool that is commonly used to determine which G protein subtypes are involved in
a receptor signal transduction system is the Bordetella pertussis toxin (PTX). PTX
covalently modifies (process known as ADP-ribosylation) particular G protein asubunits (i.e., Gi and Go, not Gs) and inhibits the coupling between the receptor and
G protein (Gilman, I984; Watkins et al., I985). Using PTX, it was demonstrated that
the 5-HT IA receptor couples to a PTX-sensitive G protein in hippocampal subfields CAI
and CA3 (Andrade et al., I986; Okuhara and Beck, I994).

Potassium Channel Linked to the 5-HT 1Areceptor
Activation of the 5-HT 1Areceptor on hippocampal subfield CAI pyramidal cells
evokes an inward rectifying potassium current that hyperpolarizes the cell membrane
potential (Andrade and Nicoll, I 987; Colina and Haliwell, I 987; Beck et al., I 992).
Activation of the 5-HT IA receptor on subfield CA3 pyramidal cells also produces a
hyperpolarization via an increase in an inward rectifying potassium current (Beck and
Choi, I99I; Beck et al., I992; Okuhara and Beck, I994).
Very little is known about the potassium channel linked to the 5-HT 1Areceptor
signal transduction system. The channel is probably a member of the recently cloned
G protein inward rectifying potassium (GIRK) channel family (Lesage et al., I 994, I 995;
Kobayashi et al., I995; Ponce et al., I996; Spausches et al., I996). The potassium
channels linked to the 5-HT1A receptor in subfield CAI appear to be activated by
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G protein

J3y subunits, and the channel gating kinetics modified by ATP (Oh et al.,

I995).
While the 5-HT 1A receptor signal transduction system is composed of similar
components in subfields CAI and CA3, the pharmacological properties of the receptor is
different between the two subfields. For example, 5-HT is less potent and elicits a
greater hyperpolarization response in subfield CA3 cells compared to cells from subfield
CAI (Beck et al., I 992). 5-HT 1A receptor antagonist that are competitive in subfield
CAI are insurmountable in subfield CA3 (Beck et al., I 992). The different
pharmacological properties of the 5-HT 1A receptor signal transduction system in subfield
CAI and CA3 may be due to differences in signal transduction components (i.e.,
G protein or potassium channel subtype) or coupling affinity between components.

Corticosteroid Modulation of the 5-HT 1AReceptor System in Subfield CAI
Corticosteroids modulate the 5-HT 1A receptor system in the hippocampus. Shortterm (20 min to 4 hrs) activation of MR with basal levels of corticosterone or
aldosterone decreases the 5-HT 1A receptor-mediated hyperpolarization compared to cells
from adrenalectomy or sham animals (Joels et al., I99I, Joels and de Kloet, I992; Beck

et al., I996). Short-term GR activation does not affect the magnitude of the 5-HT 1A
receptor-mediated hyperpolarization (Joels and de Kloet, I 992; Beck et al., I 996) but
increases the EC 50 value of the 5-HT concentration-response curve (Beck et al., I996).
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Due to conflicting results, the effects of corticosteroids on the number of 5-HT IA
binding sites is not clear. Adrenalectomy either increases (Chalmers et al., 1993; TejaniButt and Labow, 1994) or has no effect on the number of 5-HT IA binding sites in
subfield CAI (de Kloet et al., 1986b; Mendelson and McEwen, 1992a,b; Meijer and de
Kloet, 1994; Kuroda et al., 1994; Holmes et al., 1995b). In the reports where
adrenalectomy increased the number of 5-HT IA binding sites, corticosterone treatment
reversed the adrenalectomy-induced effect.
The corticosteroid-induced alterations in the 5-HT IA receptor-mediated responses
cannot always be explained by changes in the number of 5-HT IA receptor binding sites.
For example, an increase in the number of 5-HT IA receptor binding sites (Chalmers et

al., 1993; Tejani-Butt and Labow, 1994) in adrenalectomized animals would predict a
greater or more sensitive 5-HT IA receptor-mediated response. However, there is no
difference in the 5-HT IA receptor-mediated hyperpolarization between adrenalectomized
and adrenally-intact animals (Joels et al., 1991, Joels and de Kloet, 1992; Beck et al.,
1996). Therefore, corticosteroids may be altering the 5-HT IA receptor signal
transduction system at sites downstream of the receptor.
In addition to changes in the number of 5-HT IA receptor binding sites,
corticosteroids may alter G protein expression or activity. The regulation of G protein
levels by glucocorticoids has been examined in several tissue types including liver (Kawai

et al., 93), aorta (Haigh et al., 1990) vascular smooth muscle (Schelling et al., 1994),
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fetal forebrain tissue (Slotkin et al., 1994), cortex (Saito et al., 1989), and hippocampus
(Wolfgang et al., 1994; Gannon et al., 1995).
The action of glucocorticoids on G protein expression is different in the cortex and
hippocampus. In the cerebral cortex, adrenalectomy decreases Gi, increases Gs, and has
no effect on G0 a-subunit levels when compared to sham (Saito et al., 1989).
Corticosterone replacement reversed the adrenalectomy-induced effects on G protein
levels in the cortex. In contrast to the cortex, adrenalectomy has no effect on Gi and G1
a-subunit levels in the hippocampus (Gannon et al., 1994). Only one study has
examined the effects of high corticosteroid exposure on G protein levels in the
hippocampus. Chronic stress increases Gs and Go but does not affect Gi a-subunit levels
(Wolfgang et al., 1994).
Finally, corticosteroids may also alter effector molecule activity. To date,
corticosteroid-induced changes were only examined in effector proteins that regulate
second messenger production. For example, glucocorticoids alter adenylyl cyclase
activity and mRNA levels in the rat hippocampus (Gannon et al., 1994; Wolfgang et al.,
1994). The effects of corticosteroids on the properties of the potassium channel linked
to the 5-HT lA receptor signal transduction system in the hippocampus are not known.
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Concluding Remarks
Corticosteroids modulate hippocampal neural activity at two known levels. First
corticosteroids alter the electrical membrane properties of pyramidal cells. Second they
modulate the responses elicited by the activation of neurotransmitter receptors. Current
research has focused on the action of corticosteroids on the electrical membrane
properties and responses elicited by the activation of the 5-HT 1A receptor on
hippocampal pyramidal cells in subfields CAI. Nothing is known about effects of
corticosteroids on the electrical membrane properties and 5-HT 1A receptor-mediated
responses in subfield CA3. This deficiency of information makes it difficult to elucidate
the role of corticosteroids in hippocampal information processing. As reviewed in the
previous section (The Hippocampus and HPA Axis Feedback Regulation) signals in the
hippocampus are processed along a trisynaptic pathway~ the neurons and the local
network in each subfield have distinct properties. Therefore, it is important to determine
the effects of corticosteroids in each subfield to understand how neural signaling in the
hippocampus is influenced by the steroids.

Clinical Importance
Corticosteroids maintain homeostasis by regulating sugar metabolism, ion balance,
immune responses and the responses to stress. Prolonged altered corticosteroid secretion
induces pathological conditions that often become neurotoxic (Uno et al., 1994). There
are several conditions that are associated with altered corticosterone secretion including
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prolonged or chronic stress, senescence, and depression. The following section reviews
the current information on stress, senescence, and depression and their relationship to
corticosteroids.

Stress
One of the key physiological responses to stress is an increase in corticosteroid
secretion, thereby increasing energy sources and limiting non-vital processes (Selye,
1936, 1946; Munck et al., 1984). Normally, corticosterone levels are brought back to
basal levels through feedback regulation. Prolonged stress is known to produce brain
damage and psychiatric disorders (reviewed by Sapolsky, 1992). Cerebral cortical
atrophy and hippocampal cell loss are commonly found in the brains of torture or abuse
victims (Jensen et al., 1982; Uno et al., 1989). Cognitive functions are also disrupted
with prolonged stress (reviewed by McEwen and Sapolsky, 1995). For example, certain
types of learning and memory performances are impaired in rats exposed to repeated
stress (Luine et al., 1994a,b).
Hippocampal neurons are particularly sensitive to prolonged stress and high
concentrations of glucocorticoids. Stress or high glucocorticoid levels induces neuronal
cell loss, (Sapolsky et al., 1985a; Uno et al., 1989; Stein-Behrens et al., 1995) atrophy,
and reduced branching of subfield CA3 pyramidal cell apical dendrites (Woolley et al.,
1990; Watanabe et al., 1992; Magarinos and McEwen, 1995a,b). Furthermore, stress or
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high glucocorticoid levels exacerbate hippocampal cell damage induced by a number of
different insults, i.e., ischemia (Sapolsky, 1985).
The exact mechanism underlying the toxic effects of glucocorticoids in hippocampal
subfield CA3 are not known. There is some indication that part of the deleterious effects
of glucocorticoids is due to the disruption of energy availability (Sapolsky, 1986;
Kadekaro, et al., 1988; Freo et al., 1992). Another important factor in glucocorticoidinduced toxicity in the hippocampus is the involvement of excitatory amino acid
neurotransmitters and calcium. Briefly, glucocorticoids increase excitatory amino acid
neurotransmission and they impair the ability of hippocampal neurons to maintain
intracellular calcium concentrations (reviewed by Sapolsky, 1994).

Senescence
Senescence is associated with elevated HP A axis activity in rats (reviewed by
Sapolsky et al., 1986; Sapolsky, 1992) and humans (Raskind et al., 1994). Aged rats
display higher ACTH and/or corticosterone plasma levels, and prolonged corticosterone
plasma levels following the removal of the stressor (Sapolsky et al., 1984b; 1985b;
Landfield, 1987).
The mechanism underlying the senescence-induced changes in HP A axis activity
involves the hippocampus (reviewed by Landfield and Eldridge, 1994). The hippocampus in aged rats display several physiological changes that may influence HP A axis
activity. For example, hippocampal corticosteroid receptor binding is decreased in aged
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rats (Sapolsky et al., l 983a; Rigter et al., 1984; Reul et al., 1988) and their regulation is
altered (Eldridge et al., 1989a,b). The changes in HPA axis activity in senescent rats
resemble the changes that occur with hippocampectomy (Fendler et al., 1961; Feldman
and Conforti 1976, 1980; Kant et al., 1984; Sapolsky et al., l 984b, 1989; Margarinos et

al., 1987). An age related loss in hippocampal neurons has also been reported (Coleman
et al., 1987; Sapolsky, 1992).
Based on the association between high glucocorticoid levels and hippocampal
neuron damage with stress and aging, Sapolsky and colleagues (1986) put forth a
glucocorticoid cascade hypothesis of neuronal damage. Briefly, a prolonged exposure to
elevated glucocorticoid levels, due to either stress or prolonged excitatory neural inputs
into the HP A axis, decreases corticosteroid receptor levels in the hippocampus. The
reduced corticosteroid receptor levels attenuate HP A axis feedback, further prolonging
the elevated glucocorticoid exposure. Eventually, the glucocorticoids produce toxic
effects (discussed above), inducing hippocampal cell loss.

Depression
Altered HP A axis activity is often associated with depression. The abnormalities of
the HPA system in depression are manifested as an: 1) increased level of cortisol in the
urine (free cortisol), plasma, and cerebral spinal fluid; 2) alterations in cortisol levels
during the diurnal rhythm; 3) an attenuation of the CRF-induced release of ACTH; and
4) decreased ability of dexamethasone to suppress cortisol secretion (reviewed by

56

Murphy 1991a; Checkley et al., 1992). Similar abnormalities are also observed in aged
rats (Issa et al., 1990).
It is not known why the HPA axis activity is elevated in depression, or how

corticosteroids and depression are linked. However, several lines of evidence implicate
corticosteroids in the etiology and treatment of depression (Barden et al., 1995). For
example, suppressing hypercortisol secretion has been reported to abate depression in
several independent studies (Jeffcote et al., 1979; Kelly et al., 1980; 1983; Nieman et al.,
1985; Murphy 1991b; Murphy et al., 1991a,b). Also chronic treatment with
antidepressant agents increases MR and GR binding capacity (Reul et al., 1993) and
mRNA levels in the rat hippocampus (Brady et al., 1991; Seckl and Fink, 1992; Yau et

al., 1995).

Cushing Syndrome and Hypercorticosteroid Secretion
Drugs targeting the HP A axis may be a viable resource for treating pathological
conditions associated with hypercorticosteroid secretion. It is well documented that
hypersecretion of corticosteroids is associated with prolonged stress, aging, and
depression. However, it has been difficult for investigators to show directly that
hypercorticosteroid secretion can precipitate these conditions. The best evidence
available supporting a direct link between hypercorticosteroid secretion with stress and
depression is derived from Cushing' s syndrome patients.
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One of the clinical features of Cushing' s syndrome is a persistent elevation in plasma
corticosteroid levels (Cushing, 1932). These patients also display many of the same
features characteristic of prolonged stress. For example, cerebral cortical atrophy and
hippocampal cell loss are commonly found in the brains of patients with Cushing' s
syndrome (Jensen et al., 1982; Uno et al., 1989; Starkman et al., 1992). Depression is a
clinical symptom in approximately half of the Cushing's syndrome cases (Jeffcoate et al.,
1979; Cohen, 1980) and suppressing the hypercorticosteroid secretion in these patients
dramatically reduces their depression (Jeffcote et al., 1979; Kelly et al., 1980, 1983;
Nieman et al., 1985).

Concluding Remarks
The hippocampus contains the highest density of corticosteroid receptors in the
brain, which leads to the suggestion that corticosteroids may have a profound influence
on hippocampal signal processing. Previous investigations have demonstrated that
corticosteroids modulate several cell membrane electrophysiological characteristics and
responses elicited by the activation of several different neurotransmitter receptors on
pyramidal cells in the hippocampus (Joels et al., 1991, Joels and de Kloet, 1992; Beck et

al., 1994; Birnstiel and Beck, 1995; Beck et al., 1996). The mechanism by which
corticosteroids modulate signal processing in the hippocampus is not completely
resolved. One piece of information that is missing is the effects of corticosteroids on
neural activity in all of the different hippocampal regions and subfields. The effects of
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corticosteroids on pyramidal cell membrane electrophysiological properties and 5-HT IA
receptor signal transduction system are not known in subfield CA3. This is an important
point since the neurons in subfield CA3 have a critical role in processing synaptic
information based on their unique synaptic organization (Knowles, 1992; Bernard and
Wheal, 1994), electrophysiological characteristics (Nunez et al., 1990; Beck et al., 1992;
Spruston and Johnston, 1992) and responses elicited by the activation of neurotransmitter receptors (Beck et al., 1992, 1995). Information on the actions of corticosteroids
on pyramidal cell membrane electrophysiological properties and the 5-HT IA receptor
signal transduction system will contribute to a basic understanding of how
corticosteroids alter cell excitability, alter responses elicited by the activation of
G protein-linked neurotransmitter receptors, and will help to elucidate the role of
corticosteroid receptors in information processing in the hippocampus.

CHAPTER III
CORTICOSTEROIDS ALTER PYRAMIDAL CELL ELECTROPHYSIOLOGICAL
CHARACTERISTICS IN HIPPOCAMP AL SUBFIELD CA3

Abstract
The hippocampus contains the highest density of MR and GR in the central
nervous system. The modulation of neuron excitability by corticosteroids in
hippocampal subfield CAI is well documented. However, it is not known if
corticosteroids produce different effects across the various hippocampal subfields.
Therefore, we used intracellular recording techniques to examine the actions of chronic
corticosteroid treatment (2 weeks) on the electrophysiological properties of rat
hippocampal subfield CA3 pyramidal cells. The treatment groups used in this
investigation were, adrenalectomy (ADX), selective MR activation with aldosterone
(ALD), MR and GR activation with high levels of corticosterone (HCT), and SHAM.
Corticosteroid treatment altered the percentage of nonburst and burst firing
neurons. The largest differences were observed with ADX animals where the
percentage ofnonbursting cells was 74% compared to 42% and 41% in ALD and
SHAM animals. Corticosteroids did not alter the membrane input resistance,
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resting potential, or time constant. Corticosteroids also had no effect on the slow- or
fast-afterhyperpolarizing potential amplitude or duration. The action potential duration
was longer in cells from ADX animals compared to cells from HCT and ALD animals.
Based on our results, we conclude that corticosteroids altered the firing mode and
decreased the action potential duration in subfield CA3 pyramidal cells. Both of these
findings are novel results which are distinct from those previously reported for subfield
CAI, suggesting that corticosteroids have different effects across hippocampal
subfields.

Introduction
Corticosteroids (glucocorticoids and mineralocorticoids) are steroid hormones that
maintain homeostasis by influencing energy production and electrolyte balance (Henkin,
1970; Munck et al., 1984, de Kloet, 1991). Corticosteroids are synthesized in the
adrenal cortex and their release regulated by the hypothalamic-pituitary-adrenal (HP A)
axis. Corticosteroids regulate gene expression through two receptor subtypes: MR (or
type I) and GR (or type II) (Joels et al., 1994b). MR has a high affinity for
corticosterone (Kn= 0.5 - 0. 7 nM) and is 70-80% occupied at basal physiological
corticosterone plasma levels (Krozowski and Funder, 1983; Reul and de Kloet, 1985;
Reul et al., 1987a,b). GR has a lower affinity for corticosterone, Kn= 2.5 - 5 nM, and
its occupancy changes from 15% at basal to 90% at peak and stress circulating
corticosterone levels (Reul and de Kloet, 1985; Reul et al., 1987a,b).

61

The hippocampus contains the highest concentration of corticosteroid receptors in
the CNS (McEwen et al., I968; Warembourg, I975; Sapolsky et al., I983b; Sarrieau et

al., I984; Reul and de Kloet, I985, I986; Magarinos et al., I989). Corticosteroids
have a profound influence on cells in the hippocampus (de Kloet et al, I 993; McEwen

et al., I993). The effects of MR and GR activation on pyramidal cell excitability and
ionic currents are well documented for subfield CAI. Generally, MR activation
increases CAI pyramidal cell excitability while GR activation decreases cell excitability
(Beck et al., I994; Joels and de Kloet, I994).
It is not known if corticosteroids have a different effect on neuron

electrophysiological properties in subfield CA3. This is an important issue since the
hippocampus processes information along a trisynaptic lamellar pathway (Andersen et

al., I971b; Andersen, I975) with the pyramidal cells in subfield CAI receiving their
inputs via Schaffer collaterals from the pyramidal cells in subfield CA3. It is important
to determine how corticosteroids modulate synaptic transmission along this pathway.
Neurons in each subfield have a distinct role in processing synaptic transmission based
on their different local intemeuron circuits (Knowles, I 992), electrophysiological
characteristics (Brown et al., I98I; Nunez et al., I990; Beck et al., I992; Spruston and
Johnston, I 992) and neurotransmitter-mediated responses (Beck et al., I 992, I 995).
Furthermore, the MR/GR ratio is greater in subfield CAI (6.5:I) compared to CA3
(I: I) as determined by a receptor binding investigation (Reul and de Kloet, I 985).
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We used intracellular recording techniques to examine the effects of chronic
corticosteroid treatment on the electrophysiological properties of pyramidal cells in
hippocampal subfield CA3. Our hypothesis is that corticosteroids will produce a
different modulatory action in subfield CA3 neurons as compared to those previously
reported for subfield CAI. These results will contribute to a basic understanding of
how corticosteroids alter cell excitability and will help to elucidate the role of
corticosteroid receptors in information processing in the hippocampus.

Materials and Methods
Materials
Corticosterone pellets were purchased from Innovative Research of America
(Sarasota, FL). Aldosterone was purchased from Steraloids Inc. (Wilton, NH).
Osmotic minipumps were purchased from Alzet Cooperation (Palo Alto, CA). All
other chemicals were obtained from standard commercial sources.

Animals
Four different treatment groups were used for the experiments in this investigation

(Table 1). The adrenalectomy was performed as described previously (Beck et

al., 1994, 1996; Birnstiel and Beck, 1995). Male Sprague-Dawley rats (Harlan) 751OOg were used for all treatment groups. Bilateral adrenalectomies were performed on
all treatment groups, except the SHAM group, to remove circulating corticosteroids.
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Table 1.- Treatment groups
Treatment
SHAM
ADX
ALD

Surgery
Intact
Adrenalectomy
Adrenalectomy

HCT

Adrenalectomy

Implant
Nothing
Nothing
Aldosterone ( 10 µg/h
minipump)
200 to 300 mg
corticosterone

ACSF
1 nM corticosterone
no steroid
3 nM aldosterone
100 nM corticosterone

Animals were anesthetized with ether. A small incision was made into the abdominal
cavity, just below the rib cage, and the adrenal glands carefully removed. The muscle
wall was then sutured and the skin closed using wound clips. The ADX group received
no further treatment. The ALD group had an osmotic minipump containing
aldosterone (Alzet model 2002) implanted subcutaneoulsy at the time of
adrenalectomy, to selectively activate MR. The minipump delivered 10 µg/h
aldosterone dissolved in propylene glycol. MR and GR were activated in another
group of animals (HCT) by subcutaneously implanting 200-300 mg corticosterone
pellets, 2 to 3 week release, in the back of the neck at the time of adrenalectomy. The
SHAM group of animals was produced by visualizing the adrenal glands but leaving
them intact. After surgery the animals were maintained on a standard twelve hour
light/dark cycle and rat chow, ad libitum. SHAM animals were given standard drinking
water while the ADX, ALD, and HCT animals were given 0.9 % NaCl drinking water
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ad libitum. At the end of 13 - 15 days, the animals were sacrificed in the morning and
hippocampal slices immediately prepared for electrophysiological recording. At the
time of sacrifice, trunk blood was collected to determine the plasma corticosterone
levels by radioimmune assay (Burgess and Randa, 1992).

Hippocampal Slice Preparation
Hippocampal slices were prepared for electrophysiological recording as previously
described (Okuhara and Beck, 1994). Rats were sacrificed by decapitation and the
brain rapidly removed and placed in ice cold artificial cerebrospinal fluid (ACSF)
containing in mM: NaCl 125, KCl 3, NaH2P04 1.25, MgS04 2, CaCli 2.5, dextroselO,
and NaHC03 28. The ACSF was also supplemented with steroids, as outlined in
Table 1, to maintain the treatment paradigm. We previously reported that steroids

must be present in the ACSF to preserve the corticosteroid-induced effects on neuron
cell properties (Beck et al., 1994). The hippocampus was dissected free and the dorsal
section cut in 500 - 550 µm sections on a vibratome. The hippocampal slices were then
placed in a holding vial containing ACSF bubbled with 95% Oi-5% C0 2 at room
temperature. The slices remained in the holding vial for at least one hour after
dissection before being transferred to the recording chamber. In the recording
chamber, the slice was stabilized between two nylon nets and continuously perfused
with ACSF bubbled with 95% 0 2-5% C0 2 at a rate of2-3 ml/min, at 3 l-32°C.
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Intracellular Recording
Intracellular recordings were made as previously described (Okuhara and Beck,
1994). Electrodes were pulled from borosilicilate capillary tubing on a Brown and
Flaming electrode puller (Sutter Instruments) to a resistance of 30-35 Mil (2 M KCl).
Pyramidal cells were impaled with brief ejections of positive current through the
electrode. The impaled cells were sealed by applying 1 nA hyperpolarizing current.
Electrical signals were collected and amplified using an Axoclamp 2A and Cyberamp
320 amplifier (Axon Instruments, Foster City, CA) and recorded on a Gould Series
3200 chart recorder (Gould Electronics, Valley View, OH). Data were collected online with pCLAMP software (Axon Instruments).

Statistical Analysis
Statistical comparisons were performed using analysis ofvariance (ANOVA). The
Student-Newman-Keuls method was used for post-hoc tests. A chi-square test was
used to determine if the percentage of bursting and nonbursting cells was different with
corticosterone treatment. All values are reported as mean± S.E.M. A p < 0.05 was
considered significant.

Results
Corticosterone Plasma Levels
SHAM corticosterone plasma levels ranged from 0 - 4.13 µg/dl (1.23 ± 0.24 µg/dl,

66

n = 22). ADX corticosterone plasma levels ranged from 0 - 0.5 µg/dl (0.21±0.05
µg/dl, n = 20). ALD corticosterone plasma levels ranged from 0 - 0.6 µg/dl (0.12 ±
0.05 µg/dl, n = 18). The lower and upper limits of the corticosterone radioimmune
assay were 0.05 and 50 µg/dl respectively. Adrenalectomies that produced
corticosterone concentrations :::; 0. 6 µg/ di were considered successful. Two SHAM, 12
ADX, and 13 ALD animals had corticosterone levels less than 0.05 µg/dl. The
concentration of aldosterone used in our experiments was based on an investigation by
Kuroda et al., ( 1994). The ALD treatment decreased MR binding by 61 % ( n = 5
animals) in the cytoplasm (data not shown) as determined using a homogenate binding
assay. HCT plasma concentrations greater than 20 µg/dl were considered successful.
HCT corticosterone plasma levels ranged from 25 to> 50 µg/dl (39.96 ± 2.90 µg/dl,
n = 11).

Passive Membrane Properties
The analysis of cell characteristics was as described previously (Beck et al., 1994).
Two different firing modes have been described for neurons in subfield CA3 (Wong
and Prince, 1978, 1981; Masukawa et al., 1982; Bilkey and Schwartzkroin, 1990).
One type of firing mode is a regular spiking pattern of action potentials in response to a
long depolarizing pulse (nonbursting cells) while the other mode is a cluster of spikes
which reside on a slow depolarizing potential (bursting cells). We also observed burst
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and nonburst firing in the present investigation (Figure 7). A chi-square analysis
indicated that the percentage of bursting and nonbursting cell types was dependent on
the type of corticosteroid treatment (Table 2). Since it is not known if corticosteroids
have different effects on nonbursting and bursting cell types, the pyramidal cell
characteristics data were divided into nonbursting and bursting cell types. The data
were first analyzed using a two-way ANOVA with treatment as one variable and cell
type as the other variable. If there were no significant effects between cell type, the
data were then analyzed using one-way ANOVA, collapsing across cell type and
grouping according to treatment only.
The membrane potential was read directly from the amplifier display. Corrections
for the input offset were done after the electrode was withdrawn from the cell. The
membrane input resistance and membrane time constant were calculated from currentvoltage plots. The current-voltage plot data were generated by injecting 300 ms pulses
of -900 to 0 pA in 100 pA increments into the cell while recording the cell's membrane
potential. The membrane input resistance was calculated from the slope of the linear
portion of the current-voltage plots. The membrane time constant corresponded to the
length of time required for the membrane potential to reach 63% of its final value
during a 300 ms pulse of -100 pA. There were no differences in resting membrane
potential, input resistance, or membrane time constant between either cell type or
corticosteroid treatment (Table 3).
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Figure 7. Membrane potential changes in a nonbunting and bunt firing cell.
A: Nonbursting cell. B: Bursting cell. The cells received an injection of -700 and
400 pA current pulses, 300 ms in duration. Plots were generated from digitized data,
therefore, action pote11tials appear truncated. Notice the slow depolarizing envelope in
the bursting cell (arrow).
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Table 2.--Number of nonbursting and bursting cells recorded from
the different corticosterone treatment groups
SHAM
13

ADX
29

ALD
11

HCT
16

bursting

19

10

15

10

% nonbursting

41

74

42

62

nonbursting

Proportion of nonbursting and bursting cells are different between
treatment groups.

x2 = 9.592, d.f = 3, P = 0.022.

Table 3.--The effects of corticosteroids on passive membrane electrophysiological
properties
Treatment & cell type
SHAM NB
B
ADX
NB
B
ALD
NB
B
HCT
NB
B

RMP
(mV)
68.4 ± 1.4 (13)
72.0 ± 1.2 (19)
68.8 ± 0.9 (29)
69.3 ± 1.4 (10)
68.4 ± 1.8 (11)
71.7± 1.2 (15)
68.6 ± 1.5 (16)
68.6 ± 2.1 (10)

All values are reported as mean± SEM (n)
Cell type NB, nonbursting; B, bursting

Resistance
(Mn)
50.1 ± 2.8 (13)
51.0 ± 1.9 (19)
51.6 ± 2.3 (29)
48.6 ± 3.0 (10)
45.2 ± 2.3 (11)
49.8± 2.9 (15)
54. 7 ± 1. 7 ( 16)
47.7 ± 4.8 (9)

Tau
(ms)
49.3 ± 4.2 (13)
49.3 ± 3.6 (19)
42.8 ± 2.4 (29)
53.4 ± 5.7 (10)
43.8 ± 5.4 (11)
48.1 ± 6.0 (15)
44.5 ± 4.3 (15)
55.1±6.1 (9)
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Action Potential and fAHP Properties
Table 4 summarizes the effects of corticosteroids on action potential and fAHP
properties. Action potentials were generated with short 2-4 ms depolarizing pulses.
The action potential threshold was the membrane potential value just before the action
potential spike began to rise. The action potential threshold was used as the baseline
value to calculate its height and baseline duration. The action potential height was
measured from baseline to the peak of the spike. The action potential half-width was
the width of the spike at 50% of its peak amplitude. The action potential baseline
duration was the spike width along its baseline. fAHP' s were generated with 20 ms
pulses of enough current (300-600 pA) to generate a single action potential. The fAHP
amplitude was measured from threshold to the peak hyperpolarizing amplitude which
occurred 1-4 ms after the end of the spike. The fAHP t 112 corresponds to the amount
of time for the fAHP to decrease from its peak amplitude to one-half of its value.
Based on a two-way ANOVA examination, neither corticosteroid treatment nor
cell type had an effect on the action potential threshold. The action potential peak
amplitude was smaller in bursting cells (80.3 ± 0.7 mV, n = 52.) compared to
nonbursting cells (82.7 ± 0.6 mV, n = 69) (F = 6.252; d.f = 1, 113; P = 0.014).
However, corticosteroid treatment had no effect on the action potential peak amplitude
(F = 2.021; d.f. = 3, 113; P = 0.115). Corticosteroid treatment did alter the action
potential duration. The action potential half- and baseline widths were wider in cells

71

from ADX animals compared to cells from ALD and HCT animals (Figure 8). The
action potential half-width was also wider in cells from SHAM animals compared to
ALD.

sAHP and Accommodation
The effects of corticosteroids on sAHP and accommodation properties are
summarized in Table 5. sAHP's were generated by injecting 300-500 ms pulses of
800-1200 pA to elicit a train of sodium action potentials. A train of sodium action
potentials usually generate two types of afterhyperpolarizing potentials, a mediumafterhyperpolarizing potential followed by a sAHP (Madison and Nicoll, 1984).
Therefore, the sAHP amplitude was measured after the medium-afterhyperpolarizing
potential ended (approximately 100 to 250 ms after the current pulse terminated). The
sAHP t 112 corresponds to the amount of time for the sAHP to decrease from its peak
amplitude to one-half of its baseline value. Spike accommodation corresponds to the
number of action potentials that occurred during a 300 ms depolarizing pulse.
Two-way ANOVA analysis of the data indicated that the sAHP amplitude was
smaller in nonbursting cells (10.8 ± 0.5 mV, n = 65) compared to bursting cells (12.4 ±
0.5 mV, n = 38) (F = 5.822; d.f = 1, 111; P = 0.017). Consistent with the larger sAHP
in bursting cells, accommodation was also greater in bursting cells (4.5 ± 0.47 spikes, n

= 53) compared to nonbursting cells (5.7 ± 0.3, n = 64) (F = 5.743; d.f = 1, 110;

Table 4.-The etTect of corticosteroids on action potential and fAHP properties.

Treatment
& cell type
SHAM NB
B
NB
ADX
B
ALD
NB
B
HCT
NB
B

Threshold
(mV)
50.9 ± 0.6 (13)
50.8 ± 0.4 (I9)
51.4 ±-0.5 (29)
51.7 ± 0.7 (IO)
51.9 ± 0.7 (11)
50. I ± 0.5 (I4)
52.0 ± 0.7 (I6)
51.7 ± 0.6 (9)

Action Potential
Half-width a
Amplitude
(mV)
{f:!s}
82.2 ± 1.4 (13) 963 ± 40 (13)
79.7 ± 0.8 (I9) 926 ± 20 (I9)
84.0 ± I. I (29) ·975 ± 20 (28)
82.5 ± 0.5 (IO) 940 ± 30 (10)
83.5 ± 1.3 (I I) 877 ± 20 (I I)
79.9 ± 1.4 (I4) 862 ± 20 (I4)
81.0 ± 1.3 (I6) 896 ± 20 (I6)
896 ± 30 (9)
79.2 ± I .4 (9)

fAHP
Baseline width b
(ms)
1.67 ± 0.06 (13)
I .60 ± 0.04 (I 9)
I .68 ± 0.04 (28)
1.64 ± 0.07 (10)
1.52 ± 0.04 (I I)
I .49 ± 0.05 (I4)
1.53 ± 0.04 (16)
I .58 ± 0.06 (9)

Amplitude
(mV)
7.8 ± 0.4 (13)
7.7 ± 0.4 (17)
7.8 ± 0.6 {26)
6.7 ± 0.5 (9)
7.2 ± 0.8 (I I)
7.6 ± 0.5 (15)
9.0 ± 0.6 (I4)
8.4 ± 0.7 (10)

t112
(ms)
3.3 ± 0.3 (13)
3.0 ± 0.2 (I 7)
2:9·± 0.2 (26)
2.4 ± 0.2 (9)
2.7 ± 0.2 (11)
2.9 ± 0.3 (I5)
2.8 ± 0.2 (I4)
3.1 ± 0.4 (10)

All values are reported as mean± SEM (n)
Cell types NB, nonbursting; B, bursting
• ADX (966 ± 20 µs, n =38) different from ALD (869 ± I 0 µs, n = 25) and HCT (896 ± 20 µs, n = 25)
SHAM (94I ± 20 µs, n =32) different from ALD. One-way ANOVA F = 4.419; d.f = 3,I 13; P = 0.006.
Student-Newman-Keuls p < 0.05
b

ADX (I .67 ± 0.04 ms, n = 38) different from ALD (1.5 I ± 0.03 ms, n = 25) and HCT (1.55 ± 0.03 ms, n = 15)

t:j
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P

= 0.018).

d.f

= 3,

Corticosteroid treatment had no effect on the sAHP amplitude (F = 2.096,

111; P

= 0.105) or accommodation properties (F = 0.04; d.f = 3,

110; P

=

0.989).

2omvl
1 ms

Figure 8. Superimposed action potentials in a cell from an ADX and HCT
animal. Each trace represents an average of five action potentials in a cell from either
an ADX (solid line) or HCT (broken line) treated animal.
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Table 5.-The effect of corticosteroids on sAHP and accommodation
properties
Treatment & cell
type
SHAM NB
B
ADX
NB
B
ALD
NB
B
HCT
NB
B

sAHP
AmElitude {mV}
11.8 ± 0.9 {13)
13.7 ± 0.8 {19)
11.7± 0.6 (28)
11.3 ± 1.1 (10)
9.9 ± 1.2 {11)
13.8± 1.1 {15)
9.7 ± 1.0 (13)
10.9 ± 1.1 {9}

sAHP
ti12 {ms}
1001±86 (6)
945 ± 55 {11)
1126 ± 84 (19)
961±65 (9)
1186 ± 238 (10)
1022 ± 55 (12)
853 ± 106 (11)
1052 ± 58 {6}

Accommodation
{no. of SEikes2
5.2 ± 0.6 {13)
5.1±0.4 {19)
6.4 ± 0. 7 (26)
4.0 ± 0.7 (9)
4.9 ± 0.5 {11)
4.1±0.5 (15)
6.3 ± 0.9 (14)
3.9 ± 0.5 {10}

Discussion
We examined the effects of corticosteroids on pyramidal cell electrical properties
in subfield CA3. The primary finding was that the percentage of nonbursting and
bursting cell types was dependent upon corticosterone treatment. Therefore, we
analyzed the cell characteristics according to treatment and cell type. There were
several cell characteristics that were different between nonbursting and bursting cell
types. Nonbursting cells had a larger action potential peak amplitude, less
accommodation, and a smaller sAHP amplitude compared to bursting cells. However,
corticosteroid treatment had no effect on the these cell characteristics. Corticosteroids
also had no effect on the passive membrane properties (membrane potential, input
resistance, and time constant), fAHP amplitude and duration. Corticosteroids did
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increase the action potential duration in cells from ADX animals compared to ALD and
HCT. The action potential duration was also longer in cells from SHAM animals
compared to ALD.

Percentage ofNonbursting and Bursting Cells
The pyramidal cells in subfield CA3 are divided into bursting and nonbursting cell
types, depending on their firing pattern. Bursting cells produce a burst of 3-5 action
potentials on top of a slow depolarizing envelope (Wong and Prince, 1978, 1981;
Masukawa et al., 1982; Bilkey and Schwartzkroin, 1990). The percentage of
nonbursting cells we observed in subfield CA3 in SHAM and ALD animals (41 % 42%) is similar to the values reported for naive animals (40% - 41%) (Masukawa et

al., 1982; Bilkey and Schwartzkroin, 1990). ADX produced the largest shift in the
percentage of nonbursting cells, increasing the amount of nonbursting cells to 74%.
The effect of corticosteroids on the ratio of burst and nonbursting cells do not
appear to be secondary to changes in cell viability. The cell resting membrane
potential, resistance, and time constant were not altered by corticosterone treatment,
and were comparable to those reported in naive animals (Beck et al., 1992).
Adrenalectomy has been reported to induce granule cell degeneration in the
dentate gyrus. While the most severe cell loss occurs between 4 or more months after
adrenalectomy (Sloviter et al., 1989; 1993; Roy et al., 1990; McNeil et al., 1991;
Sapolsky et al., 1991; Jaarsma et al., 1992), granule cell degeneration was also
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reported to occur between 1 to 3 weeks after adrenalectomy (Gould et al., 1990;
Sloviter et al., 1993). Granule cells form synapses with subfield CA3 pyramidal cells
and the loss of granule cells induced by adrenalectomy may account for the large shift
in the percentage of nonbursting cells. However, there is no evidence to support that
the degenerating granule neurons are altering the physiological or biochemical
properties of CA3 pyramidal cells.
Based on several lines of evidence it is unlikely that the large shift in percentage on
nonbursting cells observed with ADX treatment is due to the loss of dentate granule
cells. First, Sloviter et al. (1993, 1995) report a large variation in granule cell
degeneration at any given time point and the percentage of degenerating granule cells
following 14 days of adrenalectomy was not reported. The large variation in
degenerating granule cells may have a significant effect on the results if only a small
number of animals were used. However, we examined the effects of ADX in twenty
rats, a sample size comparable if not greater then that used by Sloviter et al., (1993).
Second, it is unlikely that the massive loss of granule cells only influenced the firing
pattern and action potential duration of CA3 neurons. Such a huge loss in synaptic
inputs should attenuate numerous electrical membrane properties. Finally, it was
reported that within one week of adrenalectomy both cell loss and mitosis was induced
(Cameron and Gould, 1996), therefore, the overall synaptic integrity between the
dentate and subfield CA3 may not altered with adrenalectomy. While the loss of

77

granule cells following 14 days of adrenalectomy is important and may have a
significant effect on neuronal signaling between the dentate and subfield CA3, it does
not readily explain or diminish the significance of the large difference in the percentage
of nonburstings cells observed in ADX treated animals.
A possible explanation for the increased number of nonbursting cells is that
corticosteroids modulate the ionic current that influences the bursting firing mode. The
exact nature of burst firing is not known. Early investigations reported that burst firing
is due to a slow Ca2+ current (Wong and Prince, 1978, 1981 ), however, there is also
evidence supporting the role ofNa+ current in burst firing, possibly a persistent Na+
current (Konnerth et al., 1986; French et al., 1990; Azouz et al., 1996; Jensen et al.,
1996). The ionic conductances underlying pyramidal cell burst firing may be different
across hippocampal subfields (Azouz et al., 1996; Jensen et al., 1996). Burst firing in
subfield CA3 may depend on both Na+ and Ca2+ currents (Wong and Prince, 1978,
1981; Konnerth et al., 1986), whereas, burst firing in subfield CAI cells depend upon
Na+ currents only (Azouz et al., 1996; Jensen et al., 1996). Since corticosterone
treatment influences burst firing in subfield CA3 neurons, it may be possible to
determine the exact ion currents and channels underlying burst firing in subfield CA3
cells by comparing the isolated ion currents in cells from adrenalectomized and
corticosterone treated animals.
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The effects of corticosteroids on isolated Ca2 + and Na+ currents in subfield CA3
are not known. The action of corticosteroids on Ca2+ currents in subfield CAI have
been determined but the results are not straight forward. Adrenalectomy decreased the
Ca2+ action potential area (Kerr et al., I 989; I 992) but increased Ca2+ currents (Karst
and Joels, I994). Corticosteroids also modulate Ca2+ homeostasis (Elliott and
Sapolsky, I993), which in turn, may influence the Ca2+ driving potential and/or ion
channels. Other factors contribute to burst and nonburst firing and include the relative
densities and distribution of Ca2 +-independent K+ channels along a neuron (Migliore et

al., I995) and neuron morphology (Bilkey and Schwartzkroin, I990).

Passive Membrane and Action Potential Properties
The membrane input resistance and time constant are determined by passive and
voltage-dependent ion channels that normally function near the cell's resting membrane
potential (Rall, I 977). The membrane input resistance and time constant determine the
decay of synaptic potentials in the dendrites and soma, therefore, influencing the
integration of postsynaptic potentials (Rall, I 977). Corticosteroids did not alter the
resting membrane potential, input resistance, or time constant in subfield CA3
pyramidal neurons. In contrast, the membrane input resistance and time constant in
subfield CAI pyramidal cells are altered by corticosteroids. The changes in CAI cells
may be due to alterations in IQ (Karst et al., I993; Beck et al., I994), which is less
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prominent in CA3 cells (Spruston and Johnston I 992). Therefore, corticosteroids may
alter the integration of postsynaptic potentials in CAI but not in CA3 cells.
The decrease in action potential half- and baseline width in cells from ALD and
HCT animals suggest that corticosteroids may play a role in the shaping of action
potentials. Furthermore, corticosteroids appear to have different effects on action
potential characteristics in cells from subfields CAI and CA3. Chronic low (basal)
levels of corticosterone increased action potential height and duration in pyramidal cells
from subfield CAI and decreased the fAHP amplitude (Beck et al., I994) when
compared to cells from adrenalectomized animals. In the present study we observed a
decrease in the action potential duration and no change in the action potential height
and fAHP amplitude in cells from ALD animals when compared to ADX.
The broader action potential duration in cells from SHAM and ADX animals may
be physiologically important. Wheeler et al., (I 996) reported that increasing the action
2

potential duration leads to an increase in Ca

+

influx at the presynaptic terminal and

enhances synaptic strength. Therefore, MR activation could conceivably have different
effects on Ca2+ influx at the axon terminals arising from subfields CAI and CA3. The
narrowing of action potentials may result from changes in any of the K+ and Ca2+ ion
currents which shape the action potential (Rutecki, I 992). Further experiments are
required to determine which current(s) are altered by corticosteroids.
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sAHP and Accommodation
The sAHP and accommodation characteristics in cells from subfield CAI were the
first electrophysiological membrane characteristics identified that were altered by
corticosteroids (Joels and de Kloet, I989; Kerr et al., I989; Joels and de Kloet, I990).
Both of these properties rely on a Ca2+-dependent K+ current (Madison and Nicoll,
I984; Lancaster and Nicoll, I987). In subfield CAI, short term and chronic MR
activation decreased spike accommodation and sAHP amplitude (Kerr et al., I989;
Joels and de Kloet, I990; Beck et al., I994).
Unlike the cells in subfield CAI, corticosteroids did not alter the sAHP or
accommodation in subfield CA3 neurons. This is an interesting result because both the
sAHP and burst firing are triggered by Ca2+ currents (Wong and Prince, I 978, I 98 I;
Schwartzkroin and Stafstrom, I 980; Konnerth et al., I 986; Sah and Isaacson, I 995),
yet corticosteroids only appear to alter the cell's firing mode. The relationship between
burst firing and sAHPs is not well known. There are several lines of evidence
suggesting that burst firing and sAHP may be independent properties. The channels
underlying burst firing and sAHP's may be located in different areas of the neurons
(soma versus dendrites) (Wong et al. I979; Bernardo et al., I982; Wong and Stewart et

al., I992; Sah and Bekkers, I996). In subfield CAI, the ionic currents mediating the
sAHP and burst firing appear to be separate (Azouz et al., I996). Finally, in subfield
CA3, both Na+ and Ca2+ currents influence burst firing (Wong and Prince, I978, I98I;
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Konnerth et al., 1986). Under our experimental conditions, it was not possible to
determine the nature of the current(s) that shifted the fraction of nonbursting and
bursting cells.
In conclusion, corticosteroids have numerous effects on neurons located in the
hippocampus. Corticosteroids modulate neuron electropysiological properties (Beck et

al., 1994; Joels and de Kloet, 1994; Joels et al., 1994a, 1994b), morphology (Woolley
et al., 1990; Gould et al., 1991; Watanabe et al., 1992; Magarinos and McEwen, 1995a,
I 995b) and neurotransmitter receptor-mediated responses in the hippocampus (Joels
and de Kloet, 1994; Birnstiel and Beck, 1995; Beck et al., 1996). Corticosteroids may
alter signal processing in the hippocampus through a complex mechanism, producing
different effects in each area of the trisynaptic circuitry (dentate-CA3-CAI). For
example, corticosteroids selectively alter dendritic morphology within subfield CA3
(Woolley et al., 1990; Watanabe et al., 1992; Magarinos and McEwen, 1995a,b).
Corticosteroids also have different effects on the neuron's electrophysiological
properties in subfields CAI and CA3. This distinct role of corticosteroid modulatory
actions among the different hippocampal subfields may be very important in signal
processing in the hippocampus.

CHAPTER IV
CORTICOSTEROIDS ALTER 5-HT1A SIGNAL
TRANSDUCTION SYSTEM IN HIPPOCAMP AL
SUBFIELD CA3 PYRAMIDAL CELLS

Abstract
Corticosteroids influence neuron activity in the hippocampus through the
activation of MR and GR receptors. For example, corticosteroids modulate the
responses elicited by the activation of several different neurotransmitter receptors on
hippocampal pyramidal cells. However, the effects of corticosteroids on the 5-HT iA
receptor signal transduction system (receptor-G protein-potassium channel) in subfield
CA3 are not completely known. Therefore, we used single-electrode voltage clamp
techniques to examine the actions of chronic corticosteroid treatment on the 5-HT lA
signal transduction system in rat hippocampal subfield CA3 pyramidal cells. The
treatment groups used in this investigation were: ADX, ALD, HCT, and SHAM.
Corticosteroids altered the 5-HT concentration-response curve characteristics for
the 5-HTiA receptor. The ECso value was smaller in cells from ADX compared to the
other treatment groups. The Emax value was smaller in cells from HCT compared to
SHAM and ADX animals. G protein function was also altered by corticosterone
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treatment. Less current was elicited by GTPyS in cells from HCT compared to the
other treatment groups and in cells from SHAM compared to ADX animals.
Corticosteroid treatment did not alter the current-voltage relationship or the reversal
potential of the potassium current linked to the 5-HTIA receptor. Based on these new
findings we conclude that corticosteroids alter the 5-HT IA receptor mediated-response
in hippocampal subfield CA3 neurons. Furthermore, corticosteroids alter the 5-HT IA
signal transduction system at site(s) downstream of the receptor.

Introduction
Activation of corticosteroid receptors in the hippocampus influences hippocampusrelated behaviors (de Kloet et al., 1993) and modulates HPA axis activity (Jacobson
and Sapolsky, 1991 ). Corticosteroid hormones (glucocorticoids and mineralocorticoids) regulate gene expression through the interaction with two receptor
subtypes: MR and GR (Joels et al., l 994b). MR and GR have a 5-10 fold difference in
their affinity for the rat corticosteroid hormone corticosterone. MR has a high affinity
for corticosterone and is 70-80% occupied at basal corticosterone plasma levels
(Krozowski and Funder, 1983; Reul and de Kloet, 1985; Reul et al., 1987a,b). GR has
a lower affinity for corticosterone and its occupancy changes from 15% at basal to 90%
at peak circadian or stress-induced circulating corticosterone levels (Reul and de
Kloet, 1985; Reul et al., 1987a,b).

84

One way corticosteroids alter neural activity in the hippocampus is by modulating
the responses elicited by the activation of neurotransmitter receptors (Joels and de
Kloet, I 994; McEwen, I 996), including the 5-HT tA receptor (Joels and de Kloet, I 994;
Beck et al., I 996). The 5-HT tA receptor is a G protein-coupled receptor. Activation
of the 5-HT tA receptor in the hippocampus increases an inward rectifying potassium
current linked to a PTX sensitive G protein (Andrade et al., I986; Andrade and Nicoll,
I987; Colino and Halliwell, I987; Beck I989; Beck and Choi, I99I; Okuhara and
Beck, I 994). Corticosteroids alter the 5-HT tA receptor-mediated responses in
hippocampal subfield CAI (Joels et al., I99I, Joels and de Kloet, I992; Beck et al.,
I996). However, the effects of corticosteroids on the 5-HT1A receptor-mediated
responses in subfield CA3 are not known.
Previous studies have examined the effects of corticosteroids on the number of 5HT tA binding sites and mRNA levels (Chaouloff, I 995). Corticosteroids appear to
alter 5-HT tA receptor binding sites in subfield CA3, but not in subfield CAI
(Mendelson and McEwen, I992a,b; Kuroda et al., I994). Recently, we reported that
chronic exposure to high levels of corticosteroids increased the protein levels of Gs,
Giland 2 ,

and

Go

a-subunits in the hippocampus (Okuhara et al., I996a). However, the

actions of corticosteroids on G protein function in the individual hippocampal subfields
and on G protein-evoked currents are not known.
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In the present study, we examined the effects of chronic corticosteroid treatment
on different components of the 5-HT lA signal transduction system in hippocampal
subfield CA3 pyramidal cells. Single-electrode voltage clamp techniques were used in
the brain slice preparation. We hypothesized that chronic corticosteroid treatment
would alter the 5-HT lA receptor signal transduction system in subfield CA3. The
results from these experiments will contribute to a basic understanding of how
corticosteroids alter responses elicited by the activation of G protein-linked
neurotransmitter receptors and help to elucidate the role of corticosteroids in
hippocampus-related behaviors and HP A axis feedback.

Materials and Methods
Materials
Corticosterone pellets were purchased from Innovative Research of America
(Sarasota,1FL). Aldosterone was purchased from Steraloids Inc. (Wilton, NH).
Osmotic minipumps were purchased from Alza Cooperation (Palo Alto, CA).
Tetrodotoxin and 5-HT hydrochloride were purchased from Sigma Chemicals (St.
Louis, MO). GTPyS was purchased from Boerhinger Mannheim (Indianapolis, IN).
All other chemicals were obtained from standard commercial sources.
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Animals
Four different treatment groups were used for the experiments in this investigation

(Table 1, pg. 64). The adrenalectomy was performed as described previously (Beck et

al. 1994, 1996; Bimstiel and Beck, 1995). Male Sprague-Dawley rats (Harlan) 751OOg were used for all treatment groups. Bilateral adrenalectomies were performed on
all treatment groups, except the SHAM group, to remove circulating corticosteroids.
The animal was anesthetized with ether, a small incision was made into the abdominal
cavity, just below the rib cage, and the adrenal glands carefully removed. The muscle
wall was then sutured and the skin closed using wound clips. The ADX group received
no further treatment. The ALD group had an osmotic minipump containing
aldosterone (Alzet model 2002), implanted subcutaneoulsy at the time of
adrenalectomy, to selectively activate l\1R. The minipump delivered 10 µg/h
aldosterone dissolved in propylene glycol. l\1R and GR were activated in another
group of animals (HCT) by subcutaneously implanting 200-300 mg corticosterone
pellets, 2 to 3 week release, in the back of the neck at the time of adrenalectomy. The
SHAM group of animals was produced by visualizing the adrenal glands but leaving
them intact. After surgery the animals were maintained on a standard twelve hour
light/dark cycle and rat chow, ad libitum. SHAM animals were given standard drinking
water while the ADX, ALD, and HCT animals were given 0.9 % NaCl drinking water
ad libitum. At the end of 13 - 15 days, the animals were sacrificed in the morning and
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hippocampal slices immediately prepared for electrophysiological recording. At the
time of sacrifice, trunk blood was collected to determine the plasma corticosterone
levels by radioimmune assay (Burgess and Handa, 1992).

Hippocampal Slice Preparation
Hippocampal slices were prepared for electrophysiological recording as previously
described (Okuhara and Beck, 1994). Rats were sacrificed by decapitation and the
brain rapidly removed and placed in ice cold artificial cerebrospinal fluid (ACSF)
containing in mM: NaCl 125, KCl 3, NaH2P04 1.25, MgS04 2, CaCli 2.5, dextroselO,
and NaHC0 3 28. The ACSF was also supplemented with steroids, as outlined in
Table 1 (pg. 64), to maintain the treatment paradigm. We previously reported that

steroids must be present in the ACSF to preserve the corticosteroid-induced effects on
neuron cell properties (Beck et al., 1994). The hippocampus was dissected free and the
dorsal section cut in 500 - 550 µm sections on a vibratome. The hippocampal slices
were then placed in a holding vial containing ACSF bubbled with 95% Oi-5% C02 at
room temperature. The slices remained in the holding vial for at least one hour after
dissection before being transferred to the recording chamber. In the recording
chamber, the slice was stabilized between two nylon nets and continuously perfused
with ACSF bubbled with 95% Oi-5% C02 at a rate of 2-3 ml/min, at 3 l-32°C.
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Intracellular Recording
Intracellular recordings were made as previously described (Okuhara and Beck,
1994). Electrodes were pulled from borosilicilate capillary tubing on a Brown and
Flaming electrode puller (Sutter Instruments) to a resistance of 30-35 Mn (2 M KCl).
Pyramidal cells were impaled with brief ejections of positive current through the
electrode. The impaled cells were sealed by applying 1 nA hyperpolarizing current.
Electrical signals were collected and amplified using an Axoclamp 2A and Cyberamp
320 amplifier (Axon Instruments, Foster City, CA) and recorded on a Gould Series
3200 chart recorder (Gould Electronics, Valley View, OH). Data were collected online with pCLAMP software (Axon Instruments).
Discontinuous single-electrode voltage clamp (dSEVC) technique was used under
the following conditions. Briefly, the slice was perfused with 1 µM tetrodotoxin and
the capacitance compensation was set and switching frequency adjusted to 4 kHz at the
beginning of the experiment. The cells membrane potential was clamped at a gain of 8
nA/mV and headstage continuously monitored.

5-HT Concentration-Response
Cells were voltage clamped at -65 mV and data for the 5-HT concentration
response curves were collected by perfusing the slice with increasing 5-HT
concentrations (3, 10, 30, and 100 or 110 µM) and the maximum current response
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evoked during the drug application was recorded. During drug perfusion, if the
voltage clamp deviated by more than 1 mV, the data was discarded.
The magnitude of the current response was fitted to a hyperbolic function
(Okuhara and Beck, 1994; Beck et al., 1996):
E

=

Emax I [l+(ECso I [5-HT]t]

where Eis the current produced at the 5-HT concentration [5-HT], Emax is the
maximal current response, ECso is the 5-HT concentration which produces half the
Emax response, and N is the slope index. The fitted Emax , EC 5o and N values within
each experimental group were used for statistical comparisons.

Experiments with GTPyS
The effect of corticosteroids on G protein activity was determined by measuring
the magnitude of outward current evoked by 15 mM GTPyS which was included in the
recording electrode. After the cell's membrane potential stabilized, the cell was voltage
clamped at its resting membrane potential (i.e., the potential where no current was
required to maintain the voltage clamp). The voltage clamp was then moved to -60
m V and the amount of current required to maintain the clamp was recorded.

1-V Relationship
The effect of corticosteroids on the potassium current linked to the 5-HT IA
receptor was determined by plotting the I-V curve for the outward current evoked by
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the activation of the 5-HT1A receptor. After the cell's membrane potential stabilized,
the cell was voltage clamped at its resting membrane potential (the potential where no
current was required to maintain the voltage clamp). Data for IV plots were obtained
by running voltage ramps in the presence and absence of 100 µM 5-HT. Voltage
ramps were run from approximately-125 mV to -30 mV at a rate of 1 mV/s. The 1-V
plot for the potassium current evoked by the activation of the 5-HT 1A receptor was
constructed by subtracting the control ramp values (no 5-HT) from the ramp values in
the presence of 100 µM 5-HT. The reversal potential and potential where inward
rectification occurred were analyzed for each curve.

Statistical Analysis
Statistical comparisons were performed using analysis of variance (ANOVA). The
Student-Newman-Keuls method was used for post-hoc tests. All values are reported
as mean± SEM. A p < 0.05 was considered significant.

Results
Corticosterone Plasma Levels
SHAM corticosterone plasma levels ranged from 0 - 4.13 µg/dl (1.35 ± 0.32 µg/dl,
n = 15). ADX corticosterone plasma levels ranged from 0 - 0.22 µg/dl (0.06 ± 0.03
µg/dl, n =12). ALD corticosterone plasma levels ranged from 0 - 0.56 µg/dl (0.07 ±
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0.05 µg/dl, n = 16). The lower and upper limits of the corticosterone radioimmune
assay were 0.05 and 50 µg/dl respectively. Adrenalectomies that produced
corticosterone concentrations_:::: 0.6 µg/dl were considered successful. Two SHAM, 8
ADX, and 14 ALD animals had corticosterone levels less than 0.05 µg/dl. The
concentration of aldosterone used in our experiments was based on an investigation by
Kuroda et al., (1994). The ALD treatment decreased MR binding by 61% (n=5
animals) in the cytoplasm (data not shown) as determined using a homogenate binding
assay. HCT plasma concentrations greater than 20 µg/dl were considered successful.
HCT corticosterone plasma levels ranged from 25 to> 50 µg/dl (34 ± 3 µg/dl, n = 16).

5-HT Concentration Response Curve Characteristics
for the 5-HT iA Receptor
Activation of the 5-HT 1A receptor evoked an outward current in a concentrationdependent manner (Figure 9A). The 5-HT concentration-response curve
characteristics recorded from cells from corticosterone treated animals are summarized
in Table 6. The EC 5o obtained in cells from ADX treated rats was smaller compared to
cells from either SHAM, ALD, or HCT treated animals (Figure 9B). The Emax value
was also smaller in cells from HCT when compared to cells from SHAM or ADX
treated animals (figure 9B). Corticosterone treatment did not alter the slope index.
Perfusion ofhippocampal slices with 5-HT may activate a number of different 5HT receptor subtypes. Two 5-HT receptors subtypes which may be activated by 5-HT
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and thereby modulate the 5-HT IA current are the 5-HT4 and 5-HT1 receptors. Both of
these receptors are located in the hippocampus (Lovenberg et al., 1993; Meyerhor et

al., 1993; Ruat et al., 1993; Jakeman et al., 1994; Roychowdhury et al., 1994; Waeber
et al., 1994) and are positively coupled to adenylyl cyclase (Lovenberg et al., 1993;
Ruat et al., 1993; Shen et al., 1993; Tsou et al., 1994). Activation of the 5-HT4
receptor produces a slow depolarizing response in subfield CAI pyramidal cells
(Andrade and Chaput, 1991). Since the 5-HT4 and 5-HT1 receptors have not been
characterized in subfield CA3, we determined if activation of these receptors altered the
5-HT induced outward current recorded in subfield CA3. The magnitude of the
outward current elicited by 30 µM 5-HT was not altered by the administration of I µM
GRI 13808 and ritanserin (n = 6) (Figure 10), 5-HT4 and 5-HT1 receptor antagonists,
respectively (Boess and Martin, 1994; Torres et al., 1994). Perfusion of the slice with
30 µM 5-HT while blocking the 5-HT IA receptor with either I µMWAY I 00635 or
3 µM spiperone did not produce either a depolarizing or inward current response (n=3)
(data not shown).

Activation of G proteins with GTPyS
The injection of GTPyS into neurons produced a hyperpolarization of the resting
membrane potential. There was no difference in the resting membrane potential
between treatment groups. The resting membrane potentials were SHAM -76 ± I mV,
ADX-79 ± 2 mV, ALD -74 ±I mV, and HCT-76 ±I mV. The relative amount of
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Figure 9. Concentration-dependent response of subfield CA3 pyramidal cells to
5-HT perfusion. A: Chart recording of the concentration-dependent current response
of a CA3 cell to 5-HT perfusion. The drug was applied for the duration depicted by
the line above the chart record. B: Concentration-response curves from data collected
from all of the cells from SHAM (open circles), ADX (closed circles) and HCT (closed
squares) treated animals. The data were fit to a hyperbolic function as described in
MATERIALS AND METHODS in this chapter.
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Table 6.-The effect of corticosteroids on the 5-HT concentrationresponse curve characteristics for the 5-HT tA receptor
Treatment
SHAM

ECso (-log)
4.96 ± 0.06 (15)

Emax (pA)
551±46 (15)

N
2.0 ± 0.1 (15)

ADX

5.12 ± 0.04• (18)

540 ± 47 (16)

2.3 ± 0.1 (18)

ALO

4.96 ± 0.03 (16)

469 ± 39 (15)

2.4 ± 0.2 (16)

HCT

4.85 ± 0.04 (15)

360 ± 30 (15)b

2.3 ± 0.2 (15)

All values are reported as mean± SEM (n)
F = 11.631; d.f = 3, 60; P < 0.001. Student-Newman-Keuls, ADX different
from SHAM, ALO, and HCT, p < 0.05.

a ANOVA

bANOVA F = 4.302; d.f = 3, 60; P < 0.008. Student-Newman-Keuls, HCT different
from SHAM and ADX, p < 0.05.
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Figure 10. The outward current elicited by the perfusion of 30 µM 5-HT in the
presence and absence of 5-HT4 and 5-HT7 receptor antagonists. The outward
current elicited by the perfusion of30 µM 5-HT in the presence and absence of 1 µM
of the 5-HT4 and 5-HT7 receptor antagonists GRl 13808 and ritanserin. The drugs
were applied for the duration depicted by the line above the chart record. The
magnitude of the outward current evoked by 5-HT was not different (p = 0.141, n = 6,
paired t-test) in the presence or absence of GR 113 808 and ritanserin.

current evoked by the activation of G proteins with GTPyS was determined by voltage
clamping the cell's membrane at its resting potential (when zero current is required to
maintain the voltage clamp). The voltage clamp was then moved to -60 m V for several
minutes (Figure llA). The amount of current required to maintain the voltage clamp
at -60 mV was used as a measure of the amount of current evoked by the activation of
G proteins with GTPyS. Figure llB summarizes the results of these experiments.
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Significantly less current was required in cells from HCT when compared to cells from
SHAM, ADX, and ALD treated animals. The amount of current measured in cells
from SHAM was also smaller compared to cells from ADX treated animals.

1-V relationship
1-V plots for the 5-HT lA evoked potassium current were analyzed in 2 to 3 cells
from ADX, SHAM and HCT treated animals. Representative 1-V plots in Figure 12AC demonstrate that corticosterone does not appear to alter the reversal potential nor

the inward rectification properties for the potassium current linked to the 5-HT lA
receptor. The reversal potential was between -97 to -104 mV and rectification started
at approximately-SO mV.

Discussion
The 5-HT 1A receptor is a member of the G protein-linked receptor family. In the
present study, we report the effects of chronic corticosteroid treatment on different
components of the 5-HT iA signal transduction system in hippocampal subfield CA3
pyramidal cells using electrophysiological techniques. The EC 50 value for the 5-HT
concentration-response curve was shifted to the left in cells from ADX treated animals
compared to SHAM, ALD, and HCT. The Emax value was smaller in cells from HCT
animals compared to ADX and SHAM. The shift in the 5-HT 1A response may be due
to alterations at sites downstream of the 5-HT iA receptor. Therefore, we compared the
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Figure 11. The outward current evoked by GTPyS. A: Chart recording of a cell
injected with GTPyS. The cell's membrane potential was first voltage clamped at its
resting potential (-74 mV, I= 0 pA). The clamp was then moved to -60 mV and the
current recorded (I = 340 pA). Perfusion of 100 µM 5-HT (duration depicted by the
line above the chart record) did not elicit a current response, indicating all the
G proteins linked to 5-HT receptors were activated by GTPyS. B: Summary graph
depicting the amount of current evoked by GTPyS in cells from corticosterone treated
animals. Treatment group and number of cells are labeled at the bottom axis.
ANOVA F = 12.691; d.f = 3, 61; P < 0.001.
•HCT different from SHAM, ADX, and ALD. Student-Newman-Keuls, p < 0.05,
#ADX

different from SHAM. Student-Newman-Keuls, p < 0.05.
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Figure 12. 1-V plots of steady-state 5-HT mediated current in corticosteroid
treated animals. I-V plot of steady-state 5-HT mediated current in a cell from either a
A: SHAM, B: ADX, or C: HCT treated animal.
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magnitude of the outward current evoked by the activation ofG proteins with GTPyS.
Less current was evoked by GTPyS in cells from HCT animals compared to ADX,
SHAM, and ALD. Furthermore, less current was evoked by GTPyS in cells from
SHAM compared to ADX animals. Finally, we determined the effects of
corticosteroids on the I-V relationship of the potassium current elicited by the
activation of the 5-HT iA receptor. Corticosteroid treatment did not alter the reversal
potential or inward rectification properties of the potassium current linked to the
5-HT iA receptor. Based on our results and those previously reported by other
investigators, we conclude that corticosteroids alter the response elicited by the
activation of 5-HT iA receptors by modulating the receptor's signal transduction system
at different sites.
Alterations in the number of 5-HT 1A binding sites may account for some of the
changes we observed in the 5-HT concentration response curve characteristics.
Previous investigators reported that adrenalectomy increases the number of 5-HT iA
receptor binding sites in subfield CA3 when compared to either SHAM, aldosterone,
low or high corticosterone treated animals (Mendelson and McEwen, 1992a,b;
Chalmers et al., 1993; Kuroda et al., 1994; Tejani-Butt and Labow, 1994). The
increased number of 5-HT iA receptor binding sites may account for the shift in ECso,
with no change in Emax, for the 5-HT concentration-response curve that we observed
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in cells from ADX compared to SHAM and ALD treated animals. A shift in ECso, with
no change in Emax, may occur with spare receptors (Stephenson, 1956; Yocca et al.,
1992).
It is not clear if the smaller Emax in cells from HCT compared to SHAM treated

animals is due to a decrease in the number of 5-HT 1A binding sites. It has been
reported that high levels of corticosterone (plasma concentrations > 40 µg/dl) do not
change the number of 5-HT 1A binding sites in subfield CA3 compared to sham treated
animals (Mendelson and McEwen, 1992a). However, social and restraint stress does
decrease the number of 5-HT IA binding sites in the hippocampus (Watanabe et al.,
1993; McKittrick et al., 1995). One possible explanation for the discrepancy is the
treatment length. Mendelson and McEwen (1992b) treated their animals with a
corticosterone pellet implant for 7 days. The investigations that examined the effects of
stress treated their animals for 14 days (Watanabe et al., 1993; McKittrick et al.,
1995). It is possible that exposure to elevated corticosterone plasma levels must
exceed 7 days before the down regulation of 5-HT 1A binding sites occurs.
Alternatively, the stress response may be activating other physiological processes, in
addition to increasing corticosterone plasma levels, that induces the down regulation of
5-HT 1A binding sites.
Corticosteroids also alter the 5-HT 1A signal transduction system downstream of
the receptor. ADX increased while HCT decreased the magnitude of the current
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evoked by the activation of G proteins with GTPyS. Corticosteroids could be altering
G protein levels, G protein coupling, or the properties of the channels linked to the
G proteins. However, the attenuated 5-HT1A mediated-response and G protein-evoked
current cannot be attributed to a decrease in G protein expression. We observed that
HCT treatment increased G 0 and Gil&2 a-subunit levels in the hippocampus (Okuhara et

al., 1996a), the PTX-sensitive G proteins thought to be linked to the 5-HT 1A receptor
(Andrade et al., 1986; Okuhara and Beck 1994). Based on our present results, we
propose that the increased G protein levels may be a compensatory response to a
decrease in G protein function.
Interestingly, while corticosterone clearly had an effect on the magnitude of the
outward current evoked by GTPyS, there was no change in the resting membrane
potential of pyramidal cells between treatment groups. A simple explanation for this
observation is the non-liner relationship between voltage and resistance (shunting).
Shunting accounts for large changes in current with only small changes in membrane
potential. Therefore, the activation by GTPyS of ion channels with non-linear 1-V
relationships (i.e., GIRK) could evoke different amounts of current but produce similar
changes in membrane potential in cells from the different treatment groups. Alterations
in the 5-HT IA receptor-mediated response and G protein-linked current could be
attributed to a change in pyramidal cell resting input resistance. However,
corticosteroid treatment did not alter neuron resting input resistance in subfield CA3
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pyramidal cells (Okuhara et al., I 996b). While we were able to detect corticosteroidinduced changes in the current evoked by the activation of G proteins we do not know
if corticosterone is altering G protein function or the coupling between the G protein
and potassium channel. We also do not know which G protein-linked current(s) was
modulated by corticosterone.
The potassium channel linked to the 5-HT lA receptor signal transduction system is
probably a member of the recently cloned G protein inward rectifying potassium
(GIRK) channel family (Lesage et al., I994, I995; Kobayashi et al., I995; Ponce et al.,
I 996; Spausches et al., I 996). ADX, ALD, and HCT treatment did not alter the
reversal potential or inward rectification properties of the potassium current linked to
the activation of the 5-HT 1A receptor. However, alterations in potassium channel
kinetic properties cannot be ruled out.
ADX had different effects on the 5-HT concentration response curve
characteristics in cells from subfield CAI and CA3. Previous studies reported that the
concentration-response curve characteristics for the 5-HT lA mediated hyperpolarization
in subfield CAI was not altered by adrenalectomy or chronic activation of MR with
low levels of corticosterone as compared to sham (Joels et al., I99I, Joels and de
Kloet, I 992; Beck et al., I 996). In the present investigation, ADX shifted the EC 50
value for 5-HT 1A mediated outward current compared to SHAM and ALD (chronic
MR activation). Previously, we reported that the 5-HT iA receptor signal transduction
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system is not identical between subfields CAI and CA3, based on different 5-HT
concentration-response curve characteristics for the 5-HT iA receptor in the two
subfields (Beck et al., I992; Okuhara and Beck, I994). Therefore, it is possible that
corticosteroids have different effects on the 5-HT lA receptor-mediated response in
subfields CAI and CA3.
In conclusion, chronic corticosterone treatment alters the response elicited by the
activation of 5-HT iA receptors in hippocampal subfield CA3 pyramidal cells. Some of
the modulatory actions of corticosterone occur downstream of the receptor, at the
G protein level. Furthermore, ADX and high corticosterone treatment have opposite
effects on the 5-HT iA signal transduction system. Our results provide important
information towards understanding how corticosterone modulates neurotransmitter
receptor-mediated responses in the hippocampus.

CHAPTER V
DIFFERENTIAL IMMUNOHISTOCHEMICAL LABELING OF
Gs, Gil and 2 AND Go a-SUBUNITS IN RAT FOREBRAIN

Abstract
In the previous chapter, it was concluded that corticosterone treatment alters the
5-HT 1A receptor signal transduction system at sites downstream of the receptor. The
5-HT lA receptor couples to a PTX-sensitive G protein, therefore, corticosteroids may
influence G protein levels and/or their intracellular location. Since a comparative study
of the anatomical and morphological distribution of the G proteins G0 , Gil and 2 , and Gs
a-subunits in the hippocampus has not been reported, such an investigation was
conducted using immunohistochemical techniques with rat forebrain sections prepared
from naive animals. Diffuse G0 labeling occurred in the neuropil throughout the cortex,
superficial layers of the entorhinal cortex, thalamus, several white matter fiber tracts and
hippocampus. Gil and 2 immunoreactivity was also located in the neuropil but produced a
more fibrous pattern. Fibrous labeling of Gi 1 and 2 was observed in the cortex, amygdala,
hippocampal subfield CA3 and several white matter fiber tracts. Both G0 and Gil and 2
labeling was present in the pencil fibers within the striatum and lateral geniculate nucleus.
Gs labeling, in contrast to G0 and Gi 1 and 2 , was generally cytoplasmic. Cytoplasmic
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Gs labeling was observed in the thalamus, habenula, dentate, geniculate nucleus,
hypothalamus, and hippocampus. Intense Gs labeling was observed in the striatum
parenchyma, choroid plexus and infundibular stem.
Based on our results, we conclude that the G proteins G0 , Giland 2 , and Gs are
anatomically distributed differently throughout the brain. The diffuse neuropil labeling
of G0 , fibrous neuropil labeling of Gil and 2 and cytoplasmic labeling of Gs strongly
suggests that the G proteins are also differentially distributed morphologically within a
neuron. The differential anatomical and cellular location of G proteins in the CNS may
contribute to the coupling specificity between neurotransmitter receptors and G proteins.

Introduction
Heterotrimeric G proteins transpose extracellular signals into a cell by coupling
plasma membrane receptors with effector molecules. G proteins are composed of three
subunits: a,

f3, and y.

The a-subunit binds and hydrolyzes GTP and modulates effector

molecule activity (Gilman, 1987).

There are several subtypes of G proteins based on

the sequence of their a-subunits. Four of these are Gi, G0 , Gs and G1 (Bimbaumer et al.,
1990). The different G protein a-subunits are differentially sensitive to ADPribosylation by several toxins. The G proteins Gi and G0 are ADP ribosylated by PTX
while Gs is sensitive to cholera toxin (Gilman, 1987). The

f3y subunits anchor the
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G protein complex to the cytoplasmic membrane and also modulate the activity of the
effector molecule (Birnbaumer et al., 1990).
The effector molecules are either ion channels or proteins that synthesize second
messenger molecules (i.e., cyclic AMP or inositol triphosphate), which in turn, modulate
enzyme activity in the cell (reviewed by Birnbaumer et al., 1990; Clapham, 1994). For
example, Gs increases adenylyl cyclase activity and modulates Ca2+ activated-potassium
channels, Gi decreases adenylyl cyclase activity and activates potassium channels while
G0 decreases the current linked to Ca2+ channels in the central nervous system.
Current research has focused on elucidating the specificity between receptor and
G protein coupling. A cursory examination indicates that a cell may express more types
of receptors than G proteins and that these multiple receptor subtypes can share the same
G protein (Birnbaumer, 1992). The specificity of receptor-G protein coupling is
probably established at several different levels. Factors that contribute to the receptorG protein specificity are: amino acid sequences in the different G protein subunits
(Gilman, 1987; Kleuss et al., 1993), cytoskeletal proteins (Rodbell, 1990; Sarndahl et

al., 1991), and compartment localization (i.e., golgi and mitochondria) (Ercolani et al.,
1990). The asymmetrical distribution of G proteins within rat enterocytes (Van den
Berghe et al., 1991) and in the kidney (Stow et al., 1991) suggests that the cellular
location of G proteins may also contribute to G protein-receptor coupling specificity.
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In the brain, two other factors also contribute to the coupling specificity between
receptors and G proteins: the intracellular (i.e., soma and dendrites) and anatomical
location of the G protein. There is information on the distribution of G proteins in only a
few brain areas including the cortex (Asano et al., 1987, 1990a,b; Aoki et al., 1992),
hippocampus (Asano et al., 1990b; Aoki et al., 1992), basal ganglia (Herve et al., 1993),
cerebellum (Asano et al., 1987, 1990a; Nishida et al., 1991) and olfactory bulb (Asano et

al., 1990a; Shinohara et al., 1992). In the previous chapter, it was concluded that
corticosterone treatment alters the 5-HT 1A receptor signal transduction system at sites
downstream of the receptor. The 5-HT 1A receptor couples to a G protein, therefore,
corticosteroids may influence G protein levels and/or their intracellular location. Since
the comparative anatomical and morphological distribution of the G0 , Gi 1 and 2 , and Gs asubunits in the hippocampus are not known, in the present study, we examined the
anatomical and intracellular distribution of Git and 2 , G0 , and Gs a-subunits in the rat
forebrain using immunohistochemical techniques with rat forebrain sections prepared
from naive animals.

Materials and Methods
Materials
Primary anti-G protein polyclonal antibodies were purchased from Dupont-New
England Nuclear (Boston, MA). Monoclonal rabbit peroxidase-antiperoxidase antibody
was purchased from Cappel (Durham, NC). Picric acid was purchased from Aldrich
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(Milwaukee, WI). 3,3'-diaminobenzidine tetrachloride (DAB) was purchased from
Sigma (St. Louis, MO). All other chemicals were obtained from commercial sources.

Immunohistochemical Procedure
Four male Sprague-Dawley rats (170-230g) were sacrificed with a lethal injection of
phenobarbital and perfused with 200 ml PBS (10 mM NaHP04, pH 7.4, and
150 mM NaCl) via the aorta at 650 ml/hr followed by 250 ml PA fixative
(4% paraformaldehyde, 1% glutaraldehyde, 0.2% picric acid, 2% sucrose, 0.1 M acetate
buffer, pH 6.0) as described previously (Asano et al., 1990b). After fixation, the brain
was removed, blocked, and placed in PA for 4-6 hrs. After rinsing and overnight
incubation in TBS (10 mM Tris, pH 7.6 and 150 mM NaCl) with 10% sucrose, the tissue
was embedded in paraffin, sectioned at 7 µm, and mounted on microscope slides.
Immunohistochemistry was performed following protocols described by Sternberger

et al., (1970). Briefly, tissue sections were blocked with TBS/5% bovine serum albumin
(BSA)/3% normal goat serum (NGS) for one hour at room temperature. After washing
the sections with TBS, three times for 10 minutes each, they were incubated with 1:50
anti-Gsa (RMI}, 1:50 anti-Giat and2 (AS7}, or 1:100 anti-Goa (GC2) overnight at room
temperature. Several sections were incubated with 2% NGS in place of primary
antibody to determine the level of nonspecific labeling. Sections were then washed with
TBS, three times for 10 minutes each, and incubated with 1:20 goat anti-rabbit lgG.
After one hour, sections were washed with TBS and incubated with rabbit peroxidase-
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antiperoxidase for one hour. Subsequently, the sections were washed in TBS and
developed with hydrogen peroxide and DAB as the chromagen. All antibody dilutions
were made in TBS/5% BSA/3% NGS.

Silver Intensification
Selected DAB developed sections were intensified with silver as described by Kitt et

al., (1994). All reagents used for intensification were freshly prepared. Briefly, after
developing the sections with DAB and hydrogen peroxide, sections were dehydrated and
rehydrated through a graded series of deionized water, alcohol, and xylenes. Sections
were then placed in a 2.5% silver nitrate solution for 1 hour at 56°C. After washing in
deionized water for 10-15 min, the sections were incubated in 2% gold chloride solution
for 10 min at room temperature. Sections were then rinsed in deionized water for 5 min
and incubated in a 5% sodium thiosulfate solution for 5 min at room temperature.
Sections were washed for I 0 min in deionized water and immediately dehydrated
through a series of graded alcohols and xylenes.

Western Blot Analysis
Western blots were performed on membrane protein preparations from the
hippocampus as described elsewhere (Sternweis and Robinshaw, 1984). Protein
isolation procedures were carried out at 4°C. The hippocampus was homogenized with
a hand-held dounce homogenizer in TBS, 10% sucrose, and 0.5 mM phenylmethan-
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sulfonyl fluoride. The homogenate was then centrifuged at 20,000 X g for 30 min. The
supernatant was removed and the membrane pellet resuspended in a second identical
wash and centrifuged again at 20,000 X g for 30 min. The supernatant was discarded
and the membrane pellet resuspended in TBS, I mM EDTA and I% sodium cholate and
incubated for 60 min. with constant mixing. The soluble membrane protein was
collected by centrifugation at 35,000 rpm for 60 min. and stored at -80 °C.
Western blotting techniques used are described elsewhere (Lesch and Manji, 1992).
Membrane proteins were resolved by SDS-P AGE and electrophoretically transferred to
nitrocellulose membrane filters. After transfer, the nitrocellulose was blocked with TBS,
0.2% NP-40, and 5% nonfat dry milk at room temperature. After blocking for 60 min.
the nitrocellulose was incubated with a 1/10,000 dilution of AS7, RMI, or GC2
overnight at 4°C. The nitrocellulose was then incubated with a 1/10,000 dilution of goat
anti-rabbit IgG for 60 min. at room temperature followed by an incubation with 1/10,000
dilution of rabbit PAP. The blots were developed with the ECL detection kit
(Amersham, Arlington Heights, IL) and exposed to x-ray film. All antibody dilutions
were in TBS, 5% BSA, and 0.2% NP-40. The nitrocellulose filter was washed with
TBS/0.2% NP-40 between every antibody incubation and prior to development with the
ECL kit.
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Results
W estem blot analysis
The RMI antibody consistently labeled a 45 kDa protein band in the Western blots

(Figure 13) corresponding to the short form of Gs (Bray et al., 1986; Robinshaw et al.,
1986; Kozasa et al., 1988). A 54 kDa band (long form of Gs) was also detected but its
detection was not consistent (data not shown). When the band was detected, it was faint
and indistinct. The AS7 and GC2 antibodies labeled a single 40 kDa band (Figure 13)
corresponding to the appropriate size for Gi 1 and 2 and G0 respectively (Goldsmith et al.,
1987; Cooper et al., 1990).
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Figure 13. Western blot of G proteins in the rat hippocampus.
Lane 1: Gs (RM 1 antibody). Lane 2: Gil and 2 (AS 7 antibody). Lane 3: Go (GC2
antibody).
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Immunohistochemical Techniques
The immunohistochemical labeling with the primary antibodies described in this
investigation is very sensitive to variations in labeling and tissue preparation protocols.
For instance, we found that the inclusion of0.05% NP-40 detergent decreased Gs and
Gil and 2 labeling throughout the entire brain and the exclusion ofBSA from the blocking
solution increased nonspecific Gs labeling. The fibrous neuropil staining pattern observed
with Gil and 2 in paraffin embedded tissue was distorted in cryostat cut sections. Tissue
prepared with a paraformaldehyde-lysine-periodate (PLP) fixative produced less intense
but similar antibody labeling patterns as the picric acid fixed tissue. In the present study,
the tissue preparation and immunohistochemical protocols were maximized and identical
for all three antibodies. Silver intensification and dark field microscopy were used to
increase visualization of the specific staining in selected sections.
In control sections (2% NGS in place of primary antibody), nonspecific labeling was
faint under normal light microscopy. Under dark field, a low level of nonspecific labeling
was detected in some white matter fiber tracts, cortical cell bodies and hippocampal
pyramidal cell bodies (data not shown). Serial dilutions of the primary antibody
decreased the intensity of labeling. The differential labeling by the three antibodies used
in this study also demonstrates the specificity of antibody binding.
The technical data sheets supplied by Du Pont NEN also provided information on
the specificity of the three antibodies. The GiaI and 2 antibody, AS7, is specific for only
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Gial and 2 . The Gsa antibody, RMI, cross reacts with Golf· The G0 antibody, GC2, is

specific for Goa.

Cortex
We observed G0 and Gi 1 and 2 immunoreactivity in the neuropil of the rat cortex but
with different labeling patterns. G0 immunoreactivity was very intense and diffuse.
Gil and 2 immunoreactivity was very fibrous and less intense than G0 • Diffuse G0 labeling

was observed in the neuropil throughout the entire cortex while neuronal cell bodies
were not labeled. The immunoreactivity in the molecular layer (layer I) of the cortex
was more intense than layers II-VI. The pyramidal cell bodies and dendritic processes in
layer V were immunonegative and stood out against the positive neuropil (Figure 14A).
Gi 1 and 2 labeling in the cortex, and throughout the forebrain, was characterized by a

fibrous pattern in the neuropil. The antibody also labeled individual fibers extending
from the external capsule into the deep cortical layers V and VI (Figure 14B). The G0
or Gs antibody labeled the neuropil in a diffuse pattern and fiber labeling was not
observed. In the entorhinal cortex, the superficial layers adjacent to the cortical
amygdala and piriform cortex were also strongly immunopositive for Gi and G0 ,
however, we were not able to distinguish the different nuclei in the amygdala.
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Figure 14. Photographs of G protein labeling in the cortex.
A: G0 labeling in the superficial cortical layers. Immunolabeling was located in the
neuropil, while the neuronal cell body (large arrow) and processes (small arrow) were
immunonegative. Note the intense labeling of G0 in layer I of the cortex (located near
the top of photomicrograph). X200. B: Gi 1 and 2 labeling (intensified with silver) in the
deep cortical layers adjacent to the external capsule (ec). Fibers arising from the external
capsule (arrow) were intensely stained. X200. C: Cytoplasmic Gs labeling in a cell
(arrow) located in the lateral middle cortical layers. X200. Insert: The same neuron
(arrow) viewed at X300.
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Gs labeling in the cortex displayed a generally light diffuse neuropil staining. However,
in a few sections, cytoplasmic staining was present in cortical cells (Figure 14C). In the
entorhinal cortex, the G8 antibody labeled the neuropil in a diffuse pattern. The Gs
antibody did not label neuronal cell bodies in the entorhinal cortex.

Hippocampus
G protein immunoreactivity in the hippocampus was different for all three
antibodies. In subfield CAI, G0 and Gi 1 and 2 labeling were detected in the neuropil while
the pyramidal cell bodies were immunonegative (Figure 15A,C). G0 staining was more
intense than Gil and 2 and dendritic processes were often distinguished against the heavily
stained neuropil. Gs immunoreactivity was also detected in subfield CAI but as a thin
cytoplasmic ring near the perimeter of the pyramidal cells (Figure 15E). G0 labeling in
subfield CA3 was similar to subfield CAI (Figure 15B). Gil and 2 and Gs labeling in
subfield CA3 was different from the patterns observed in subfield CAI. Gi 1 and 2-like
immunoreactivity was detected as fibrous patches surrounding the pyramidal cells in
subfield CA3 (Figure 15D). Gs immunoreactivity in subfield CA3 was found throughout
the entire neuronal cytoplasm (Figure 15F). Intense G0 and Gi 1 and 2-like
immunoreactivity was also detected in the fimbria.
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Figure 15. Photographs of G protein labeling in the hippocampus.
The labeling ofG proteins in the hippocampal subfields CAI (A,C,E) and CA3 (B,D,F).
The radiata (Rad), orien (Or), and pyramidal striata (Py) in subfield CAI (Panel A) and
CA3 (Panel B) are indicated. All photomicrographs are at X200. A: G0 labeling in
hippocampal subfield CAI. Location of the alveus (alv) is marked by an arrow.
Arrowheads point to immunonegative dendrites. B: G0 labeling in subfield CA3 . The
diffuse labeling makes it difficult to delineate the different striata. Location of the
fimbria (fi) is marked by an arrow. C: Gi 1 and 2 labeling (intensified with silver) in subfield
CAI. alv, alveus. D: Gi 1 and 2 labeling (intensified with silver) in subfield CA3 . A fibrous
patch ofGi 1 and 2 labeling (small arrow) surrounding a pyramidal cell (hallow circle).
Location of the fimbria (fi) is marked by the larger arrow. E: Gs labeling in the perimeter
(arrowhead) of subfield CAI pyramidal cells. alv, alveus. F: Cytoplasmic labeling of Gs
in a pyramidal cell (arrowhead) located in subfield CA3. fi, fimbria.
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Subcortical Nuclei
The three antibodies produced different labeling patterns in several subcortical
nuclei. Generally, the G0 antibody labeled the neuropil in a diffuse pattern; Gil and 2
immunoreactivity was also detected in the neuropil but produced a fibrous pattern; and
Gs staining was located in the cytoplasm.
G protein labeling with all three antibodies in the striatum appears as irregular
patches surrounding immunonegative cell bodies. Intense G0 and Gil and 2 -like
immunoreactivity was detected in the white matter pencil fibers of the striatum and a
much lighter label in the parenchyma (Figure 16A). In contrast, Gs staining was absent
from the pencil fibers but diffusely present within the striatum parenchyma and not
detected in the cell cytoplasm (Figure 16B). In the habenula, G0 and Gil and 2
immunoreactivity was located in the neuropil (Figure 16C) while Gs immunoreactivity
was localized to the cell cytoplasm (Figure 16D).
G protein labeling in the thalamus also produced different immunoreactive patterns.
Intense G0 and Gil and 2 -like immunoreactivity was located in the neuropil of the ventral
posterior thalamic nuclei {VPT) (Figure 17A). G0 and Gil and 2 immunopositive
myelinated fibers were also detected in the VPT. These fibers probably arise from the
medial lemniscus and internal capsule. Moderate G0 and Gil and 2 -like immunoreactivity
was detected throughout the lateral thalamic posterior nuclei (LP), and dorsal and
ventral lateral geniculate nuclei (DLG, VLG). Moderate Gs labeling was detected in the
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Figure 16. Photographs of G protein labeling in the striatum and habenula.
A: Gil and 2 labeling (intensified with silver) in the striatal pencil fibers (pf) and
parenchyma (stm). XIOO. B: Gs labeling in the striatum. pf pencil fibers~ stm,
parenchyma XlOO. C: G0 labeling in the neuropil of the habenula. Note the
immunonegative cell bodies (arrowhead). 3v, third ventricle. X25. D: Cytoplasmic Gs
labeling of a cell (arrowhead) in the habenula. The third ventricle is indicated (3v). X25.

cytoplasm of cells in the VPT, LP, DLG, VLG nuclei, central medial thalamic nuclei,
mediodorsal thalamic nuclei, and paraventricular thalamic nuclei.
Light to moderate G0 and Gil and 2 -like immunoreactivity was observed in the
hypothalamus and median eminence. Moderate to intense cytoplasmic Gs labeling was
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detected in the hypothalamic tuberomammillary nucleus, median eminence, and
infundibular stem (Figure 17B).

Figure 17. Photographs of G protein labeling in the thalamus, infundibular stem,
and white matter fiber tracts. A: Gil and 2 labeling (intensified with silver) in the ventral
posterior thalamus. See figure 18 for orientation. Immunopositive white matter fibers of
the internal capsule are indicated by a white arrow. X25 . B: Gs labeling in the
infundibular stem X200. C: Gi 1 and 2 labeling (in the mammilothalamic tract (mt) and
fornix (fx). 3v, third ventricle. X25.
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Fiber Tracts and Choroid Plexus
In general, the G 0 and Gil and 2 -like immunoreactivity was very intense in most of the
forebrain white matter fiber tracts. The mammilothalamic (Figure 17C), fornix (Figure

17C), optic tract, medial lemniscus, internal capsule (Figure 17A), and lateroventral
aspect of the external capsule were heavily labeled by the G0 and Gi 1 and 2 antibodies. The
fasciculus retroflexus was the area with the heaviest labeling of Go. Gs-like
immunoreactivity was not readily found within white matter fiber tracts. In several
sections, the fornix and mammillothalamic tract were actually lighter than the
surrounding background (data not shown). The choroid plexus was labeled by all three
antibodies and was the location of intense Gs staining. Table 7 and Figure 18 highlight
the G protein labeling patterns.

Discussion
We compared the anatomical and intracellular distribution of the G proteins Gs, G 0
and Gil and 2 in the rat forebrain and our results suggest that the a-subunits of Gs, G0 and

Gi 1 and 2 are differentially located both within neurons and among different brain areas.
G 0 was detected in the neuropil throughout all areas of the brain. Cell bodies and
dendritic processes were often immunonegative. Gi 1 and 2 labeling was also located in the
neuropil but produced a very fibrous pattern throughout many brain areas. Cell bodies
were immunonegative but the dendritic and axonal processes in certain brain areas were
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Table 7.--G protein like immunoreactivity in medial rat brain sections
Brain region
Cortex
layer 1
middle and deep layers
entorhinal cortex
corpus callosum (cc)
alveus (alv)
cingulum (cg)
Hippocampus
CAI pyramidal (Py)
oriens layer (Or)
radiatum (Rad)
CA2-4 pyramidal (Py)
oriens layer (Or)
radiatum (Rad)
dentate granular
Habenula
Thalamus
ventral posterior (VPT)
central medial (CM)
mediodorsal (MD)
paraventricular (Pv)
lateral post (LP)
dorsal (DLG) and ventral
(VLG) lateral geniculate
nucleus
Hypothalamus
tuberal nucleus (TMC)
dorsomedial (DM)
arcuate nucleus (Arc)
median eminence (J\1£)
infundibular stem (InfS)
Striatum parenchyma (stm)
pencil fibers (pt)
optic tract (opt)
Continued next page

Gs

Gil aod2

Ga

++d
+c
+++d

++d
+++f
+++d
++
++++
++++

++++d
+++d
+++d
++
++
++

++c
+d
+d
+++c
+d
+d
++d
+++c

++d
++d
+++f
+d
+d

+++d
+++d

+++f

+++d

++c
++c
++c
++c
++c

+++f
+f
+f
+f
++f

+++d
++d
++d
++d
++d

++f

+++d

+d
+d
+d
++
++
+d
++++
++++

+d
+d
+d
++
++
+d
+++
+++

++c
++c
++c
++++
++++
+++d

++d
++d
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Table 7.-- Continued
Brain region
Internal capsule (ic)
External capsule (ec)
mediodorsal
lateroventral
Medial lemniscus (ml)
Fornix (fx)
Mammilothalamic tract (mt)
Choroid plexus (cp)
Fasiculus retroflexus (fr)

+

+
+
+
++++

Ga

G;1 and2
++++

+++

+++

+++

+++

+++
++
++
++
++to +++

++++
++
++
++to +++
+++

++++

Direct comparisons are made within a column. Indirect comparisons may be made
between columns.
Key: negative-; light+; moderate,++; intense+++; highest amount of staining,++++.
d

diffuse neuropil

f

fibrous neuropil

c

cytoplasm.
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Figure 18. Camera lucida of G protein labeling in the subcortex. Cytoplasmic Gs
labeling is indicated by dots in upper figure while Gil and 2 neuropil and white matter fiber
tract labeling is indicated by diagonal lines in the lower figure. A star marks the area of
the photomicrograph in figure 17A. Abbreviations: ARC, hypothalamic arcuate nucleus;
CM, thalamic central medial nucleus; DLG, thalamic dorsal lateral geniculate nucleus;
DM, hypothalamic do~sal medial nucleus; fr, fasiculus retroflexus; fx, fornix; Hb,
habenula; ic, internal capsule; InfS; infundibular stem; LP, thalamic lateral posterior
nucleus; :MD, thalamic mediodorsal nucleus; ml, medial lemniscus; mt, mammilothalamic
tract; optic tract; Pv, thalamic paraventricular nucleus; stm, striatum; TMC,
hypothalamic tuberal nucleus; VLG, thalamic ventral lateral geniculate nucleus; VPT,
thalamic ventral posterior nucleus; 3v, third ventricle.
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immunopositive. In contrast to G0 and Gil

and 2,

Gs was detected primarily in the

neuronal cytoplasm.

Cortex
In our investigation, the three different antibodies label the cortex with different
intensities with G0 > Gi 1 andl >Gs, consistent with quantitative Western blot studies
(Saito et al., 1989). The cortex is enriched with neurotransmitter receptors that couple
to G0 , Gil and 2 , or Gs (McCormick, 1992). Our results show that G0 immunoreactivity in
the cortex is located in the synaptic rich neuropil and is consistent with those reported by
other investigators (Worley et al., 1986; Asano et al., 1987; Terashima et al., 1988;
Aoki et al., 1992). Interestingly, we did not observe any G0 labeling within the
perikarya as described by Aoki et al., (1992) and Jordon (1990). There are a number of
reasons for the discrepancy concerning the morphological location of G0 • Different
antibody sources and immunohistochemical protocols were used in previous reports.
Indeed, Aoki et al., (1992) report that G0 labeling in the perikarya was observed only
after higher dilutions of the primary antibody were used to decrease the signal in the
neuropil.
Our detection of Gi 1 and 2 in the neuropil agrees with the observations of Asano et al.,

(l 990b) and Aoki et a!-, (1992). However, we also detected Gi 1 and 2 in the fibers arising
from the external capsule. The Gil and 2 immunoreactivity may be located in a subset of
cortical fibers since the antibody labeled discrete individual fibers.
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There is very little information available from previous reports on the morphological
location of Gs in cortical neurons. The low abundance of Gs in the central nervous
system and antibody specificity contribute to the difficulty of analyzing the distribution of
Gs using immunohistochemical techniques. However, we detected Gs in the cytoplasm of
some cortical neurons. It is unlikely that our observations are due to a cross-reactivity
with Golf since a previous study reported that the cortex did not contain detectable
levels of G0 lf protein or mRNA (Herve et al., 1993).

Hippocampus
Our results generally agree with earlier investigations which established the location
ofG proteins in the hippocampus (Worley, et al., 1986; Terashima et al., 1988, 1993;
Asano et al., l 990b; Aoki et al., 1992). In addition, we also report that the different
G protein antibodies produced different labeling patterns within the same subfield. The
differential labeling patterns may represent different synaptic locations for the G proteins.
The patchy Gil and 2 immunoreactivity concentrated near the perimeter of the pyramidal
cell body in subfield CA3, suggests that the G proteins are located at terminals near the
cell soma. A previous report by Aoki et al. (1992) described G0 and Gi 1 and 2
immunoreactivity within neuronal postsynaptic densities, axons, somata, and dendrites
using electron microscopy. The contrasting locations of G0 (diffuse neuropil) and Gs
(cytoplasm) is also very interesting. Different locations of the G proteins may reflect
different synaptic locations but other factors may also contribute to the different labeling
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patterns. Some of these factors include differences in cell function and G protein
storage. Our results also extend into subfield CA3 where we observed different
immunoreactive patterns when compared to subfield CA 1. The different labeling
patterns maybe due to differences in synaptic locations or differences in cell size or type.
The hippocampus contains several types of G protein-linked receptors. The 5-HT 1A,
adenosine, and GABA8 receptors all couple to PTX-sensitive G proteins (i.e., G0 and G)
(Andrade et al., 1984; Zgombick et al., 1989; Okuhara and Beck, 1994) but it is not
known if these receptors couple to the same PIX-sensitive G protein. Our results
suggest that if these receptors are located at different sites on the neuron, they may
indeed couple to different PIX-sensitive G proteins.
The different labeling patterns for Gi and G0 in subfields CA 1 and CA3 may provide
an explanation for the differences in 5-HT concentration-response curves in the two
subfields. In the hippocampus, 5-HT 1A receptor-activation increases an inward rectifying
potassium current in both subfields CAI (Andrade and Nicoll, I 987; Colino and
Halliwell, I 987) and CA3 (Okuhara and Beck, I 994). However, 5-HT has a smaller
maximal response and is more potent in subfield CAI (Beck et al., I 992). One possible
explanation for this difference is that the 5-HT lA receptor may couple to different
G proteins in the two subfields. Both the 5-HT lA receptor and G protein appear to be at
different sites along the neuron in subfields CAI and CA3. The 5-HT lA receptor is
closer to the cell body in subfield CA3 than in subfield CAI (Pazos and Palacios, I 985).
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Therefore, based on our observations, the 5-HT lA receptor may couple to Gi in subfield
CA3 and couple with either Gi or G0 in subfield CAI.

Striatum
The presence of all three G protein types in the striatum is not surprising since these
nuclei contain many different G protein-linked receptors (Graybiel, 1990) along with
mRNA for Gs and G0 (Brann et al., 1987; Largent et al., 1988). There is very little
Gi mRNA in the striatum (Aronin and DiFiglia, 1992), suggesting that the Git and 2
immunoreactivity observed in the parenchyma in our study and in the study by Aronin
and DiFiglia (1992) is located in the axon terminals. However, based on the detailed
light and electron microscopic localization of Gi in the different basal ganglia structures
(Aronin and DiFiglia, 1992) cytoplasmic labeling cannot be ruled out. While the
immunohistochemical localization of the G proteins in the striatum is not a novel finding,
there are several differences between our observations and previous reports. The
G protein labeling pattern in our investigation and others (Worley et al., 1986; Aronin
and DiFiglia, 1992) does not resemble the patch-matrix distribution often observed in the
striatum with antibodies against tyrosine hydroxylase or autoradiographic localization of
µ-opiate receptor binding sites (Gerfen et al., 1987). However, while the detection of
G0 and Gitand 2 in the striatal pencil fibers is the outstanding feature in our investigation,
G0 and Gitand 2 labeling in the parenchyma is the outstanding feature in previous reports
(Worley et al., 1986; Aronin and DiFiglia, 1992).
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RMI labeling in the striatum is difficult to interpret because this antibody crossreacts with Golf· Previous studies with the RMI antibody (Cooper et al., I 990; Drinnan

et al., I99I) report at least two immunoreactive bands on Western blots prepared with
tissue from the striatum. One of these bands corresponds to

Golf

based on

immunological and mRNA analysis (Drinnan et al., I99I; Herve et al., I993). Our
observations in the striatum with RMI may reflect G0 lf labeling since our labeling pattern
resembles the one previously reported for G0 lf (Herve et al., 1993). However, it is clear
from our results that neither Gs nor Golf is located with the striatal pencil fibers.

Thalamus
The homogeneous distribution of G0 throughout the different thalamic nuclei is in
agreement with a previous study by Worley et al. {1986). However, the fibrous labeling
pattern of Gii and 2 in the neuropil is a novel finding. The thalamus contains a variety of
neurotransmitter systems, including G protein-linked receptors, enabling it to function as
a relay between the cortex and several sensory systems (McCormick, 1992). The
moderate to intense presence of both Git and 2 and G0 in the ventral posterior thalamic
nuclei, medial lemniscus, and internal capsule suggest that these G proteins have
important roles in conveying somatosensory signals. The ventral posterior nuclei relay
somatosensory information from the dorsal column-medial lemniscal system to the
somatosensory cortex via the posterior limb of the internal capsule. The geniculate
nucleus also contains neurotransmitter receptors that link to G proteins (Matute et al.,
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1993). The moderate to intense Gitand 2 and G0 immunoreactivity in the optic tract and
lateral geniculate nuclei suggests that these G proteins may also have important roles in
conveying visual signals.

Hypothalamus
In our study we demonstrate that the G proteins are differentially localized in cells
of the hypothalamus, median eminence, and arcuate nucleus. Our results are consistent
with previous mRNA and Western blot analysis detecting G protein expression in the
hypothalamus (Largent et al., 1988; Viollet et al., 1994). The detection of PTXsensitive G proteins Gi and G0 in the median eminence and infundibular stem coincide
with the presence of 5-HT 1 (Biegon et al., 1982) and melatonin receptors (Vanecek et

al., 1987; Lopez-Gonzalez et al., 1991), two receptors which couple to PTX-sensitive
G proteins (Andrade et al., 1986; Reppert et al., 1994). The detection of Gi and G0
immunoreactivity in the median eminence and infundibular stem suggests that these
G proteins may be important in the secretions of hormones at these sites.
The release of growth hormone-releasing hormone and dopamine by the
parvocellular neurons in the arcuate nucleus is regulated by G protein-linked
neurotransmitter receptors. For example, growth hormone-releasing hormone and the
somatostatin receptor have been shown to colocalize within the same neurons in the
arcuate nucleus (Bertherat et al., 1992; McCarthy et al., 1992). The detection of Gs,
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Gil and 2 , and G0 in the arcuate nucleus supports the observations that G protein-linked
receptors play a role in hormone secretion in the hypothalamus (reviewed by Renaud et

al., 1992; Liposits, 1993).
Very little is known about the function of the tuberomamillary nucleus and the types
of neurotransmitter receptors located in the nucleus. However, our detection of
G proteins in the tuberomamillary nucleus suggests that these neurons may contain
neurotransmitter receptors that link to G proteins and may also help to explain the
nucleus' role in Alzheimer's disease. The tuberomamillary nucleus projects to the
cerebral cortex and is

~everely

affected in Alzheimer's and Parkinson's disease (Braak

and Braak, 1992). Furthermore, G protein and neurotransmitter receptor coupling are
attenuated in cortical tissue isolated from Alzheimer's disease patients (Warpman et al.,
1993; Wang and Friedman, 1994). Therefore, altered coupling between neurotransmitter
receptors and G proteins in the tuberomamillary nucleus may contribute to some of the
symptoms observed in patients with Alzheimer's disease.

Fiber Tracts and Choroid Plexus
Our novel detection of G proteins within white matter fiber tracts should be
interpreted cautiously, especially since previous immunohistochemical studies have not
described the labeling of G proteins in white matter fiber tracts. It is unlikely that our
detection of G0 and Gi 1 and 2 is due to nonspecific labeling since the labeling intensity and
distribution were different in at least three tracts: the alveus, hippocampal fissure, and the
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dorsomedial and lateroventral aspects of the external capsule. Furthermore, we also
observed white matter fiber tract labeling using a different immunohistochemical
protocol utilizing a substantially lower antibody concentration.
Since the G proteins are located at axon terminals {Aoki et al., 1992; Aronin and
DiFiglia, 1992), G protein immunoreactivity within fiber tracts may be due to axonal
transport of the proteins (Hendry and Crouch, 1991; Crouch et al., 1994). The
presence of G protein immunoreactivity may also be due to the labeling of G proteins in
oligodendrocytes. Indeed, neurotransmitter receptors have been detected in glial cells
(reviewed by Ransom and Sontheimer, 1992; Chiu and Kriegler, 1994). It is clear from
our investigation and previous reports that the G proteins are located and serve functions
at sites beyond the synapse.
All three antibodies labeled the choroid plexus and this was the area of intense G5
immunoreactivity.

Th~

presence of G0 in the choroid was previously described by

Peraldi et al. {1989) where it was detected at the apical pole of choroidal
ependymocytes. The distribution of G proteins, Na-K-ATPase (Ernst et al., 1986),
neurotransmitter receptors (Yagaloff and Hartig, 1985; Conn et al., 1986), and other ion
channels in the choroid plexus suggests that the function of the choroid may be
modulated by molecules in the cerebral spinal fluid or neuronal innervation (Peraldi et

al., 1989).
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Concluding remarks
The differential distribution of G proteins and neurotransmitter receptors within
neurons and in different brain areas may contribute to the coupling specificity between
the receptors and G proteins. In our investigation, we observed that the G proteins Gs,
G0 and Gi 1 and 2 are distributed differently within the rat forebrain. We also observed

differences in the intraneuronal labeling patterns between the G proteins. Gs labeling was
observed in the cytoplasm while G0 and Gi 1 and 2 labeling was located in the neuropil.
G0 and Gi 1 and 2 labeling in the neuropil also produced different patterns. G0 labeling was

diffuse while Gi 1 and 2 labeling was fibrous. The differences in G protein labeling patterns
between brain areas and in neurons suggests that unique synaptic organizations may exist
between the different brain nuclei. For example, certain brain areas may contain a high
concentration of dendrodendritic synapses while other areas are characterized by
dendrosomatic synapses. Unique synaptic organizations may also exist among different
cell types. The co localization of receptor and G proteins may be different between a
mossy fiber and pyramidal cell synapse when compared to one between a basket cell and
pyramidal cell. In order to determine if unique synaptic organizations do exists among
the different brain areas, the brain nuclei in which differential labeling patterns for the
G proteins were observed (i.e., hypothalamus, white matter fiber tracts, and habenula)
should be analyzed, in detail, at the electron microscopic level.

CHAPTER VI
CORTICOSTERONE ALTERS G PROTEIN a.-SUBUNIT
LEVELS IN THE RAT IIlPPOCAMPUS.

Abstract
The HP A axis regulates the synthesis and secretion of glucocorticoid steroid
hormones. The hippocampus, a component of the limbic system, contains the highest
concentration of corticosteroid receptors in the brain and may play an important role in
regulating hypothalamic-pituitary-adrenal axis activity and mediating physiological
responses to stress. In Chapter IV, it was concluded that corticosterone treatment alters
the 5-HT lA receptor signal transduction system at sites downstream of the receptor. The
5-HT lA receptor couples to a PTX-sensitive G protein, therefore, corticosteroids may
influence G protein levels and/or their intracellular location. The glucocorticoid
corticosterone alters the response elicited by activation of several different G proteinlinked neurotransmitter receptors in the hippocampus. In the present study we used
Western blot and immunohistochemical techniques to determine the effects of chronic
adrenalectomy (AD:X), low (CT) and high (HCT) plasma corticosterone concentrations
on Gs, Gi 1 and 2 and Go a.-subunit levels and intracellular location in the rat hippocampus.
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CT treatment increased Gs a-subunit levels and HCT treatment increased the levels
of Gs, Gi I and 2 and Go a-subunits when compared to sham as detected on Western blots.
No change in the intracellular location of the G protein a-subunits was detected using
immunohistochemistry. Based on our results, we conclude that corticosterone alters
G protein a-subunit levels in the rat hippocampus without altering their intracellular
location. These results provide an important piece of information towards understanding
how glucocorticoids alter G protein-linked neurotransmitter responses.

Introduction
Glucocorticoids directly influence protein expression by binding to intracellular
steroid receptors designated as :MR and GR. In rats, the two corticosteroid receptors
have different affinities for the glucocorticoid corticosterone (Corini et al.,
and de Kloet, 1985).

?:JR binds to corticosterone with a Kn= 0.5 nM.

1985~

Reul

GR has a lower

affinity for corticosterone with a Kn= 2.5 - 5 nM. The corticosteroid receptors in
humans and other primates have affinities for corticosterone that are similar to rats
(Tsuboi et al., 1979; Yu et al., 1981; Brooke et al., 1994). The hippocampus contains
the highest concentration of corticosteroid receptors in the central nervous system
(McEwen et al., 1968; Gerlach and McEwen, 1972; Maraginos et al., 1990)
consequently, the function of corticosteroid receptors in the hippocampus is under
intense investigation (review by de Kloet et al., 1993; Joels and de Kloet, 1994).
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Corticosterone alters the response elicited by the activation of several different
G protein-linked neurotransmitter receptors. For example, in the rat hippocampus,
corticosterone alters the responses elicited by activation of 5-HT IA receptors linked to
G/Go (Joels et al., 1991; Joels and de Kloet, 1992; Beck et al., 1996) and 5-HT4
(Bimsteil and Beck, 1995) and P-adrenergic receptors linked to G1 (Roberts et al., 1984;
Harrelson et al., 1987; Joels et al., 1989; Gannon and McEwen, 1990). In Chapter IV it
was concluded that corticosteroids also alter the response elicited by activation of 5HT IA receptors in hippocampal subfield CA3. The mechanism by which glucocorticoids
alter the G protein-linked neurotransmitter receptor responses is not completely known
and is currently under investigation. Depending on the receptor system, glucocorticoids
may alter the receptor, G protein, and/or effector molecules. For example, in the rat
brain glucocorticoids alter dopamine D 1 and D2 (Biron et al., 1992) and serotonin
5-HT2c (Holmes et al., l 995a,b) receptor mRNA levels, P-adrenergic receptor binding
levels (Roberts and Bloom, 1981 ), and 5-HT IA receptor binding and mRNA levels
(reviewed by Chaouloff, 1995). Glucocorticoids also modulate effector molecule
function and expression. For example, glucocorticoids alter adenylyl cyclase activity and
mRNA levels (Gannon et al., 1994; Wolfgang et al., 1995) in the rat hippocampus.
In addition to the changes in neurotransmitter receptor levels and effector molecule
activity, glucocorticoids may also alter G protein expression or activity. The regulation
of G protein levels by ~ucocorticoids has been examined in several tissue types including
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liver (Kawai and Arinze, 1993), aorta (Haigh et al., 1990), fetal forebrain tissue (Slotkin

et al., 1994), and vascular smooth muscle (Schelling et al., 1994). However, there is
little information on the effects of corticosterone on G protein expression and function in
the hippocampus. In Chapter IV it was concluded that corticosteroids altered the
outward current evoked by the activation of G proteins with GTPyS. Changes in
G protein function may reflect changes in protein levels and/or intracellular location,
altering the interaction between specific receptor-G protein-effector molecule complexes.
Therefore, in the present study, we used Western blotting and immunohistochemical
techniques to determine the effects of corticosterone on G protein a-subunit levels and
distribution in the hippocampus.

Materials And Methods
Materials
Corticosterone pellets were purchased from Innovative Research of America
(Sarasota, FL). G protein a-subunit polyclonal antibodies RMI (GJ, AS7, (Gi1 and 2),
and GC2 (G0 ) were purchased from Dupont-New England Nuclear (Wilmington, DE).
Monoclonal rabbit peroxidase-antiperoxidase antibody was purchased from Cappel
(Durham, NC). Picric acid was purchased from Aldrich (Milwaukee, WI). 3,3'diaminobenzidine tetrachloride (DAB) was purchased from Sigma (St. Louis, MO). All
other chemicals were obtained from commercial sources.
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Animals
Male Sprague-Dawley rats (75-100 g; Harlan) were maintained on a twelve hour
light-dark cycle (7 a.m. to 7 p.m. light on). Bilateral adrenalectomies (ADX) were
performed under ether anesthesia. An incision was made just below the rib cage and the
adrenal gland removed. The muscle wall was then sutured and the skin closed using
wound clips. To predominately activate MR and mimic basal levels of plasma
corticosterone, one group of animals (CT) received a subcutaneous 12.5 mg
corticosterone pellet. To activate both MR and GR, another group of animals (HCT)
received 300 mg corticosterone pellets subcutaneously. A sham group of animals was
produced by visualizing the adrenal glands but leaving them intact. Following surgery,

all animals were given standard laboratory chow ad libitum. SHAM animals were given
standard drinking water while the ADX, CT, and HCT animals were given 0.9 % NaCl
drinking water ad /ibitum. All animals were sacrificed 2 weeks after surgery. Sacrifices
occurred before 12:00 noon and blood samples were collected at that time to determine
plasma corticosterone levels (Burgess and Handa, 1992).

Membrane Preparation
Membrane protei~s were isolated from hippocampal tissue using a procedure
described elsewhere (Stemweis and Robinshaw, 1984; Okuhara et al., 1996c). Protein
isolation procedures were carried out at 4°C. Briefly, the animals were decapitated and
the hippocampus dissected free. The hippocampus was homogenized with a hand-held
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dounce homogenizer in TBS (10 mM Tris, pH 7.6 and 150 mMNaCl), 10% sucrose,
and 0.5 mM phenylmethansulfonyl fluoride. The homogenate was then centrifuged at
20,000 X g for 30 min. The supernatant was removed and the membrane pellet was
resuspended in a second identical wash and centrifuged again at 20,000 X g for 30 min.
The supernatant was removed and the membrane pellet was resuspended in TBS, 1 mM
EDTA and 1% sodium cholate and incubated for 60 min with constant mixing. The
supernatant containing the soluble membrane protein was separated by centrifugation at
35,000 rpm for 60 min and stored at -80 °C.

Western Blot Analysis
Western blotting techniques used in this investigation are described elsewhere
(Lesch and Manji, 1992. Briefly, membrane proteins ( 6 µg) were resolved by SD Sp AGE and electrophoretically transferred to nitrocellulose membrane filters. Equal
loading of protein samples was verified by staining a parallel polyacrylamide gel with
Coomassie blue. After transfer, the nitrocellulose was incubated in TBS, 0.2% NP-40,
and 5% nonfat dry milk at room temperature to block non-specific binding. After 60
min the nitrocellulose was incubated with a 1/10,000 dilution of AS7, RMI, or GC2
overnight at 4°C. The nitrocellulose was then incubated with a 1/10,000 dilution of goat
anti-rabbit IgG for 60 min at room temperature followed by an incubation with 1/10,000
dilution of rabbit PAP. The blots were developed with the ECL chemiluminiscent
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detection kit (Amersham, Arlington Heights, IL} and exposed to x-ray film. All antibody
dilutions were in TBS, 5% BSA, and 0.2% NP-40. The nitrocellulose filter was washed
with TBS/0.2% NP-40 between every antibody incubation and prior to development
with the ECL kit.
The optical density and area of the G protein bands were obtained using the NIH
Image analysis program. Gray scale density readings were calibrated using a transmission
step wedge standard fitted to the Rodbard equation. An integrated optical density (IOD)
was calculated by summing the optical densities within the area of a band. To determine
the IOD of the G protein bands, the bands were outlined three times and the mean IOD
was calculated. An area adjacent to the G protein band was used to calculate the
background optical density of the film and was subtracted from the integrated optical
density of the G protein band. The linear range of the XAR film was determined by
including a range ofhippocampal protein (0.5 to 3 fold) in each Western blot. Five
animals were used for each treatment group. Western blot experiments were repeated
three times for each antibody. Each blot contained tissue samples from SHAM and
either ADX, CT, and HCT treated animals, therefore, the IOD values for the ADX, CT,
and HCT groups were standardized to their respective SHAM values and reported as
% change from

S~

(SHAM= 0%). The results from three Western blot experiments

were averaged and a two-way analysis of variance was performed using ADX, CT, and
HCT treatment as one factor and G protein a.-subunit as another factor. The Student-
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Newman-Keuls method was used as the post-hoc test. To compare the effects of ADX,
CT, or HCT directly to the effects of SHAM treatment, the IOD of the G protein bands
on each Western blot were compared using a Student's I-test.

Immunohistochemical Procedure
The animals were sacrificed with a lethal injection of phenobarbital and perfused
with 200 ml PBS (IO mM Nal-IP04, pH 7.4, and I50 mM NaCl) via the aorta at 650

ml/h, followed by 250 ml PA fixative (4% paraformaldehyde, I% glutaraldehyde, 0.2%
picric acid, 2% sucrose, 0.1 M acetate buffer, pH 6.0) as described previously (Asano et

al., I 990; Okuhara et al., l 996c). After fixation, the brain was removed, blocked, and
placed in PA for 4-6 h. After rinsing and overnight incubation in TBS/I 0% sucrose, the
tissue was embedded in paraffin, sectioned at 7 µm, and mounted on microscope slides.
Immunohistochemical labeling of Gs and Go a-subunits was performed following
protocols described by Sternberger et al., (I 970). Briefly, tissue sections were blocked
with TBS/5% bovine

~rum

albumin (BSA)/3% normal goat serum (NGS) for I hour at

room temperature. After washing the sections with TBS, three times for 10 min each,
they were incubated with RMI diluted I: 50 or GC2 diluted I: I 00 overnight at room
temperature. Several

~ctions

were incubated with 2% NGS in place of primary

antibody to determine the level of nonspecific labeling. Sections were then washed with
TBS, three times for IO min each, and incubated with goat anti-rabbit IgG diluted I:20.
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After I h, sections were washed with TBS and incubated with rabbit peroxidaseantiperoxidase for I h. All antibody dilutions were made in TBS/5% BSA/3% NGS.
Immunohistochemical labeling of Gil and 2 a-subunits was performed with the Vectastain

Elite kit (Vector Laboratories, Inc., Burlingame, CA). Briefly, after blocking with NGS,
tissue sections were incubated overnight with AS7 diluted I :400. All sections were
washed in TBS and developed with hydrogen peroxide and DAB as the chromagen.
Each immunohistochemistry experiment was repeated once and analyzed
independently without knowledge of the treatment. The location of the antibody label
within the dorsal hippocampus was recorded for each slide. Three animals were used for
each treatment group.

Results
Corticosterone Plasma Levels
The mean plasma corticosterone levels were (mean± SD, n=3): 3.2 ± 4.2 µg/dl for
SHAM, 0 ± 0 for ADX, 3.1±1.5 for CT, and 25.1±6.4 for HCT. These corticosterone
levels are comparable to those reported previously by our laboratory (Beck et al., 1994;
1996; Bimstiel and Beck 1995) and other investigators (Reul and de Kloet, 1985;
Holmes et al., l 995a).
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Western Blots
On Western blots prepared with the membrane fraction from hippocampal tissue,
antibodies labeled the appropriate size bands (Okuhara et al., 1996c). The RMI
antibody labeled a 45 kDa and 54 kDa protein (Figure 19A) corresponding to the short
and long forms of the G1 a-subunit (Bray et al., 1986; Robinshaw et al., 1986; Kozasa et

al., 1988). Detection of the 54 kDa band was inconsistent. When the band was
detected, it was a faint and indistinct. The AS7 and GC2 antibodies labeled a 40 kDa
band (Figure 19A) corresponding to the appropriate size bands for

Gi1and2

and G0

a-subunits respectively (Goldsmith et al., 1987; Cooper et al., 1990).
The coefficient of variation (standard deviation+ mean) for the SHAM IOD values
were calculated for each antibody to determine the variability in the control data. The
mean coefficient of variation (mean± S.E.M, n = 9 for all antibodies) was 0.20 ± 0.05,
0.15 ± 0.01, and 0.14

*

0.02 for the AS7, GC2, and RMI antibodies respectively.

A two-way analysis of variance of the data indicated that corticosterone treatment
produced a significant effect (F = 11.3, P < 0.001) on G protein a-subunit levels. The
percent change in G protein a-subunit levels relative to SHAM was greater in tissue
from HCT treated animals compared to ADX (q = 6.390, p < 0.05) and CT (q = 5.037,
p < 0.05) based on Student-Newman-Keuls post hoc tests. In comparison to the SHAM
group, ADX treatment did not alter the levels of Gs, Gil and 2 and Go a-subunits. CT
treatment only increased G1 a-subunit levels. HCT treatment increased the levels of G1,
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FIGURE .19. Western blots of G protein a-subunits prepared from hippocampal
membrane fractions. A: Antibody labeling of G protein a-subunits. Lane 1, anti-Gs
(RMI). Lane 2, anti-Gi1and2 (AS7). Lane 3, anti-G0 (GC2). B: Antibody labeling of
G protein a-subunits isolated from five SHAM (S) and five HCT (HCT) animals.
G protein a-subunit subtype is indicated on the left.
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Gn and 2 and Go a-subunits when compared to SHAM (Figure 19B). Analysis of
Coomassie blue stained gels verified that equal amounts of protein were loaded into each
lane and that there were no overall changes in total protein levels. However, the
Coomassie stained gels revealed that HCT appeared to alter the protein levels for several
bands when compared to SHAM; some bands increased while others decreased (Figure

20). Based on the similar migration of the labeled bands, neither ADX, CT, or HCT
treatment appeared to alter G protein size. Figure 21 summarizes the results from three
different Western blot experiments for each G protein a-subunit antibody.

s

H

202 ....

133 ....
71 ....

41.8 ....

30.6 ....

Figure 20. Coomassie blue stained gel of tissue samples used for Western Blots. A
SDS-PAGE gel was prepared identically as in figure 19 and stained with Coomassie
blue. S, SHAM; H, HCT. Molecular weight markers are in the first lane on the left.

146

200
~
<(

J:
00

E

0

"-

150

*

100

*

*

Q)

C>

c:
cu
.c:

50

~
0

0

(.)

-50

x

1-x1-x101-u 01-u

~t>~

--~~

Go

Gs

Gi1 &2

Figure 21. Changes in G protein a-subunit levels with different corticosterone
treatments. The graph summarizes the results from three Western blot experiments
(mean± SEM), n = 3. ·The bars are grouped by G protein a-subunit subtype; G0 (open),
Gs (light stippled gray), and Gi1and 2 (dark stippled gray). Treatment group and G protein
a-subunit type is indicated along the x-axis.

* Significantly different from

SHAM, Students I-test, P < 0.05. SHAM is 0%.

Immunohistochemistry
While Western blot analysis can be used to detect a change in G protein levels,
changes in the location of G protein a-subunits within specific areas of the hippocampus
or in specific locations within neurons cannot be determined. Therefore, we used
immunohistochemistry techniques to address these questions. As reported previously,
the labeling pattern for the G protein a-subunits varied across subfields and among the
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different G proteins examined (Okuhara et al., 1996c). G, a-subunit labeling was
located in the cytosol of the soma in hippocampal subfields CAI-CA4 (Figure 22B). In
contrast to Gs, the labeling of Go a-subunits was located in the neuropil in subfields
CAI-CA4 (Figure 22D) and dentate gyrus (Figure 22F). Gii and 2 a-subunits labeling
was equally intense in the soma cytosol and neuropil. In control tissue sections, where
the primary antibody was omitted, nonspecific labeling was very faint and
distributed.evenly throughout the entire tissue section (data not shown). The distribution
of the G proteins among the various hippocampal subfields and their location within
neurons was not altered in any treatment group.

Discussion
G proteins couple plasma membrane receptors to intracellular effector molecules to
transduce extracellular signals into biochemical and physiological changes within a cell.
In the present study, we examined the effects of several chronic corticosterone

treatments on G protein a-subunit levels and distribution in the hippocampus. Chronic
basal concentrations of corticosterone increased G, a-subunit levels while higher
concentrations of corticosterone increased the a-subunit levels of Gs, Gi1 and 2 and Go as
detennined by Western blot analysis. None of the corticosterone treatments altered the
intracellular location of G proteins based on our immunohistochemistry results.
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Figure 22. Imunohistochemical labeling of G protein a-subunits and cresyl violet
staining of nissel bodies in the hippocampus. B: G, labeling in subfield CA3 in
sections from a SHAM animal. X200. Or, oriens layer; Py, pyramidal layer; rad, radiatum
layer. D: Cytoplasmic labeling of G1 in a pyramidal cell (arrow head). Or, oriens layer;
Py, pyramidal layer; rad, radiatum layer. G0 labeling in subfield CAI in sections from a
SHAM animal. X200. F: Go labeling in the dentate gyrus in sections from a ADX
animal. XIOO. g, granular layer. Panels A, C, and E are photomicrographs of cresyl
violet stained nissel bodies from similar tissue sections of subfields CA3, CAI, and
dentate gyros respectively.
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Adrenalectomy had no effect on G protein ct-subunit levels or distribution. Two other
studies examined the effects of corticosterone on G protein ct-subunit levels in the
hippocampus. The increase in Gs and Go ct-subunit levels that we observed with high
corticosterone concentrations was also reported by Wolfgang et al., (1995) using
animals subjected to restraint stress. Gannon et al., (1994) reported that neither
adrenalectomy nor corticosterone treatment altered the levels of Gs or Gi ct-subunits in
the hippocampus. We also observed no change in the a-subunit levels of Gi1 and 2 with
adrenalectomy or basal concentrations of corticosterone. We did detect an increase in
the ct-subunit levels of Gs with basal corticosterone concentrations and this increase may
not have been detected by Gannon due to important differences in the treatment .
paradigms. In Gannon's study, the animals were sacrificed at the peak of the diurnal
surge when both :MR and GR are occupied in the sham animals. In contrast, our animals
were sacrificed during the trough of the diurnal surge when only a small fraction of GR is
occupied. The time of sacrifice maybe a very important experimental parameter to take
into account since both GR and :MR mRN A levels show circadian variation (Holmes et

al., l 9995a).
The effects of glucocorticoids on G protein expression have been examined in other
tissue with various results. Adrenalectomy decreased Gi and increased Gs a-subunit
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levels in the rat aorta when compared to sham (Haigh et al., 1990). In the cerebral
cortex, corticosterone replacement decreased Gi and increased Gs a.-subunit levels when
compared to adrenalectomy (Saito et al., 1989). Finally, in the liver, dexamethasone
(which selectively activates GR) increased the a-subunit levels of both Gs and Gi (Kawai
and Arinze, (1993). It is clear from the various effects of glucocorticoids on G protein
levels in different tissue types that the effects of glucocorticoids are tissue specific.
Examining the effects of glucocorticoids on G protein levels may help to determine
the mechanism by which glucocorticoids modulate the responses associated with
different G protein-linked neurotransmitter receptors. For example, it is known that
glucocorticoids modulate neurotransmitter stimulated cAMP accumulation in both
periphery and central nervous systems (reviewed by Harrelson and McEwen, 1987). For
example, adrenalectomy increases NA stimulated cAMP accumulation in the limbic
forebrain and frontal cortex (Mobley and Sulser, 1980a,b). Adrenalectomy also increased
cAMP accumulation in response to vasoactive intestinal peptide but decreased the same
response to histamine (Harrelson et al., 1987). In the hippocampus, adrenalectomy
increased the NA stimulated cAMP accumulation (Roberts et al., 1984; Harrelson et al.,
1987) without altering '3-adrenergic receptor binding (Roberts et al., 1984) or forskolinstimulated adenylyl cyclase activity (Mobley et al., 1983; Harrelson et al., 1987; Gannon
and McEwen, 1990). The administration of corticosterone reversed the effects of
adrenalectomy in the hippocampus (Roberts et al., 1984) and cortex (Mobley et al.,
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1983) while even higher levels of corticosterone attenuated the NA response below
control levels in the hippocampus (Gannon and McEwen, 1990). We observed no
change in G protein a-subunit levels with ADX. Therefore, the glucocorticoid-induced
effects on NA stimulated cAMP accumulation are not occurring by directly altering
neurotransmitter receptor binding or G protein levels. Adrenalectomy may be altering
the coupling between signal transduction components.
Unlike the noradrenergic receptors, several studies have shown that glucocorticoids
modulate 5-HT IA receptor expression in the hippocampus. Despite some conflict on the
effects of glucocorticoids among the various subfields (reviewed by Chaouloff, 1995),
adrenalectomy appears to increase 5-HT IA receptor binding (Mendelsohn and McEwen,
l 992a,b; Chalmers et al., 1993; Kuroda et al., 1994; Tejani-Butt and Lablow, 1994;
Zhong and Ciaranello, 1995) and mRNA levels (Chalmers et al., 1993; Meijer and de
Kloet, 1994; Zhong and Ciaranello, 1995). The effects of adrenalectomy on 5-HT IA
expression and binding is reversed with corticosterone.
In the present study, ADX did not alter the a-subunit levels of Gi and Go, the
G proteins probably linked to the 5-HT IA receptor in subfield CA3 (Okuhara et al.,
1994). Therefore, neither the smaller EC 5o value nor the larger GTPyS evoked current
observed in cells from ADX treated animals reported in Chapter IV is due to changes in
Gi or G0 a-subunit levels. Furthermore, the HCT-induced increase in Gi or G0 a-subunit
levels observed in the present investigation also does not account for the larger EC 5o
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value or smaller GTPyS evoked current observed in cells from HCT treated animals
reported in Chapter IV. The increase in G protein a-subunit levels may be a
compensatory response to changes in the receptor signal transduction system. Therefore,
corticosteroids may be altering the 5-HT tA receptor signal transduction system by
modulating the kinetic properties of the potassium channel linked to the receptor,
coupling between the G protein and potassium channel, or G protein activity.
There are several reasons why changes in G protein levels and neurotransmitter
receptor responses may not coincide. Neurotransmitter receptors, G proteins, and
effector molecules are all targets for post-translational modifications, such as
phosphorylation (Bushfield et al., 1990; Akiho et al., 1993; Girault, 1993; Yamane and
Fung, 1993; Levitan, 1994; Morris et al., 1994; Siegelbaum, 1994; Levistre et al., 1995;
Neer, 1995; Pfeifer et al., 1995; Premont et al., 1995). Post-translational modifications
may alter the coupling of receptor, G proteins, and effector molecules and therefore their
ability to function (reviewed by Girault, 1993; Yamane and Fung, 1993; Levitan, 1994;
Siegelbaum, 1994; Neer, 1995; Premont et al., 1995). Future studies will address issues
of the phosphorylation state of the G protein signal transduction components.
Another reason why it is difficult to correlate changes in G protein levels with
changes in receptor-mediated responses is the potential interaction of the different
G protein subunits and effector molecules. It is clear the

~y-subunits

as well as
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a-subunits modulate the activity of the various adenylyl cyclase isoforms (reviewed by
Bimbaumer and Bimbaumer, 1995) and ion channel activity (Kofuji et al., 1995).
Although glucocorticoids do regulate '3-subunit levels in the rat aorta (Haigh et al.,
1990), adipocytes (Ros et al., 1989), and liver (Kawai and Arinze, 1993), they do not
regulate '3-subunit expression in the rat cortex (Saito et al., 1989. Glucocorticoid effects
on J3y-subunits in the hippocampus are not known.
In conclusion, G proteins are associated with a large number of biochemical and

physiological processes including hormone, neurotransmitter, and growth factor receptor
mediated responses. The steroid hormone corticosterone alters the responses of
neurotransmitter receptors which are linked to G proteins. In the present study, high
concentrations of corticosterone increased the G protein a-subunit levels of Gs, G0 , and
Giland 2 in the hippocampus. Our results provide important information towards
understanding how corticosterone modulates neurotransmitter receptor-mediated
responses in the hippocampus.

CHAPTER VII
DISCUSSION

Major Findings
The hippocampus contains the highest density of corticosteroid receptors in the
brain, which leads to the suggestion that corticosteroids may have a profound influence
on hippocampal signal processing. Previous investigations have demonstrated that
corticosteroids modulate hippocampal pyramidal cell membrane electrophysiological
characteristics and responses elicited by the activation of different neurotransmitter
receptors (Joels and de Kloet, 1992; Beck et al., 1994; Bimstiel and Beck, 1995; Beck

et al., 1996). However, these findings are limited to the cells in subfield CAI. The
effects of corticosteroids on neuron cell properties for other hippocampal regions (i.e.,
dentate gyrus and subiculum) and subfields (i.e., CA2 and CA3) are not known.
Information on the actions of corticosteroids in all regions of the hippocampus is
essential to determine how corticosteroids modulate signal processing in the
hippocampus. Therefore, it was the goal of this dissertation to examine the actions of
corticosteroids on cell membrane electrophysiological characteristics and the 5-HT IA
receptor signal transduction system in subfield CA3 pyramidal cells. There are two
basic hypotheses for this dissertation. First, corticosteroids influence cell membrane
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electrophysiological properties in subfield CA3 pyramidal cells. Second, corticosteroids modulate the response elicited by the activation of the 5-HT IA receptor.
Furthermore, corticosteroids modulate the 5-HT IA receptor-mediated response by
altering different components (i.e., receptor, G protein, potassium channel) of the
5-HT IA receptor signal transduction system.
One major finding of this dissertation is that chronic corticosteroid treatment
influenced pyramidal cell membrane electrical properties in subfield CA3. Corticosteroid treatment shifted the ratio of nonburst and burst firing neurons and the action
potential duration in subfield CA3. The effects of corticosteroids on the cell firing
mode and action potential duration are not likely to be due to changes in cell viability.
The cell membrane potential, resistance, and time constant were the same in all
treatment groups and similar to those reported in naive animals (Beck et al., I 992).
The effects of corticosteroids on the cell firing mode and action potential duration may
be secondary to changes in CA3 cell morphology. However, it unlikely that changes in
cell morphology would only affect the cell firing mode and action potential duration.
The alteration in cell firing pattern and action potential duration may have a
significant effect on the synaptically encoded signals sent from subfield CA3 to CAI.
Shifting the firing pattern of subfield CA3 cells represents a prominent and critical
change in the pattern of communication between subfields CAI and CA3. Further
experiments are required to determine the ion channels and mechanism underlying the
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corticosteroid-induced changes in cell firing pattern and action potential duration. It is
also important to determine if the ratio of burst and nonburst firing cells changes
during the diurnal surge of corticosteroids.
Another major finding of this disseration is that chronic corticosteroid treatment
altered the 5-HT concentration-response curve characteristics for the 5-HT IA receptor
on subfield CA3 pyramidal cells. Furthermore, corticosteroids altered the 5-HT IA
receptor signal transduction system at sites (i.e., G protein) downstream of the
receptor. The corticosteroid-induced changes in the 5-HT concentration-response
curve characteristics for the 5-HT IA receptor may be due to changes in G protein
function. The smaller EC 50 and greater Emax value observed in cells from ADX
treated animals was also accompanied by an increase in the current evoked by the
activation of G proteins with GTPyS . Similarly the larger EC 5o and smaller Emax
value observed in cells from HCT treated animals was accompanied by a decrease in
the current evoked by the activation of G proteins. However, the ADX- and HCTinduced effects are not directly due to changes in G protein Gi1and2 or Go a-subunit
levels. Based on Western blot analysis, ADX treatment had no effect while HCT
treatment increased Gi1and2 and Go a-subunit levels when compared to SHAM.
Based on these results, there are several possible mechanisms by which
corticosteroid treatment may be altering the 5-HT IA receptor system. Corticosteroids
may influence the kinetic properties of the potassium channel linked to the 5-HT IA
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receptor. Cortiocosteroid may also modulate G protein function by altering the
coupling between G protein and potassium channels, GTP hyrolysis, or the exchange
rate of GDP for GTP. These changes in G protein activity or ion channel kinetics may
occur through post-translational modification mechanisms (i.e., phosphorylation).
Based on the results from this dissertation and those previously reported by
collaborating colleagues (Beck et al., I994, I996), it can be concluded that
corticosteroids also modulate neural signal processesing in the hippocampus by
differentially modulating neuron membrane properties in subfields CA I and CA3.
Adrenalectomy and lvfR activation have opposite effects on action potential duration in
subfield CAI and CA3 cells. There was no difference in the 5-HT concentrationresponse curve characteristics for the 5-HT IA receptor in cells from SHAM and ADX
treated animals in subfield CAI. In contrast, the ECso value was shifted in cells from
ADX compared to SHAM treated animals in subfield CA3. The different effects of
corticosteroids on neuron membrane electrical properties in subfields CAI and CA3
further supports the critical roles that the different hippocampal subfields have on HP A
axis activity. One future study that may help to determine the roles ofhippocampal
subfields CA I and CA3 on HP A axis activity is examining the effects of stimulating
subfields CAI and CA3 in different treatment groups (i.e. HCT and lvfR) on
corticosterone plasma levels.
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Synaptic Activity
The new findings resulting from this dissertation work provide important
information on the action of corticosteroids on neural signal processing in the
hippocampus. Earlier investigations examined the action of corticosteroids on
synaptically driven field potentials in subfield CAI. Stimulating the Schaffer collaterals
arising from subfield CAJ pyramidal cells evokes action potentials in CA 1 pyramidal
cells that summate and produce a corresponding population spike (Andersen et al.,
1971). The population spike amplitude in subfield CAI is decreased in hippocampal
sections from adrenalectomized compared to adrenally-intact animals (Rey et al.,
1987a,b; Doi et al., 1991; Joels and Femhout, 1993). The adrenalectomy-induced
effect was reversed when the slice was perfused with basal physiological concentrations
of corticosterone. Consistent with the decrease in population spike amplitude, a study
using intracellular recording techniques reported that the probability for inducing
synaptically driven action potentials was decreased in adrenalectomized compared to
adrenally-intact animals (Joels and de Kloet, 1993). However, the decrease in firing
probability was not accompanied by a decrease in the excitatory postsynaptic potential
(EPSP) amplitude (Joels and de Kloet, 1993). Recently, it was demonstrated that the
EPSP and inhibitory postsynaptic potential (IPSP) both are decreased in cells from
adrenalectomized compared to adrenally-intact animals (Bimstiel and Beck, 1995).
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The decrease in population spike amplitude may be explained by the change in
pyramidal cell nonbursting to burst firing ratio observed in this dissertation work. A
shift in the pyramidal cell's firing pattern in subfield CA3 may decrease the population
spike amplitude evoked in subfield CAI. However, this is only a conjecture since the
relationship between subfield CA3 nonburst and burst firing cells with the EPSP and
population spike amplitude in CA I cells is not known.
Several important questions have developed from this dissertation. First, what are
the mechanisms underlying the shift in the ratio of nonburst to burst firing cells? Since
the current( s) underlying burst firing have not been fully characterized, this is a difficult
question to address. Second, how is the ratio of nonburst to burst firing cells in
subfield CA3 related to the population spike, or EPSP, recorded in subfield CAI?
Finally, does corticosteroid treatment also shift the ratio of nonburst to burst firing cells
in other regions of the hippocampus? The answers to these questions will provide
more insight into the mechanism by which corticosteroids alter neuronal signal
processing in the hippocampus.

Chronic Corticosteroid Treatment
Normally, plasma corticosteroid concentrations fluctuate according to circadian
rhythm or acute stress (reviewed by Dallman et al., I 987). However long-term
increases in plasma corticosteroid concentrations are observed during chronic stress
and senescence and are accompanied by changes in hippocampal physiology (Sapolsky
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1985; Sapolsky et al., 1985a, 1986; Stein-Behrens et al., 1994). Therefore,
investigators have focused on elucidating the mechanisms underlying the changes in
hippocampal physiology observed with long-term exposures to high corticosteroid
concentrations.
Briefly, chronically high levels of corticosteroids increase the vulnerability of
hippocampal CA3 neurons to cell damage (Sapolsky 1985; Sapolsky et al., l 985a;
Stein-Behrens et al., 1994). An alteration in Ca2+ homeostasis is proposed as one
factor that may increase the vulnerability of hippocampal CA3 neurons to cell damage.
Increasing the excitability of neurons may elevate intracellular Ca2 + concentrations
enough to damage a cell (Landfield and Eldridge, 1994). However, HCT treatment did
not selectively alter any of the cell membrane properties examined in this dissertation
work. Therefore, a two week chronic treatment with high concentrations of
corticosterone does not appear to lead to changes in membrane electrical properties
that influence neuron excitability in subfield CA3. The effects of HCT treatment on
Ca2+ homeostasis or isolated Ca2+ currents were not examined in this dissertation.

An increase in CA3 pyramidal cell excitability may occur from alterations in the
5-HT IA receptor-mediated response observed in this dissertation work. A decrease in
the maximum current elicited by the activation of 5-HT IA receptors was observed in
cells from HCT compared to SHAM treated animals. Physiologically, the HCTinduced change decreases the inhibitory response of CA3 pyramidal cells to 5-HT,
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which may lead to an increase in the cell's response to excitatory inputs. This question
may be addressed by using extracellular recording techniques and examining the effects
ofHCT treatment on the response ofCA3 cells to the stimulation of 5-HT inputs (i.e.,
raphe).

G protein-linked Receptor Signal Transduction System
Previous investigators have demonstrated that corticosteroids influence the
hippocampal 5-HT system in at least two ways. First, corticosteroids alter the response
elicited by the activation of either the 5-HT lA (Joels et al., 1991, Joels and de Kloet,
1992; Beck et al., 1996) or 5-HT 4 receptors (Birnstiel and Beck, 1995). Second,
corticosteroids modulate the number of 5-HT iA receptor binding sites and mRNA
expression (reviewed by Chaouloff, 1995). Based on the results from this dissertation
work, it was shown that corticosteroids also alter the 5-HT IA signal transduction
system at site(s) downstream from the receptor. This observation bears an interesting
question. Are other G protein-linked receptor signal transduction systems altered by
corticosteroids?
Similar to the results in this dissertation work, the

~-adrenergic

receptor-mediated

response in the hippocampus is also increased in adrenalectomized animals compared to
adrenally-intact animals. Adrenalectomy increases NA stimulated cAMP accumulation
(Roberts et al., 1984; Harrelson et al., 1987) without altering

~-adrenergic

receptor
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binding (Roberts et al., 1984) or forskolin-stimulated adenylyl cyclase activity (Mobley

et al., 1983 ~ Harrelson et al.,

1987~

Gannon and McEwen, 1990).

No changes in G protein a-subunit levels with ADX were observed in this thesis
work. Therefore, the adrenalectomy-induced effect on NA stimulated cAMP
accumulation is not occurring by directly altering neurotransmitter receptor binding or
G protein levels. Adrenalectomy may be altering the coupling between signal
transduction components. In support of this hypothesis, it was observed in this thesis
work that the ECso value for the 5-HT IA receptor-mediated response was smaller (i.e.
5-HT was more potent) in cells from ADX compared to SHAM animals. Furthermore,
the current elicited by the activation of G proteins with GTPyS was also greater in cells
from ADX compared to SHAM animals. Therefore, adrenalectomy may alter the
coupling or activity of signal transduction components downstream of the receptor for
either the

~-adrenergic

or 5-HT IA receptors.

The Hippocampus and HP A Axis Feedback
Finally, the results from this dissertation work provide some insight into how the
hippocampus processes its feedback signal to the HP A axis. :rv1R activation is
important for maintaining the cell's firing pattern, action potential duration, and
sensitivity to 5-HT in subfield CA3 pyramidal cells. Since :rv1R activation modulates
pyramidal cell characteristics as well as the 5-HT IA receptor-mediated response, the

164

activation of :MR. influences any input signals arriving at subfield CA3 cells.
In contrast, chronic activation of :MR. and GR together, had no selective effects on
cell membrane electrophysiological characteristics but did decrease the inhibitory
response of CA3 pyramidal cells to 5-HT. Therefore, the feedback signal from the
hippocampus during chronic :MR. and GR activation may depend on the attenuation of
5-HT mediated responses in the hippocampus.
This dissertation work has contributed new and important information towards
elucidating the mechanism by which corticosteroids modulate neural signal processing
in the hippocampus. It is now clear that corticosteroids have different effects on cell
membrane characteristics and 5-HT I..\ receptor-mediated responses in subfields CAI
and CA3. Furthermore the selective actions of corticosteroids in the hippocampus may
have important ramifications on the development of the HP A axis feedback signal and
hippocampus related behaviors.
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